EurekaMag PDF full texts Chapter 64,566

Fouquereau, N.; Chevalier, A. 2014: Rle du cahier des charges et de lvaluation de sites web sur leffet de conformit travers la gestion de contraintes et la qualit ergonomique de pages web. Revue Européenne de Psychologie Appliquée/European Review of Applied Psychology 64(4): 195-202

Minier, L.; Blaye, A.; Maugard, A.; Fagot, J.; Glady, Y.; Thibaut, J.-P. 2014: Rle du contrle excutif dans le raisonnement par analogie chez lenfant et le primate non humain. Psychologie Française 59(1): 71-87

Demain, A.; Karachi, C.; Le Douget, J.-E.; Da Silva, K.; Marchal, V.; Drevelle, X.; Fernandez-Vidal, S.; Bardinet, E.; Welter, M.-L. 2014: Rle du noyau sous-thalamique dans linitiation de la marche chez lhomme. Neurophysiologie Clinique/Clinical Neurophysiology 44(5): 496-497

Ben Othman, R.; Berriche, O.; Abdesselem, H.; Boumefteh, S.; Zameli, A.; Bhouri, S.; Amrouche, C.; Jamoussi, H.; Blouza, S. 2014: Rle possible de lhyperinsulinmie et de linsulino-rsistance dans la baisse des niveaux de vitamine D chez les patients obses. Annales D'endocrinologie 75(5-6): 453-454

Millet, P; Landel, Véréna; Virard, I; Morello, M; Féron, Fçois 2014: Rles bnfiques de la vitamine D sur la neurodgnrescence et les troubles mentaux. Cahiers de Nutrition et de Diététique 49(6): 279-293

Veil-Picard, M.; Viguier, J. 2014: Rles des instances : exemple de lINCa. Revue des Maladies Respiratoires Actualités 6(2): 71-73

Sachse, M Max; Fenchel, K; Wagner, G 2014: Rückbildung B-RAF-Inhibitor-assoziierter Keratoakanthome durch Acitretin - welche Auswirkungen haben Retinoide auf den RAF/MEK/ERK-Signalweg?. Jddg: Journal der Deutschen Dermatologischen Gesellschaft 12(8): 721-723

Gaulrapp, H. 2014: Rückenschmerz und LWS – Interdisziplinäres Praxisbuch entsprechend der nationalen Versorgungsleitlinie Kreuzschmerz. Fuß & Sprunggelenk 12(3): 173-174

Müller, T 2014: Rückenschmerz: Finger weg von Op. und Opioid!. Cme: Premium-Fortbildung für die Medizinische Praxis 11(4): 38-38

Sporn, H 2014: Rückfallanalyse und -bearbeitung bei Alkoholabhängigen. Psychotherapeut 59(4): 317-322

Buchwald, D. 2014: Rückfluss gut – alles gut. Zeitschrift für Herz-, Thorax- und Gefäßchirurgie 28(6): 428-429

Giese, T.; Bletzer, J.; Huber, J.; Maibaum, S. 2014: Rückkehr zum Leistungssport nach Elmslie-Trillat-Operation. Arthroskopie 27(2): 142-146

Hill, T 2014: Rüdiger Bittner on Autonomy. Erkenntnis 79(7 Suppl): 1341-1350

Babikov, Y L.; Mikhailenko, S N.; Barbe, A; Tyuterev, V G. 2014: S&MPO An information system for ozone spectroscopy on the WEB. Journal of Quantitative Spectroscopy and Radiative Transfer 145: 169-196

Satar, S; Açikalin, Aça; Akpinar, O; Koc, F; Sahan, M; Gulen, M; Icme, F; Topal, M; Ay, M O. 2014: S-100B Levels in Stroke Patients. Neurosurgery Quarterly 24(1): 87-90

Tanaka, H; Hirata, M; Shinonome, S; Wada, T; Iguchi, M; Dohi, K; Inoue, M; Ishioka, Y; Hojo, K; Yamada, T; Sugimoto, T; Masuno, K; Nezasa, K-ichi; Sato, N; Matsuo, K; Yonezawa, S; Frenkel, E P.; Shichijo, M 2014: S-222611, an oral reversible tyrosine kinase inhibitor of EGFR and HER2. A representative histological image of the colon treated with S-222611 (25 mg/kg). Cancer Science 105(8): August Cover-August Cover

Rungatscher, A.; Hallström, S.; Linardi, D.; Milani, E.; Gandhi, K.; Luciani, G.; Mazzucco, A.; Faggian, G. 2014: S-Nitroso Human Serum Albumin Vs Inhaled Nitric Oxide in Experimental Right Ventricular Failure on Prolonged Overcirculation-Induced Pulmonary Hypertension. Journal of Heart and Lung Transplantation 33(4): S309-S310

Yang, W; Little, C; Court, R 2014: S-Transform and its contribution to wind turbine condition monitoring. Renewable Energy 62: 137-146

Bolin, T B. 2014: S-XANES analysis of thermal iron sulfide transformations in a suite of Argonne Premium Coals: A study of particle size effects during pyrolysis. International Journal of Coal Geology 131: 200-213

Zou, K 2014: S-Zero Stack: A converted wave processing to extract subsurface density information. Geophysics 79(3): N1-N10

Khadivi-Khub, A; Zamani, Z; Fattahi, R; Wünsch, A 2014: S-allele diversity in Prunus L. Cerasus subgenus from Iran. Biochemical Systematics and Ecology 53: 1-7

Hsu, M-Hsiang; Chang, C-Jung 2014: S-doped ZnO nanorods on stainless-steel wire mesh as immobilized hierarchical photocatalysts for photocatalytic H2 production. International Journal of Hydrogen Energy 39(29): 16524-16533

Quinet, M; Kelecom, S; Raspé, O; Jacquemart, A-Laure 2014: S-genotype characterization of 13 North Western European pear (Pyrus communis) cultivars. Scientia Horticulturae 165: 1-4

Cachi, A M.; Wünsch, A 2014: S-genotyping of sweet cherry varieties from Spain andS-locus diversity in Europe. Euphytica 197(2): 229-236

Schmoock, C; Börnick, H; Vogel, M; Lehmann, F; Kutschke, S; Raff, J; Dittmar, T; Worch, E 2014: S-layer proteins as possible immobilization matrix for photocatalysts OH radical scavenging capacity and protein stability. Journal of Photochemistry and Photobiology A: Chemistry 277: 12-18

Roopa, S.; Narasimhan, S.V. 2014: S-transform based on analytic discrete cosine transform for timefrequency analysis. Signal Processing 105: 207-215

Chen, H-peng; Zhu, L-bao; Wang, Q-dong; Zhang, P; Yang, Y-hang 2014: S-wave velocity structure of the North China from inversion of Rayleigh wave phase velocity. Journal of Asian Earth Sciences 88: 178-191

Marriott, J.L.; Larson, I.; Costelloe, M.; Youmans, S.; Brock, T.; Edsall, P.; Holle, L.; Fitzgerald, J. 2014: SABER and MyDispense: Building better pharmacy education through innovation and sharing. Research in Social and Administrative Pharmacy 10(5): E65-E66

Li, X.Z.; Zhang, W.Y.; Sellmyer, D.J. 2014: SAED and HREM Studies of Zr2Co11 Intermetallic Compound. Microscopy and Microanalysis 20(S3): 242-243

Ho, W Shin; Khor, C Seong; Hashim, H; Macchietto, S; Klemeš, Jří Jaromír 2014: SAHPPA: a novel power pinch analysis approach for the design of off-grid hybrid energy systems. Clean Technologies and Environmental Policy 16(5): 957-970

Byun, I; Coleman, A W.; Kim, B 2014: SAM meets MEMS: reliable fabrication of stable Au-patterns embedded in PDMS using dry peel-off process. Microsystem Technologies 20(10-11): 1783-1789

Knopf, A 2014: SAMHSA report on Medicaid coverage shows gaps for MAT. Alcoholism and Drug Abuse Weekly 26(47): 5-6

Gil Posada, J Omar; Hall, P J. 2014: SANS characterization of porous magnesium for hydrogen storage. International Journal of Hydrogen Energy 39(16): 8321-8330

Kim, T-Hwan; Han, Y-Soo; Jang, J-Dae; Seong, B-Seok 2014: SANS study on self-assembled structures of Pluronic F127 triblock copolymer induced by additives and temperature. Journal of Applied Crystallography 47(1): 53-59

Veil-Picard, M.; Gagnadoux, F. 2014: SAOS, sommeil et mtabolisme glucidique. Revue des Maladies Respiratoires Actualités 6(2): 185-188

Planinsic, P; Singh, J; Gleich, D 2014: SAR Image Categorization Using Parametric and Nonparametric Approaches Within a Dual Tree CWT. IEEE Geoscience and Remote Sensing Letters 11(10): 1757-1761

Linlin Xu, ; Li, J; Yuanming Shu, ; Junhuan Peng, 2014: SAR Image Denoising via Clustering-Based Principal Component Analysis. IEEE Transactions on Geoscience and Remote Sensing 52(11): 6858-6869

WenSen Feng, ; Hong Lei, 2014: SAR Image Despeckling Using Data-Driven Tight Frame. IEEE Geoscience and Remote Sensing Letters 11(9): 1455-1459

Peng, Q; Zhao, L 2014: SAR Image Filtering Based on the Cauchy–Rayleigh Mixture Model. IEEE Geoscience and Remote Sensing Letters 11(5): 960-964

Xianxiang Qin, ; Shilin Zhou, ; Huanxin Zou, 2014: SAR Image Segmentation via Hierarchical Region Merging and Edge Evolving With Generalized Gamma Distribution. IEEE Geoscience and Remote Sensing Letters 11(10): 1742-1746

Dong Yang, ; Guisheng Liao, ; Shengqi Zhu, ; Xi Yang, ; Xuepan Zhang, 2014: SAR Imaging With Undersampled Data via Matrix Completion. IEEE Geoscience and Remote Sensing Letters 11(9): 1539-1543

Gong, M; Li, Y; Jiao, L; Jia, M; Su, L 2014: SAR change detection based on intensity and texture changes. Isprs Journal of Photogrammetry and Remote Sensing 93: 123-135

Hou, X; Zhang, L; Gong, C; Xiao, L; Sun, J; Qian, X 2014: SAR image Bayesian compressive sensing exploiting the interscale and intrascale dependencies in directional lifting wavelet transform domain. Neurocomputing 133: 358-368

Glentis, G-Othon; Zhao, K; Jakobsson, A; Abeida, H; Li, J 2014: SAR imaging via efficient implementations of sparse ML approaches. Signal Processing 95: 15-26

Yuan Zhang, ; Jinping Sun, ; Peng Lei, ; Wen Hong, 2014: SAR-Based Paired Echo Focusing and Suppression of Vibrating Targets. IEEE Transactions on Geoscience and Remote Sensing 52(12): 7593-7605

Kim, T-Sung; Park, K-Ae; Li, X; Hong, S 2014: SAR-derived wind fields at the coastal region in the East/Japan Sea and relation to coastal upwelling. International Journal of Remote Sensing 35(11-12): 3947-3965

Patricios, J.; Zondi, P. 2014: SASMA: happy to be 'hip', wary of being too 'hip happy'. British Journal of Sports Medicine 48(14): 1071-1072

D'Amico, A.; Galván, L.S.; Romero, J.; Arturi, V.; Collado, M.V.; Gόmez, G.; Spindler, A.; Rojas, G.; Fillippin, F.; Vita, L.; Cόrdova, R.; Panόpulos, A.; Khoury, M.C.; García, M.A.; Rodriguez, G.; Carosella, A.; Moreno, C.; Sarano, J.; Barreira, J.C. 2014: SAT0001Multicentric Study of Cognitive Impairment in Sle: the Ecles Study: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 590.1-590

Kikuchi-Taura, A.; Tsuji, S.; Ohshima, S.; Yura, A.; Katayama, M.; Watanabe, A.; Teshigawara, S.; Yoshimura, M.; Kudo-Tanaka, E.; Harada, Y.; Katada, Y.; Matsushita, M.; Kitatoube, A.; Hashimoto, J.; Saeki, Y. 2014: SAT0002Quantitative CD64 Molecules on Peripheral Blood Monocytes in Systemic Lupus Erythematosus (SLE). Annals of the Rheumatic Diseases 73(Suppl 2): 590.2-590

Yura, A.; Tsuji, S.; Kitatoube, A.; Kikuchi-Taura, A.; Katayama, M.; Watanabe, A.; Teshigawara, S.; Yoshimura, M.; Kudo-Tanaka, E.; Harada, Y.; Matsushita, M.; Katada, Y.; Ohshima, S.; Hashimoto, J.; Saeki, Y. 2014: SAT0003Quantitative Monocyte CD64 (MCD64) Expression is Useful Biomarker for Disease Activity in Systemic Lupus Erythematosus (SLE) Patients: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 590.3-591

Antovic, A.; Vikerfors, A.; Woodhams, B.; Adam, M.; Svenungsson, E. 2014: SAT0004Increased Levels of Thrombin Activatable Fibrinolysis Inhibitor - TAFI Correlate with Complement Activation in Patients with the Antiphospholipid Syndrome. Annals of the Rheumatic Diseases 73(Suppl 2): 591.1-591

Tolonen, J.; Häme, A.; Forss, N.; Harjola, V.-P.; Luosujärvi, R.; Mattila, J. 2014: SAT0005Sle Patients in Emergency. the Evaluation of SLE Patients in Helsinki University Central Hospital Emergency during 2003-2012. Annals of the Rheumatic Diseases 73(Suppl 2): 591.2-591

Askanase, A. 2014: SAT0006The Real (Rapid Evaluation of Activity in Lupus) Correlates Well with Bilag and Sledai. Annals of the Rheumatic Diseases 73(Suppl 2): 591.3-591

Gasparin, A.A.; Hendler, J.; Souza, L.; Chakr, R.; Moro, A.L.; Hax, V.; Zanchet, D.; Siqueira, I.; Palominos, P.E.; Brenol, C.; Kohem, C.; Xavier, R.; Brenol, J.C.; Monticielo, O.A. 2014: SAT0007Systemic Lupus Erythematosus: Survival Analysis in Patients Followed at A Tertiary Care Center in Southern Brazil. Annals of the Rheumatic Diseases 73(Suppl 2): 591.4-592

George, A.; Pope, J.E. 2014: SAT0008Low Socioeconomic Status (SES) as Measured by Education is (NOT) Associated with Worse Outcome in Sle: Data from the 1000 Canadian Faces of Lupus. Annals of the Rheumatic Diseases 73(Suppl 2): 592.1-592

Broder, A.; Blanco, I.; Vila, C.; Jonhston, C.; Neugarten, J. 2014: SAT0009The Prevalence and Patterns of Antiphospholipid Antibodies in SLE and Non-Sle Patients with END Stage Renal Disease: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 592.2-592

Meunier, B.; Harle, J.-R.; Chekroun, M.; Chiche, L. 2014: SAT0011Characteristics, Needs and Sources of Information of A French Online Community of Systemic Lupus Erythematosus Patients. Annals of the Rheumatic Diseases 73(Suppl 2): 593.1-593

Lauwerys, B.; Nieuwland Husson, S.; Maudoux, A.-L.; Badot, V.; Houssiau, F.A. 2014: SAT0012Serum Sil7r Concentrations Reflect Disease Activity in the Lupus Kidney. Annals of the Rheumatic Diseases 73(Suppl 2): 593.2-593

Koo, B. S.; Kim, Y. J.; Oh, J. S.; Hong, S.; Seo, W. J.; Kim, Y.- G.; Lee, C.- K.; Yoo, B. 2014: SAT0013 Lupus Enteritis: Clinical Characteristics and Risk Factors Associated with Recurrence. Annals of the Rheumatic Diseases 73(Suppl 2): 594-594

Huang, C.; Li, M.; Wang, Q.; Zhao, J.; Zeng, X. 2014: SAT0014 Registry of Pulmonary Arterial Hypertension in Chinese Patients with Systemic Lupus Erythematosus: 10-Years' Experience from A Single Center in China. Annals of the Rheumatic Diseases 73(Suppl 2): 594-594

Perricone, C.; Ceccarelli, F.; Gigante, A.; Massaro, L.; Barbano, B.; Spinelli, F.R.; Alessandri, C.; Cianci, R.; Valesini, G.; Conti, F. 2014: SAT0015Ultrasonographic Evaluation of Renal Arteries in Patients with Antiphospholipid Syndrome: Focus on Resistive Index and Stenosis: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 594.3-595

Gronwall, C.; Reynolds, H. R.; Buyon, J.; Kim, J.; Goldberg, J. D.; Silverman, G. J.; Clancy, R. M. 2014: SAT0016 Correlation of Carotid Intimal Plaque in SLE with Non-Traditional Serum Biomarkers. Annals of the Rheumatic Diseases 73(Suppl 2): 595-595

Nalli, C.; Iodice, A.; Andreoli, L.; Lojacono, A.; Motta, M.; Fazzi, E.; Tincani, A. 2014: SAT0018Neurodevelopmental Long Term Outcome in Children Born to Mothers with Systemic Lupus Erythematosus and Antiphospholipid Syndrome. Annals of the Rheumatic Diseases 73(Suppl 2): 595.3-596

Mok, C.C.; Chan, K.L.; Ho, L.Y. 2014: SAT0019Effect of Depressive/Anxiety Symptoms on Quality of Life and Work Disability in Patients with Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases 73(Suppl 2): 596.1-596

Mok, C.C.; Kosinski, M.; Jolly, M. 2014: SAT0020Cross Cultural Adaptation and Validation of Lupuspro in Southern Chinese Patients with Systemic Lupus Erythematosus: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 596.2-596

Baldini, C.; Luciano, N.; Sernissi, F.; Martini, D.; Francesco, F.; Gaia, T.; Mosca, M.; Bombardieri, S. 2014: SAT0021Prognostic Value of Salivary Gland Ultrasonography (SGUS) in Primary SjGren's Syndrome. Annals of the Rheumatic Diseases 73(Suppl 2): 596.3-597

Mendoza-Pinto, C.; García-Carrasco, M.; Méndez-Martínez, S.; Vallejo-Ruiz, V.; Taboada-Cole, A.; Pezzat-Said, E.; Rodríguez-Gallegos, A.; Munguía-Realpozo, P.; Reyes-Leyva, J.; Ruiz-Arguelles, A. 2014: SAT0022Lack of Association between Serum 25-Hydroxyvitamin D Concentrations and Cervical Human Papillomavirus Infection in Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases 73(Suppl 2): 597.1-597

Mavragani, C.P.; Fragoulis, G.E.; Tzioufas, A.G.; Moutsopoulos, H.M. 2014: SAT0023Clinical and Laboratory Predictors of Distinct Histological Classes of Lupus Nephritis-Can They Substitute the Renal Biopsy?. Annals of the Rheumatic Diseases 73(Suppl 2): 597.2-597

Miranda, D.; Angeles, U.; Jara, L.J.; Gomez, E.; Saavedra, M.A. 2014: SAT0024Mortality in Hospitalized Patients with Systemic Lupus Erythematosus and Hematologic Manifestations: A Case-Control Study. Annals of the Rheumatic Diseases 73(Suppl 2): 597.3-598

Tegzova, D.; Andelova, K.; Kucerova, I.; Madar, J.; Stejskal, J.; Vlasakova, V.; Figurova, E.; Kovarik, J.; Dostal, C. 2014: SAT0025Pregnancy Outcomes in A Cohort of Women with Sle. Long Term 20 Years Observation. Annals of the Rheumatic Diseases 73(Suppl 2): 598.1-598

Monova, D.; Monov, S. 2014: SAT0026Survival and Mortality Rates in Lupus Nephritis Patients. Annals of the Rheumatic Diseases 73(Suppl 2): 598.2-598

Roth, D.; Thompson, A.; Tang, T.; Hammer, A.; Molta, C. 2014: SAT0027Baseline Factors That PREDICT High Blys Levels (2 NG/ML) in Patients with Systemic Lupus Erythematosus: Data from the BLISS Trials. Annals of the Rheumatic Diseases 73(Suppl 2): 598.3-598

Hill, D.; Eudy, A.; Powell, M.; Fu, Q.; Petri, M. 2014: SAT0028Pregnancy Outcomes in Systemic Lupus Erythematosus: Experiences from A Single US Academic Medical Center Hopkins Lupus Pregnancy Cohort. Annals of the Rheumatic Diseases 73(Suppl 2): 599.1-599

Bartoloni, E.; Alunno, A.; Bistoni, O.; Caterbi, S.; Luccioli, F.; Santoboni, G.; Mirabelli, G.; Cannarile, F.; Terenzi, R.; Valentini, V.; Gerli, R. 2014: SAT0030Circulating Endothelial Microparticles and Endothelial Progenitors Cells in Primary SjGren's Syndrome: New Markers of Chronic Endothelial Damage?. Annals of the Rheumatic Diseases 73(Suppl 2): 599.3-600

Suzuki, Y.; Fujii, H.; Hamano, R.; Mizushima, I.; Yamada, K.; Kawano, M. 2014: SAT0031Clinicopathological Characteristics of Anti-Centromere Antibody- And/Or Anti-Ssa Antibody-Positive SjGren's Syndrome. Annals of the Rheumatic Diseases 73(Suppl 2): 600.1-600

Joo, Y.B.; Bang, S.-Y.; Lee, H.-S.; Bae, S.-C. 2014: SAT0032Assessment of the Accrual Clinical Manifestation, Organ Damage, and Disease Activity in 996 Korean Patients with Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases 73(Suppl 2): 600.2-600

Ye, Z.; Yin, Z.; He, W.; Luo, X. 2014: SAT0033The Clinical Application of Detection of Antinuclear Antibodies Spectrum Eighteen Items in Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases 73(Suppl 2): 600.3-601

Zhan, Z.; Chen, D.; Yuan, S.; Liang, L. 2014: SAT0034Assessment of Ovarian Reserve with Anti-MLlerian Hormone in Female Patients with Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases 73(Suppl 2): 601.1-601

Haraoui, B.; Jovaisas, A.; Bensen, W.; Faraawi, R.; Kelsall, J.; Dixit, S.; Rodrigues, J.; Sheriff, M.; Rampakakis, E.; Sampalis, J.S.; Lehman, A.; Otawa, S.; Nantel, F.; Shawi, M. 2014: SAT0035Impact of Corticosteroid Use on Remission Sustainability and Infection Rates among Rheumatoid Arthritis Patients in Remission While on Infliximab: Treatment Implications Based on A Real-World Population. Annals of the Rheumatic Diseases 73(Suppl 2): 601.2-601

Gabay, C.; Riek, M.; Hetland, M.; Hauge, E.M.; Pavelka, K.; Tomsic, M.; Canhao, H.; Chatzidionysiou, K.; van Vollenhoven, R.; Lukina, G.; Nordström, D.; Lie, E.; Ancuta, I.; Loza Santamaria, E.; van Riel, P.; Kvien, T. 2014: SAT0036Retention of Tocilizumab Therapy: A Comparison between Tocilizumab in Monotherapy and in Combination with DMARDS Based on the Tocerra Collaboration. Annals of the Rheumatic Diseases 73(Suppl 2): 601.3-602

van Schaardenburg, D.; Maksymowych, W.P.; Boers, M.; van Beers-Tas, M.H.; Marotta, A. 2014: SAT0037Serum 14-3-3Eta Predicts the Risk of RA Development and Its Higher Titres Are Associated with Higher Risk. Annals of the Rheumatic Diseases 73(Suppl 2): 602.1-602

Mcwilliams, D.F.; Walsh, D.A. 2014: SAT0038Factors Predicting Pain and Early Discontinuation of Tumour Necrosis Factor-Alpha-Inhibitors in People with Rheumatoid Arthritis: Results from the British Society for Rheumatology BIOLOGICS Register: Table 1:. Annals of the Rheumatic Diseases 73(Suppl 2): 602.2-602

Alemao, E.; Joo, S.; Allison, P.; Al, M.; Rutten-van Molken, M.; L'Italien, G.; Iannaccone, C.; Frits, M.; Shadick, N.; Weinblatt, M.; Liao, K. 2014: SAT0039Development and Validation of A Prognostic Clinical Model for RAPID Radiographic Progression in Patients with RA. Annals of the Rheumatic Diseases 73(Suppl 2): 603.1-603

Norli, E.S.; Lie, E.; Brinkmann, G.H.; Kvien, T.K.; Bjørneboe, O.; Nygaard, H.; Haugen, A.J.; Stolt, P.; Thunem, C.; Mjaavatten, M.D. 2014: SAT0040Remission without DMARDS in Patients Fulfilling the 2010 Classification Criteria for Rheumatoid Arthritis: the Impact of Duration of Joint Swelling. Annals of the Rheumatic Diseases 73(Suppl 2): 603.2-603

Boire, G.; Carrier, N.; de Brum-Fernandes, A.J.; Liang, P.; Masetto, A.; Gui, Y.; Murphy, M.; Maksymowych, W.P.; Marotta, A. 2014: SAT004114-3-3Eta Predicts Radiographic Progression in Recent-Onset Polyarthritis Patients. Annals of the Rheumatic Diseases 73(Suppl 2): 603.3-604

Castrejόn, I.; Dougados, M.; Combe, B.; Guillemin, F.; Fautrel, B.; Pincus, T. 2014: SAT0043Radiographic Progression of 5 of 448 Units over 1 Year in the ESPOIR French Multicenter Early Arthritis Cohort is Seen in Fewer than 15% of Patients, but More Likely in Patients not in Remission, with NO Differences According to 6 Remission Criteria. Annals of the Rheumatic Diseases 73(Suppl 2): 604.2-604

An, J.; Alemao, E.; Cheetham, T.; Reynolds, K.; Kawabata, H.; Solomon, D. 2014: SAT0044The Role of C-Reactive Protein or Erythrocyte Sedimentation Rate in Predicting Cardiovascular Outcomes in Rheumatoid Arthritis: Analysis of Data from US Managed Care Organization. Annals of the Rheumatic Diseases 73(Suppl 2): 605.1-605

Katayama, K.; Okubo, T.; Sato, T.; Fukai, R.; Abe, S.; Ito, H.; Kamishima, T. 2014: SAT0046Extensive MRI Osteitis is Associated with RAPID Radiographic Progression in Early but not Advanced Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 605.3-606

Ma, M.H.; Garrood, T.; Li, W.; Defranoux, N.; Kingsley, G.H.; Scott, D.L.; Cope, A.P. 2014: SAT0047Multi-Biomarker Disease Activity (Vectra DA Algorithm) Score is Associated with Power Doppler Ultrasound in Patients with Rheumatoid Arthritis in Low Disease Activity State: the Remira Cohort. Annals of the Rheumatic Diseases 73(Suppl 2): 606.1-606

Greenwald, M.; Ball, J.; Paulus, H. 2014: SAT0049Dermal Temperature to Identify Rheumatoid Arthritis Patients with Erosive Progressive Disease in Less than 1 Minute. Annals of the Rheumatic Diseases 73(Suppl 2): 607.1-607

Jurgens, M.; van der Goes, M.C.; Bakker, M.F.; Welsing, P.M.; Boers, M.; Bijlsma, J.W.; Lafeber, F.P.; Jacobs, J.W. 2014: SAT0051Alternative Ways to Analyze Remission: Applying the Conrew Score and Patient Vector Graph to Camera Trial II Data. Annals of the Rheumatic Diseases 73(Suppl 2): 607.3-608

Jani, M.; Chinoy, H.; Warren, R.B.; Fu, B.; Griffiths, C.E.; Morgan, A.W.; Wilson, G.; Hyrich, K.L.; Isaacs, J.D.; Barton, A. 2014: SAT0052Influence of Immunogenicity and Drug Levels on the Efficacy of Long-Term Treatment of Rheumatoid Arthritis with Adalimumab and Etanercept: A Uk-Based Prospective Study. Annals of the Rheumatic Diseases 73(Suppl 2): 608.1-608

Gärtner, M.; Alasthi, F.; Supp, G.; Mandl, P.; Smolen, J.; Aletaha, D. 2014: SAT0053Persistence of Subclinical Joint Activity in Rheumatoid Arthritis Joints. Annals of the Rheumatic Diseases 73(Suppl 2): 608.2-608

Khan, N.; Spencer, H.; Sokka, T. 2014: SAT0054Is Extended-Joint Count Better for Rheumatoid Arthritis Remission Assessment Compared to 28-Joint Count?:. Annals of the Rheumatic Diseases 73(Suppl 2): 609.1-609

Molano-Gonzalez, N.; Arcos-Burgos, M.; Rojas-Villarraga, A.; Anaya, J.-M. 2014: SAT0055Exploration of Risk Factors for Rheumatoid Arthritis Using Advance Recursive Partitioning Approach. Annals of the Rheumatic Diseases 73(Suppl 2): 609.2-609

Santos-Moreno, P.; Saavedra-Martinez, G.; Villarreal, L.; Palomino, A.; Giraldo, V.; Gomez, D.; Bello-Gualtero, J.; Tamer, L. 2014: SAT0057Cost Savings through Decreasing the Number of Eligible Patients for Biological Therapy Using A Treat to Target Strategy. Annals of the Rheumatic Diseases 73(Suppl 2): 610.1-610

van Vollenhoven, R.F.; Bolce, R.; Hambardzumyan, K.; Saevarsdottir, S.; Forslind, K.; Ernestam, S.; Petersson, I.F.; Sasso, E.H.; Hwang, C.C.; Segurado, O.G.; Geborek, P. 2014: SAT0058Using the Multi-Biomarker Disease Activity Score as a Complementary Inclusion Criterion for Clinical Trials in Rheumatoid Arthritis May Enhance Recruitment. Annals of the Rheumatic Diseases 73(Suppl 2): 610.2-610

Uhlig, T.; Norvang, V.; Lie, E.; Rødevand, E.; Mikkelsen, K.; Lexberg, Å. S.; Kalstad, S.; Kvien, T.K. 2014: SAT0060Best Chance of Achieving Remission in RA Patients with Very Short Disease Duration:. Annals of the Rheumatic Diseases 73(Suppl 2): 611.1-611

Nystad, T.W.; Fenstad, A.M.; Havelin, L.I.; Furnes, O.; Skredderstuen, A.K.; Fevang, B.-T.S. 2014: SAT0061Reduction in Joint Replacement Surgery in Patients with Reumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 611.2-612

Higuchi, T.; Nakamura, A.; Tanino, M.; Koyama, Y. 2014: SAT0062Association of Obesity with Rheumatoid Arthritis: the Visceral/Subcutaneous FAT Ratio Affects Disease Activity, Resistance to Methotrexate Treatment and the Expression of FAS Gene in Peripheral Blood. Annals of the Rheumatic Diseases 73(Suppl 2): 612.1-612

Kojima, T.; Takahashi, N.; Funahashi, K.; Asai, S.; Hirabara, S.; Hanabayashi, M.; Yoshioka, Y.; Yabe, Y.; Ishiguro, N. 2014: SAT0063Importance of Concomitant Methotrexate with TOCILIZUMAB and Assessment of Structual Damage for Achieving Better Clinical Outcomes for Rheumatoid Arthritis Patients with High Disease Activity: an Observational Cohort Study. Annals of the Rheumatic Diseases 73(Suppl 2): 612.2-612

Tsuchida, T.; Kubota, A.; Inoue, M. 2014: SAT0064Basic Clinical Conception of Remission in Patients with Rheumatoid Arthritis (RA) for Implementation of Treat to Target (T2T) Strategy: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 613.1-613

Jørgensen, T.; Kristensen, L.; Christensen, R.; Bliddal, H.; Lorenzen, T.; Hansen, M.; Østergaard, M.; Jensen, J.; Zanjani, L.; Laursen, T.; Butt, S.; Dam, M.; Lindegaard, H.; Espesen, J.; Hendricks, O.; Kumar, P.; Kincses, A.; Larsen, L.; Andersen, M.; Næser, E.; Jensen, D.; Grydehøj, J.; Unger, B.; Dufour, N.; Sørensen, V.; Vildhøj, S.; Hansen, I.; Raun, J.; Krogh, N.; Hetland, M. 2014: SAT0065Effectiveness and Drug Adherence of Biologic Monotherapy in Danish Rheumatoid Arthritis Patients: A Cohort Study of Clinical Practice in the Danbio Registry. Annals of the Rheumatic Diseases 73(Suppl 2): 613.2-614

Schwill, U.; Kordbarlag, C.; Reutermann, P.; Listing, J.; Zaenker, M. 2014: SAT0066Interrelationship between Rheumatoid Arthritis, Poverty and Education. Annals of the Rheumatic Diseases 73(Suppl 2): 614.1-614

Navarro-Compán, V.; Landewé, R.; Provan, S.A.; Ødegård, S.; Uhlig, T.; Kvien, T.K.; Keszei, A.P.; Ramiro, S.; van der Heijde, D. 2014: SAT0067Relationship between Types of Radiographic Damage and Disability in Patients with Rheumatoid Arthritis (RA) in the Euridiss Cohort: A Longitudinal Study: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 614.2-615

Povoroznyuk, V.; Karasevska, T.; Aubry-Rozier, B.; Povoroznyuk, R.; Dzerovych, N.; Hans, D. 2014: SAT0068Influence of Glucocorticoids on Trabecular Bone Score in Patients with Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 615.1-615

Rajagopalan, V.; Alemao, E.; Kawabata, H.; Solomon, D. 2014: SAT0069Performance of the Framingham Cardiovascular Risk Prediction Model with and without C-Reactive Protein or Erythrocyte Sedimentation Rate in RA: Analysis of US Electronic Medical Records Database. Annals of the Rheumatic Diseases 73(Suppl 2): 615.2-615

Bensen, W.G.; Thorne, C.; Baer, P.; Chow, A.; Arendse, R.; Baker, M.; Haraoui, B.; Jovaisas, A.; Sampalis, J.S.; Rampakakis, E.; Lehman, A.J.; Nantel, F.; Shawi, M.; Otawa, S. 2014: SAT0071Assessment of Rheumatoid Arthritis Disease Activity by Patients and Physicians: do Physicians Detect Improvement before the Patient Does?. Annals of the Rheumatic Diseases 73(Suppl 2): 616.1-616

El Miedany, Y.; El Gaafary, M.; Sayed, S.; Nasr, A.; Palmer, D. 2014: SAT0072Functional Disability: A Parameter Fit to BE A Biomarker for Inflammatory Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 616.2-616

El Miedany, Y.; El Gaafary, M.; Youssef, S.; Palmer, D. 2014: SAT0073 Physician VS Patient Global Assessment in Early Rheumatoid Arthritis: Putting the CART before the Horse. Annals of the Rheumatic Diseases 73(Suppl 2): 616-617

Nightingale, A.L.; Davidson, J.E.; Snowball, J.; Molta, C.T.; Kan, H.J.; McHugh, N.J. 2014: SAT0075Systemic Lupus Erythematosus (SLE) in UK Primary Care: Severity at Onset and Progression over Time Using the UK Clinical Practice Research Datalink. Annals of the Rheumatic Diseases 73(Suppl 2): 617.2-617

Nielsen, C.; Jöud, A.; Englund, M.; Björk, J.; Haglund, E.; Petersson, I.F. 2014: SAT0077Sickness Absence during the Ten-Year Period following Diagnosis in Swedish Patients with Different Subgroups of Spondyloarthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 618.2-618

Van Hoeven, L.; Vergouwe, Y.; Hazes, M.; Weel, A. 2014: SAT0078The Need to Perform an Impact Study before Using Referral Models for Axial Spondyloarthritis in Daily Practice:. Annals of the Rheumatic Diseases 73(Suppl 2): 618.3-619

Yoshimura, N.; Muraki, S.; Oka, H.; Tanaka, S.; Kawaguchi, H.; Nakamura, K. 2014: SAT0079Mutual Associations among Musculoskeletal Diseases, Metabolic Syndrome, and Cognitive Impairment: A 3-Year Follow-Up of the ROAD Study. Annals of the Rheumatic Diseases 73(Suppl 2): 619.1-619

Cheung, P.; de Wit, M.; Gossec, L. 2014: SAT0081Patient Involvement in Research is Widely Promoted but Practical Recommendations to Implement IT Are Heterogeneous: A Systematic Literature Review:. Annals of the Rheumatic Diseases 73(Suppl 2): 619.2-620

Macchioni, P.; Catanoso, M.; Boiardi, L.; Muratore, F.; Restuccia, G.; Chiarolanza, I.; Cavazza, A.; Luberto, F.; Salvarani, C. 2014: SAT0082Incidence and Survival of Biopsy-Proven GIANT Cell Arteritis in Northern Italy. Annals of the Rheumatic Diseases 73(Suppl 2): 620.1-620

Arendse, R.; Bensen, W.G.; Chow, A.; Rodrigues, J.; Dixit, S.; Sholter, D.; Baer, P.; Baker, M.; Choquette, D.; Fortin, I.; Jovaisas, A.; Rampakakis, E.; Sampalis, J.S.; Nantel, F.; Otawa, S.; Shawi, M.; Lehman, A.J. 2014: SAT0083Does Specific Joint Involvement in Rheumatoid Arthritis Patients PREDICT Patient Reported Outcomes? Implications for Clinical Practice. Annals of the Rheumatic Diseases 73(Suppl 2): 620.2-620

Sakalyte, R.; Arstikyte, I.; Venalis, A.; Butrimiene, I. 2014: SAT0084Incidence of Infectious Complications in Rheumatic Patients Treated with BIOLOGICS in Vilnius University, Rheumatology Centre. Annals of the Rheumatic Diseases 73(Suppl 2): 620.3-621

Moots, R.; Strand, V.; DiBonaventura, M.; Vasilescu, R.; Mahgoub, E.; Tang, B. 2014: SAT0085Burden of Rheumatoid Arthritis in Emerging and Developed Countries: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 621.1-621

Puchner, R.; Kaiser, W.; Tremetsberger, R.; Steininger, M.; Linkesch, F.; Janetschko, R.; Machold, K. 2014: SAT0086Rapid Access Rheumatology Consultation (RAC) an Office-Based Pilot Project. Annals of the Rheumatic Diseases 73(Suppl 2): 621.2-621

Rokutanda, R.; Haji, Y.; Kishimoto, M.; Min, C.; Ohara, Y.; Suyama, Y.; Shimizu, H.; Yamaguchi, K.; Takeda, A.; Matsui, Y.; Sasaki, S.; Okada, M. 2014: SAT0087Diagnostic Performance of Anti-Ccp Antibody at Annual Health CHECK Up. Annals of the Rheumatic Diseases 73(Suppl 2): 621.3-622

Nair, S.; Welsing, P. M.; Jacobs, J. W. G.; van Laar, J. M.; Rensen, W. H. J.; Wit, G. A. D.; Bijlsma, J. W. J.; Lafeber, F. P. J. G. 2014: SAT0088 Economic Evaluation of A Tight-Control Treatment Strategy Using an Imaging Device (HANDSCAN) for Monitoring Joint Inflammation in Early Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 622-622

Manrique-Arija, S.; Romero-Barco, C. M.; Ordonez-Canizares, M. C.; Urena, I.; Cano, L.; Jimenez-Nunez, F. G.; Nieves-Martin, L.; Mena-Vazquez, N.; Irigoyen, M. V.; Ponce, A.; Coret, V.; Belmonte-Lopez, M. A.; Rodriguez, M.; Fernandez-Nebro, A. 2014: SAT0089 Cost Minimization Observational Study after Dose Optimization in A Specialized Outpatient Clinic on Subcutaneous Biological Therapy. Annals of the Rheumatic Diseases 73(Suppl 2): 622-622

Fuegener, S.; Hoff, P.; Lang, A.; Gaber, T.; Rakow, A.; Simon, P.; Burmester, G.- R.; Perka, C.; Buttgereit, F. 2014: SAT0090 Analysis of Potential Risk Factors for Delayed Fracture-Healing. Annals of the Rheumatic Diseases 73(Suppl 2): 622-623

Leggett, S.; van der Zee-Neuen, A.; Boonen, A.; Beaton, D.; Verstappen, S. 2014: SAT0091 Towards A Patient Global Measure to Assess At-Work Productivity Loss in Patients with Inflammatory Arthritis and Osteoarthritis: A Qualitative Study. Annals of the Rheumatic Diseases 73(Suppl 2): 623-623

Park, S.- H.; Castrejon, I.; Choe, J.- Y.; Kim, S.- K.; Lee, H.- J.; Pincus, T. 2014: SAT0093 Association of Formal Education Level (EDUC) with Clinical Status in Korean Fibromyalgia (FM) Patients. Annals of the Rheumatic Diseases 73(Suppl 2): 624-624

Narayanan, S. 2014: SAT0094Relationship between the Duration of Rheumatology Practice Experience and Likelihood of Use and Perception towards Biosimilars in Rheumatoid Arthritis Arena. Annals of the Rheumatic Diseases 73(Suppl 2): 624.2-624

Verstappen, S.; Anderson, J.; Barton, A.; Hyrich, K. 2014: SAT0095Control of Disease Activity is Associated with Improvement in Physical Activity in Patients with Rheumatoid Arthritis: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 624.3-625

Cho, S.-K.; Sung, Y.-K.; Kim, D.; Won, S.; Choi, J.I.; Choi, C.-B.; Kim, T.-H.; Jun, J.-B.; Yoo, D.-H.; Bae, S.-C. 2014: SAT0096Safety of TNF Inhibitors and Predictors of Its Discontinuation in Elderly Patients with Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 625.1-625

Bartlett, S.J.; Bingham, C.O.; Choy, E.; Boire, G.; Haraoui, B.; Lin, D.; Pope, J.E.; Thorne, C.; Hitchon, C.A.; Tin, D.; Keystone, E.C.; Bykerk, V. 2014: SAT0097Assessing Significant Flares in Rheumatoid Arthritis: Validity of the Omeract Preliminary Flare Questionnaire (PFQ) in the Canadian Early Arthritis Cohort. Annals of the Rheumatic Diseases 73(Suppl 2): 625.2-625

Lindström, U.; Exarchou, S.; Sigurdardottir, V.; Sundström, B.; Askling, J.; Eriksson, J.K.; Forsblad d'Elia, H.; Turesson, C.; Kristensen, L.E.; Jacobsson, L. 2014: SAT0098Validity of Ankylosing Spondylitis and Spondyloarthritis Diagnoses in the Swedish National Patient Register. Annals of the Rheumatic Diseases 73(Suppl 2): 625.3-626

Kiltz, U.; Hiligsmann, M.; van der Heijde, D.; Braun, J.; Taylor, W.; Cieza, A.; Maksymowych, W.; Boonen, A. 2014: SAT0099Preferences of Patients with Spondyloarthritis for the Items of the ASAS Health Index: A Best Worst Scaling: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 626.1-626

Chowdhary, V.R.; Crowson, C.S.; Maradit-Kremers, H.; Davis, M.D.P. 2014: SAT0100Incidence of Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosuis in A Population Based Cohort from 1993-2005. Annals of the Rheumatic Diseases 73(Suppl 2): 626.2-626

Nagaraja, V.; Fox, D.A.; Francis, S.; Khanna, P.; Laing, T.; Marks, R.M.; Monrad, S.U.; Ognenovski, V.; Phillips, K.; Singer, O.; Khanna, D. 2014: SAT0102Interpretation of Patient Reported Outcomes Measurement Information System (PROMIS) by Rheumatologists. Annals of the Rheumatic Diseases 73(Suppl 2): 627.1-627

Gad El Haq, W.; Mahfoud, Z.; Aranki, G.; Hani, F.; Mandey, S.M.; Mook Kanamori, M.; AlEmadi, S.; Hammoudeh, M.; Masri, B.; Badsha, H.; Halabi, H.; Uthman, I.; Kazkaz, L.; Sahyboub, R.; Saxena, R.; Plenge, R.; Arayssi, T. 2014: SAT0103Variations in the Prescription Patterns of Physicians for Patients with RA across Several Arab States:. Annals of the Rheumatic Diseases 73(Suppl 2): 627.2-628

Peter, W.F.; Dekker, J.; Tilbury, C.; Tordoir, R.L.; Verdegaal, S.H.; Onstenk, R.; Bénard, M.R.; Vehmeijer, S.B.; Fiocco, M.; Vermeulen, E.M.; van der Linden-van der Zwaag, H.M.; Nelissen, R.G.; Vliet Vlieland, T.P. 2014: SAT0104Comorbidity in Patients with Osteoarthritis Undergoing Hip or Knee Replacement Surgery. Annals of the Rheumatic Diseases 73(Suppl 2): 628.1-628

Jin, X.; Ding, C.; Wang, X.; Antony, B.E.; Laslett, L.; Blizzard, L.; Jones, G. 2014: SAT0105Adiposity and Loss of Lean Mass Are Associated with Increased Knee Pain in Older Adults. Annals of the Rheumatic Diseases 73(Suppl 2): 628.2-629

Leung, Y.Y.; Teo, S.L.; Chua, M.B.; Raman, P.; Liu, C.; Chan, A.W. 2014: SAT0106Living Arrangements, Social Networks and Onset or Progression of Pain among Elderly in Singapore. Annals of the Rheumatic Diseases 73(Suppl 2): 629.1-629

Sung, Y.-K.; Cho, S.-K.; Kim, D.; Won, S.; Choi, J.I.; Choi, C.-B.; Kim, T.-H.; Jun, J.-B.; Yoo, D.-H.; Bae, S.-C. 2014: SAT0107Antinuclear Antibody Positivity in RA Patients and Its Impact on Persistency of TNF Inhibitors. Annals of the Rheumatic Diseases 73(Suppl 2): 629.2-629

Chalabi, Y.; Al Sawah, S.; Mettam, S.; Bushe, C. 2014: SAT0108A Systematic Review of Large Prospective Cohorts and Registries of Patients with Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases 73(Suppl 2): 629.3-630

Arida, A.; Zampeli, E.; Konstantonis, G.; Fragkiadaki, K.; Kitas, G.D.; Protogerou, A.D.; Sfikakis, P.P. 2014: SAT0109Accelerated Subclinical Atheromatosis, but not Arterial Stiffness or Hypertrophy, in Rheumatoid Arthritis Patients Free of Classical Risk Factors. Annals of the Rheumatic Diseases 73(Suppl 2): 630.1-630

Karatas, G.; Bal, A.; Yüceege, M.; Fırat, I.H.; Dulgeroglu, D.; Çakcı, A.; Ardıç, S. 2014: SAT0110Evaluation of Sleep Quality and the Effects of anti Tnf-Alpha Treatment on Sleep in Rheumatoid Arthritis Patients. Annals of the Rheumatic Diseases 73(Suppl 2): 630.2-630

Nampei, A.; Nagayama, Y. 2014: SAT0111Short Term Results of Total Elbow Arthroplasty Using Novel Linked Type Prosthesis in Rheumatoid Arthritis Patients. Annals of the Rheumatic Diseases 73(Suppl 2): 630.3-631

Rathbun, A.M.; Harrold, L.R.; Reed, G.W. 2014: SAT0112The Moderating Effects of Depression on Biologic Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 631.1-631

Kawassaki, A.M.; Pereira, D.A.S.; Kay, F.U.; Laurindo, I.M.M.; Carvalho, C.R.R.; Kairalla, R.A. 2014: SAT0113Pulmonary Involvement in Rheumatoid Arthritis: is There A Role for Low-Complexity Medical Tests?. Annals of the Rheumatic Diseases 73(Suppl 2): 631.2-631

Gherghe, A.M.; Dougados, M.; Combe, B.; Landewé, R.; Mihai, C.; Berenbaum, F.; Mariette, X.; Wolterbeek, R.; van der Heijde, D. 2014: SAT0114Prevalence of Cardiovascular Comorbidities Already Increased at Onset of Arthritis and Axial Spondyloarthritis - Results from the ESPOIR and DESIR Cohorts. Annals of the Rheumatic Diseases 73(Suppl 2): 631.3-632

Nutz, A.; Daien, C.; Barnetche, T.; Combe, B.; Morel, J. 2014: SAT0115Impact of TNF Inhibitor on Bone Mineral Density and Bone Turn over Markers in Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 632.1-632

Mantel, Ä.; Holmqvist, M.; Nyberg, F.; Tornling, G.; Frisell, T.; Alfredsson, L.; Askling, J. 2014: SAT0116What Drives the RAPID Increase in Risk of Acute Coronary Syndrome following RA Diagnosis?. Annals of the Rheumatic Diseases 73(Suppl 2): 632.2-632

Balabanceva, A.; Klyaritskaya, I.; Tkach, S.; Kuzenko, Y. 2014: SAT0117Reduction of Nsaid-Induced Small Intestinal Damage in Rheumatoid Arthritis Patients Receiving Sulfasalazine. Annals of the Rheumatic Diseases 73(Suppl 2): 633.1-633

Broder, A. 2014: SAT0118Using an Electonic Medical Record Decision Tool to Improve Cardiovascular Risk Screening in Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 633.2-633

Rollefstad, S.; Halvorsen, B.; Skarpengland, T.; Kvien, T.K.; Provan, S.A.; Semb, A.G.P. 2014: SAT0119Asymtptomatic Carotid Plaques in RA Patients is Associated with Increased HDL Function. Annals of the Rheumatic Diseases 73(Suppl 2): 633.3-633

Syngle, A.; Verma, I.; Krishan, P.; Garg, N. 2014: SAT0120Mediators of Autonomic Neuropathy in Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 633.4-634

Wahlin, B.; Meedt, T.; Jonsson, F.; Karp, K.; Henein, M.; Wållberg-Jonsson, S. 2014: SAT0122Prediction of Coronary Artery Calcification and Association with Inflammation in Rheumatoid Arthritis: A Follow-Up Study. Annals of the Rheumatic Diseases 73(Suppl 2): 634.2-635

Roubille, C.; Richer, V.; Starnino, T.; McCourt, C.; McFarlane, A.; Fleming, P.; Siu, S.; Kraft, J.; Lynde, C.; Pope, J.; Gulliver, W.; Keeling, S.; Dutz, J.; Bessette, L.; Bissonnette, R.; Haraoui, B. 2014: SAT0123 Evidence-Based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis and Psoriatic Arthritis: A Systematic Literature Search and Expert Opinion. Annals of the Rheumatic Diseases 73(Suppl 2): 635-635

Duquenne, C.; Cornec, D.; Marhadour, T.; Jousse-Joulin, S.; Cantagrel, A.; Pavy, S.; Devauchelle-pensec, V.; Saraux, A. 2014: SAT0124Lymphopenia in Early Arthritis: Impact on Diagnosis and Prognosis during the First 3 Years (Espoir Cohort). Annals of the Rheumatic Diseases 73(Suppl 2): 635.2-636

Gaujoux-Viala, C.; Rat, A.-C.; Guillemin, F.; Etcheto, A.; Dougados, M.; Fautrel, B. 2014: SAT0125Who are the Patients with Rheumatoid Arthritis with Worse than Death Scores on the Eq-5D? Results from the Comedra Study: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 636.1-636

Yukioka, C.; Nakahara, H.; Fusama, M.; Yukioka, K.; Kuroiwa, T.; Nakanishi, T.; Inoue, M.; Ohsawa, S.; Murata, N.; Takai, N.; Higashi, K.; Miura, Y.; Kuritani, T.; Maeda, K.; Sano, H.; Yukioka, M. 2014: SAT0126Correlation of Sleep Disturbance with Disease Activity, Psychological State, Self-Efficacy and Quality of Life in Patients with Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 636.2-636

Petsch, C.; Araujo, E.; Englbrecht, M.; Hueber, A.; Lell, M.; Schett, G.; Manger, B.; Rech, J. 2014: SAT0127Gout and RA: not Such A Rare Coexistence after All?. Annals of the Rheumatic Diseases 73(Suppl 2): 636.3-637

Lampropoulos, C.E.; Orfanos, F.; Bournia, V.-K.; Karatsourakis, T.; Mavragani, K.; Pikazis, D.; Manousakis, M.; Tzioufas, A.; Moutsopoulos, H.M.; Vlachoyiannopoulos, P.G. 2014: SAT0128Biologic Treatment is Associated with More Serious Adverse Reactions, Serious Infections and Admissions in Hospital than DMARDS in Patients with Rheumatoid Arthritis: A REAL World Study. Annals of the Rheumatic Diseases 73(Suppl 2): 637.1-637

Popescu, C.; BOJINCĂ, V.; OPRIŞ, D.; Ionescu, R. 2014: SAT0129Whole Body DXA Bone Tissue and Cardiovascular Risk in Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 637.2-637

Brown, M.; Kelly, C.; Nisar, M.; Arthanari, S.; Woodhead, F.; PriceForbes, A.; Middleton, D.; Dempsey, O.; Dawson, J.; Sathi, N.; Ahmad, Y.; Koduri, G.; Young, A.; Nikiphorou, E. 2014: SAT0130Rheumatoid Arthritis Related Interstitial Lung Disease is There an Association between Disease Modifying anti Rheumatic Drugs and Survival?. Annals of the Rheumatic Diseases 73(Suppl 2): 637.3-637

Solomon, D. H.; Reed, G. W.; Kremer, J. M.; Curtis, J.; Farkouh, M.; Harrold, L. R.; Hochberg, M.; Tsao, P.; Greenberg, J. D. 2014: SAT0131 Cumulative Disease Activity in Rheumatoid Arthritis and the Risk of Cardiovascular Events. Annals of the Rheumatic Diseases 73(Suppl 2): 637-638

Van Breukelen, D.; Castro Cabezas, M.; Klop, B.; de Vries, M.A.; van der Meulen, N.; van der Arend, J.; van de Geijn, G.-J.M.; Janssen, H.W.; van Casteren-Messidoro, C.; Birnie, E.; Hazes, M.J.; van Zeben, J. 2014: SAT0133Delayed Progression of Carotid Intima Media Thickness in Patients with Rheumatoid Arthritis: 1-Year Results of the FRANCIS Study. Annals of the Rheumatic Diseases 73(Suppl 2): 638.2-638

Pappas, D.A.; Lampl, K.; Kremer, J.M.; Radominski, S.C.; Gal, J.; Nyberg, F.; Malaviya, A.; Whitworth, A.; Rillo, O.L.; Gibofsky, A.; Popkova, T.V.; Ho, M.; Laurindo, I.; Reed, G.W.; Kerzberg, E.M.; Horne, L.; Zahora, R.; Saunders, K.C.; Pons-Estel, B.A.; Onofrei, A.U.; Greenberg, J.D. 2014: SAT0134Prevalence of Cardiovascular Risk Factors and Cardiovascular Disease in Rheumatoid Arthritis Patients across International Regions: A Comparison of the Corrona International and Corrona US Registries. Annals of the Rheumatic Diseases 73(Suppl 2): 639.1-639

Martín-Márquez, B.T.; Gomez, E.; Martínez García, E.; Nuñez Atahualpa, L.; Figueroa Sanchez, M.; Rocha Muñoz, A.D.; Gámez Nava, J.I.; Gόnzalez Lόpez, L.; Sanchez Hernandez, P.; Saldaña Millán, A.; Vazquez Del Mercado, M. 2014: SAT0135Low Levels of CD36 in Peripheral Blood Monocytes in Subclinical Atherosclerosis in Rheumatoid Arthritis: A Cross-Sectional Study of A Mexican Population. Annals of the Rheumatic Diseases 73(Suppl 2): 639.2-640

Ikdahl, E.; Rollefstad, S.; Olsen, I.C.O.C.; Kvien, T.K.; Hansen, I.J.W.; Soldal, D.M.; Haugeberg, G.; Semb, A.G. 2014: SAT0136Focus on Implementation of Cardiovascular Risk Factor Recording for Patients with Rheumatoid Arthritis in A Rheumatology Outpatient Clinic. Annals of the Rheumatic Diseases 73(Suppl 2): 640.1-640

Matianova, E.; Kosheleva, N.; Zemfira, A.; Evgeniy, N. 2014: SAT0137Effect of Rheumatoid Arthritis Activity in First Trimester of Pregnancy on the Disease during Gestation and Postpartum. Annals of the Rheumatic Diseases 73(Suppl 2): 640.2-640

Myasoedova, E.; Chandran, A.; Ilhan, B.; Major, B.; Matteson, E.L.; Crowson, C.S. 2014: SAT0138Cumulative Burden of Rheumatoid Arthritis Disease Severity Impacts Cardiovascular Disease Risk. Annals of the Rheumatic Diseases 73(Suppl 2): 640.3-641

Muslimova, E.V.; Yakupova, S.P.; Yakupov, E.Z.; Abdrakipov, R.Z. 2014: SAT0139Gender Differences in the Choice of Coping Strategies for Patients with Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 641.1-641

Loza, E.; Lajas, C.; Andreu, J.L.; Balsa, A.; Gonzalez-Alvaro, I.; Illera, O.; Jover, J.A.; Mateo, I.; Orte, J.; Rivera, J.; Rodríguez Heredia, J.M.; Romero, F.; Martínez Lόpez, J.A.; Ortiz, A.M.; Toledano, E.; Villaverde, V.; Carmona, L.; Castañeda, S. 2014: SAT0140Recommendations for Investigating and Managing Comorbidity in Rheumatoid Arthritis: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 641.2-641

Alvarez-Hernandez, E.; Marin, S. R.; Alvarez-Etchegaray, S. 2014: Sat0142 Comparison of the Patient's Assessment Measure (Radai) and the Physician's Assessment Measure (Das 28-Esr and Cdai) of Disease Activity in Rheumatoid Arthritis (Ra) in an Open Label Clinical Study. Annals of the Rheumatic Diseases 73(Suppl 2): 642-642

Stumbra Stumberga, E.; Stukena, I.; Erts, R.; Baltgaile, G. 2014: SAT0143Cardiovascular Events and Rheumatoid Arthritis in Latvia. Annals of the Rheumatic Diseases 73(Suppl 2): 642.2-642

Atzeni, F.; Ricci, C.; Meroni, L.; Scire', C.; Riva, A.; Galli, M.; Sarzi-Puttini, P. 2014: SAT0144Meta-Analysis of the Relationship between Rheumatoid Arthritis, Lung Disease and Biological and Non-Biological Drugs. Annals of the Rheumatic Diseases 73(Suppl 2): 642.3-642

Kim, G.-T.; Park, E.-K.; Lee, S.-G.; Baek, S.-H.; Kim, S.-H.; Lee, J.-H.; Lee, J.-W. 2014: SAT0145Increased Carotid Arterial Stiffness in Women with Rheumatoid Arthritis Assessed by Echo-Tracking Ultrasonography. Annals of the Rheumatic Diseases 73(Suppl 2): 643.1-643

Crepaldi, G.; Scirè, C.A.; Carrara, G.; Sakellariou, G.; Caporali, R.; Hmamouchi, I.; Dougados, M.; Montecucco, C. 2014: SAT0146Dissecting the Impact of Comorbidities on Disease Activity in Rheumatoid Arthritis: Ancillary Analysis from the COMORA Study: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 643.2-643

Mengi, G.; Gogus, F.; Beyazova, M. 2014: SAT0147Is IT Possible to Quantify Morning Stiffness Objectively?: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 643.3-644

Ozen, G.; Sunbul, M.; Atagunduz, P.; Direskeneli, H.; Tigen, K.; Inanc, N. 2014: SAT0148Cardiovascular Risk Estimation in Rheumatoid Arthritis: What is Missing in Traditional Risk Estimators?: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 644.1-644

Cawston, H.; Alemao, E.; Bourhis, F.; Hines, P.; Le, T.; Al, M.; Rutten-van Molken, M.; Solomon, D. 2014: SAT0149Performance of the Framingham Cardiovascular Risk Prediction Model with and without CRP in RA Patients: Analysis of UK Clinical Practice Research Data. Annals of the Rheumatic Diseases 73(Suppl 2): 644.2-644

Ito, H.; Hamamoto, Y.; Furu, M.; Hashimoto, M.; Fujii, T.; Ishikawa, M.; Yamakawa, N.; Terao, C.; Mimori, T.; Matsuda, S. 2014: SAT0150Prevalence of Forefoot Deformities in Patients with Rheumatoid Arthritis A Cross-Sectional Study from Kurama Cohort-. Annals of the Rheumatic Diseases 73(Suppl 2): 644.3-645

Kirillova, I.G.; Novikova, D.S.; Popkova, T.V.; Korsakova, Y.O.; Gorbunova, Y.N.; Markelova, E.I.; Volkov, A.V.; Kolmakova, D.S.; Karateev, D.E.; Nasonov, E.L. 2014: SAT0151Diastolic Dysfunction of the Left and Right Ventricles in Patients with Early Rheumatoid Arthritis Prior to Therapy with Basic Anti-Inflammatory Drugs: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 645.1-645

Van Den Oever, I.; Peters, M.; Lems, W.; Voskuyl, A.; van Schaardenburg, D.; Smulders, Y.; Boers, M.; Nurmohamed, M. 2014: SAT0152High Cardiovascular Risk in Patients with Rheumatoid Arthritis: is Screening Effective?. Annals of the Rheumatic Diseases 73(Suppl 2): 645.2-646

Ben Slama, I.; Allali, F.; El Kabbaj, S.; Lakhdar, T.; Medrare, L.; Ngeuleu, A.; Rkain, H.; Hajjaj-Hassouni, N. 2014: SAT0153Anxiety and Depression in Rheumatoid Arthritis: Which is More Frequent?. Annals of the Rheumatic Diseases 73(Suppl 2): 646.1-646

Cherif, I.; Hamdi, W.; Zouch, I.; Kaffel, D.; Kchir, M.M. 2014: SAT0154Correlation between Sleep Disturbance, Fatigue and Psychological Features in Patients with Rheumatoid Arthritis: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 646.2-646

Castrejόn, I.; Bergman, M.J.; Gibson, K.A.; Meyerhoff, J.; Luta, G.; Davoudzadeh, E.P.; Pincus, T. 2014: SAT0155Scores on the MDHAQ for Walk 2 Miles or 3 Kilometers, Poor Sleep and Participate in Recreation, Which Are not on the Haq, Indicate Poorer Status than Scores from the Haq: Data from the United States and Australia:. Annals of the Rheumatic Diseases 73(Suppl 2): 646.3-646

Morel, J.; Berthelot, J.M.; Constantin, A.; Debandt, M.; Gaudin, P.; Vittecoq, O.; Maillefert, J.F.; Meyer, O.; Pham, T.; Saraux, A.; Solau Gervais, E.; Spitz, E.; Wendling, D.; Guillemin, F.; Fautrel, B. 2014: SAT0156The Flare-RA (Flare in Rheumatoid Arthritis) Questionnaire is Able to Detect Disease Activity Increase, I.E., Flare, Occurring between 2 Visits to the Rheumatologist::. Annals of the Rheumatic Diseases 73(Suppl 2): 647.1-647

Park, J.; Park, Y.-B.; Lee, S.-K.; Lee, S.-W. 2014: SAT0157Concurrent Use of Methotrexate and Celecoxib Increases Risk of Silent Liver Fibrosis in Rheumatoid Arthritis Patients with Reduced Kidney Function: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 647.2-647

Vinicki, J.P.; Cintora, F.; Saad, A.; Berensztein, S.; Nasswetter, G. 2014: SAT0158Assessment of Systolic and Diastolic Cardiac Function by Tissue Echo Doppler in Ambulatory Patients with Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 647.3-648

Martínez-Morillo, M.; Zavala, R.; Granada, M.L.; Riveros-Frutos, A.; Rodríguez-Muguruza, S.; Sanint, J.; Holgado, S.; Olivé, A.; Mateo, L. 2014: SAT0159Inhibition of Adrenal Axis in Elderly Patients under Treatment with Low Dosis of Corticosteroids: Should We Supplement in Stressful Situations?. Annals of the Rheumatic Diseases 73(Suppl 2): 648.1-648

Paccou, J.; Renard, C.; Liabeuf, S.; Kamel, S.; Fardellone, P.; Massy, Z.; Brazier, M.; Mentaverri, R. 2014: SAT0160Coronary and Abdominal Aorta Calcification in Rheumatoid Arthritis: Relationships with Traditional Cardiovascular Risk Factors, Disease Characteristics and Concomitant Treatments. Annals of the Rheumatic Diseases 73(Suppl 2): 648.2-648

Zhu, J.; Zhou, Y.; Chen, X.; Li, J. 2014: SAT0161Serum Anti-Citrullinated Protein Antibody Positivity Increased the Risk of Rheumatoid Arthritis-Related Pulmonary Disease in Patients with Rheumatoid Arthritis: A Meta-Analysis. Annals of the Rheumatic Diseases 73(Suppl 2): 648.3-649

Soubrier, M.; Verny, M.-A.; Pereira, B.; Frayssac, T.; Couderc, M.; Malochet-Guinamand, S.; Tournadre, A.; Mathieu, S.; Dubost, J.-J. 2014: SAT0162Assessment of Subclinical Atherosclerosis (Flow Mediated Dilatation and Arterial Stiffness) after 24 Weeks of Tocilizumab Therapy in 22 Patients with Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 649.1-649

Robustillo-Villarino, M.; Alegre-Sancho, J.J.; Rodilla_Sala, E.; Gil-Latorre, F.; Martínez-Ferrer, À.; Ybañez-García, D.; Valls-Pascual, È.; De la Morena-Del Barrio, I.; Oller-Rodríguez, J.E.; Vicens-Bernabeu, E.; Vergara-Dangond, C.; Feced-Olmos, C.M. 2014: SAT0163Stratification of Cardiovascular Risk by Carotid Ultrasound in Patients with Rheumatoid Arthritis: Results of A Population from the EAST of Spain. Annals of the Rheumatic Diseases 73(Suppl 2): 649.2-649

Karaaslan, Y.; Doğan, I.; Şahin, K.; Yeşil, N. 2014: SAT0164How Many Patients Followed up with Rheumatoid Arthritis (RA) Diagnosis is Really Ra? 1987 ACR Classification Criteria Compared WTh 2010 Acr/Eular Criteria for REAL RA PatEnts in Turkey. Annals of the Rheumatic Diseases 73(Suppl 2): 649.3-650

Scharmga, A.; van Tubergen, A.; van den Bergh, J.; de Jong, J.; Peters, M.; van Rietbergen, B.; Geusens, P. 2014: SAT0165Cortical Breaks and Bone Erosions in the Hand Joints: A Cadaver Study Comparing Conventional Radiography with High-Resolution and Micro-Computed Tomography. Annals of the Rheumatic Diseases 73(Suppl 2): 650.1-650

Suzuki, A.; Okai, T. 2014: SAT0166Ultrasonographic Assessment of Newly Developed Elderly-Onset Rheumatoid Arthritis: A Comparison with Younger-Onset Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 650.2-650

Batticciotto, A.; Antivalle, M.; Ditto, M.C.; Varisco, V.; Rigamonti, F.; Talotta, R.; Battellino, M.; Ventura, D.; Atzeni, F.; Sarzi-Puttini, P. 2014: SAT0167Clinical and Ultrasonographic Evaluation in A Cohort of Sustained Remission Rheumatoid Arthritis Patients after Stopping Biologic Therapy: A Single Center Experience. Annals of the Rheumatic Diseases 73(Suppl 2): 650.3-651

Scheiman-Elazary, A.; Ranganath, V.K.; Ben-Artzi, A.; Duan, L.; Kafaja, S.; Borazan, N.H.; Woodworth, T.; Elashoff, D.; Clements, P.; Furst, D.E. 2014: SAT0168Validation of Musculoskeletal US of Hands and Wrists in Patients with Systemic Sclerosis. Annals of the Rheumatic Diseases 73(Suppl 2): 651.1-651

Musetescu, A.E.; Cojocaru-Gofita, I.; Vreju, F.; Florea, M.; Rosu, A.; Ciurea, P. 2014: SAT0169Ultrasound Evaluation of Ankle Joint in Rheumatoid Arthritis Patients with Clinical Remission and Low Disease Activity. Annals of the Rheumatic Diseases 73(Suppl 2): 651.2-651

Ficjan, A.; Husic, R.; Gretler, J.; Lackner, A.; Duftner, C.; Graninger, W.; Hermann, J.; Dejaco, C. 2014: SAT0170Ultrasound Composite Score for the Assessment of Inflammatory and Structural Pathologies in Psoriatic Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 651.3-652

Aga, A.-B.; Hammer, H.B.; Lie, E.; Olsen, I.C.; Uhlig, T.; van der Heijde, D.; Kvien, T.K.; Haavardsholm, E.A. 2014: SAT0171Inflammation in Early and Established RA: A Comparative Study of Different Ultrasonographic Joint Assessments. Annals of the Rheumatic Diseases 73(Suppl 2): 652.1-652

Aga, A.-B.; Hammer, H.B.; Olsen, I.C.; Uhlig, T.; van der Heijde, D.; Kvien, T.K.; Haavardsholm, E.A. 2014: SAT0172Prevalence of Ultrasonographic Joint Inflammation in Rheumatoid Arthritis (RA): A Comparative Study of 230 Early and 212 Established RA Patients Starting DMARD Treatment. Annals of the Rheumatic Diseases 73(Suppl 2): 652.2-653

Ustun, N.; Celik, M.; Kurt, M.; Sen, N.; Akcay, A.B.; Turhanoglu, A.D. 2014: SAT0173Assessment of Left Ventricular Dyssynchrony in Patients with Familial Mediterranean Fever. Annals of the Rheumatic Diseases 73(Suppl 2): 653.1-653

Ruaro, B.; Sulli, A.; Cannavale, T.; Cimmino, M.A.; Seriolo, B.; Cutolo, M. 2014: SAT0174Follow-Up of Digital Ulcers with Local Laser Speckle Contrast Analysis in Systemic Sclerosis Patients. Annals of the Rheumatic Diseases 73(Suppl 2): 653.2-653

Raffeiner, B.; Grisan, E.; Bernardi, L.; Botsios, C.; Ometto, F.; Coran, A.; Beltrame, V.; Ciprian, L.; Stramare, R.; Punzi, L. 2014: SAT0175Dynamic Automated Synovial Imaging (DASI) for Differentiating between Rheumatoid Arthritis and Simil-Rheumatoid Psoriatic Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 653.3-654

Stamenkovic, B.N.; Stankovic, A.M.; Nedovic, J.M.; Stojanovic, S.K.; Djordjevic, D.B.; Zivkovic, V.; Milenkovic, S. 2014: SAT0176Arthritis Might BE Useful in the Future to Select High Risk Patients for Systemic Inflammation and More Severe Disease- A Low Field MRI Study in Systemic Sclerosis. Annals of the Rheumatic Diseases 73(Suppl 2): 654.1-654

Pizzorni, C.; Ravera, F.; Smith, V.; Sulli, A.; Ferrari, G.; Cutolo, M. 2014: SAT0177Primary Raynaud's Phenomenon and Nailfold Videocapillaroscopy: Age-Related Changes in Capillary Morphology. Annals of the Rheumatic Diseases 73(Suppl 2): 654.2-654

Barnabe, C.; Marotte, H.; Scharmga, A.; Kraus, S.; Burghardt, A.; Hauge, E.-M.; Boutroy, S.; Toepfer, D.; Engelke, K.; Kocijan, R.; de Jong, J.; Li, X.; Stok, K.; Finzel, S. 2014: SAT0178Rheumatoid Arthritis Erosion Detection and Measurement in Longitudinal Datasets Using High-Resolution Peripheral Quantitative Computed Tomography (HR-PQCT): Reliability Exercise-2 (RELEX-2). Annals of the Rheumatic Diseases 73(Suppl 2): 654.3-655

Tani, C.; Carli, L.; Querci, F.; D'Aniello, D.; Possemato, N.; Cagnoni, M.; Delle Sedie, A.; Riente, L.; Vagnani, S.; Davide, C.; Bombardieri, S.; Mosca, M. 2014: SAT0179Mri Pattern of Arthritis in Sle: A Comparative Study with Rheumatoid Arthritis and Healthy Subjects. Annals of the Rheumatic Diseases 73(Suppl 2): 655.1-655

Hernández Díaz, C.; Robles-San Roman, M.; Vargas, A.; Lopez-Macay, A.; Santamaria Olmedo, M.G.; Lopez Reyes, A.G.; Pineda, C.; Ventura Rios, L. 2014: SAT0180Subclinical Inflammation in Rheumatoid Arthritis (RA) in Clinical Remission, Lack of Association between Cytokines Level and Ultrasound-Defined Synovitis:. Annals of the Rheumatic Diseases 73(Suppl 2): 655.2-655

Sumpton, D.J.; Weinholt, L.; Richards, B.; Youssef, P.; Adelstein, S. 2014: SAT0181: Antibodies to RO60 (SSA) Can We Use Them to Monitor Disease Activity?. Annals of the Rheumatic Diseases 73(Suppl 2): 655.3-656

Simon, D.; Faustini, F.; Englbrecht, M.; Kleyer, A.; Kocijan, R.; Haschka, J.; Kraus, S.; Hueber, A.J.; Sticherling, M.; Schett, G.; Rech, J. 2014: SAT0182Magnetic Resonance Imaging (MRI) of Hands of Psoriasis Patients: High Incidence of Inflammation. Annals of the Rheumatic Diseases 73(Suppl 2): 656.1-656

Vicente, E.; Pérez, S.; Chaparro, M.; Rodríguez-Salvanés, F.; Castañeda, S.; Gisbert, J.P. 2014: SAT0183High Prevalence of Ultrasonographic Enthesopathy in Patients with Inflammatory Bowel Disease without Clinical Signs or Symptoms of Spondyloarthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 656.2-656

Inanc, N.; Ozen, G.; Aydin, S. Z.; Kasapoglu, E.; Direskeneli, H. 2014: SAT0185 Assessment of Fifth Metatarsophalangeal Joint Erosion in Rheumatoid Arthritis by Ultrasonography. Annals of the Rheumatic Diseases 73(Suppl 2): 657-657

Golovach, I.; Vershynina, D.; Ryzhyk, V.; Dudij, P.; Mikhalchenko, E. 2014: SAT0186Bone Mineral Density as A Predictor of Early Erosive Lesions in Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 657.2-657

Martinez Cordellat, I.; Molina Almela, C.; Chalmeta Verdejo, I.; Ivorra Cortes, J.; Grau Garcia, E.; Feced Olmos, C.; Gonzalez Puig, L.; Negueroles Albuixech, R.; Nuñez-Cornejo Piquer, C.; Muñoz Guillen, M.L.; Alcañiz Escandell, C.; Valero Sanz, J.L.; Roman Ivorra, J.A. 2014: SAT0187Capillaroscopy: A Useful Tool for Identifying Primary Raynaud: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 657.3-658

Hurnakova, J.; Hanova, P.; Hulejova, H.; Zavada, J.; Klein, M.; Mann, H.; Sleglova, O.; Olejarova, M.; Forejtova, S.; Ruzickova, O.; Komarc, M.; Pavelka, K.; Senolt, L. 2014: SAT0188Serum Calprotectin (S100A8/9) Correlates with Clinical and Ultrasound Outcomes in Patients with Early Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 658.1-658

Piper, J.E.; Serafim, A.-S.R.D.S.; Ponte, C.; Singh, S.; Dasgupta, B.; Schmidt, W.; McNally, E.; Diamantopoulos, A.; Hutchings, A.; Luqmani, R. 2014: SAT0190A Diagnostic Protocol for GIANT Cell Arteritis (GCA) Using Ultrasound Assessment. Annals of the Rheumatic Diseases 73(Suppl 2): 658.3-659

Mendonça, J.A.; Nogueira, J.P.; Laurido, I.M.M.; Vierhout, C.; Peron, F.; Lyrio, A.M.; Schincariol, N.B.; Provenza, J.R.; Pedri, L.; Bonfiglioli, R. 2014: SAT0191Can Spectral Doppler Identify Nail Enthesitis in Psoriatic Arthritis?. Annals of the Rheumatic Diseases 73(Suppl 2): 659.1-659

Haschka, J.; Simon, D.; Rech, J.; Hueber, A.J.; Schett, G.; Kleyer, A. 2014: SAT0192In Vivo Detection of Cortical Micro Channels in Metacarpophalangeal Joints with Xtreme-Ct - A New Instrument to Visualize Communication between the Bone Marrow and the Joint Space. Annals of the Rheumatic Diseases 73(Suppl 2): 659.2-659

Bhamra, K.; Seymour, M.; Swales, C.; Taylor, P. 2014: SAT0193Utility of Ultrasound in the Nuffield Orthopaedic Centre Emergency Rheumatology Clinic: Survey of Clinical Effectiveness. Annals of the Rheumatic Diseases 73(Suppl 2): 659.3-660

Kilic, L.; Akdogan, A.; Karadag, O.; Kalyoncu, U.; Apras Bilgen, S.; Ertenli, I.; Kiraz, S. 2014: SAT0194Evaluation of Systemic Sclerosis Patients by Quantitative Sensory Testing for the Presence of Neuropathy. Annals of the Rheumatic Diseases 73(Suppl 2): 660.1-660

de Hooge, M.; Pialat, J.; Reijnierse, M.; van der Heijde, D.; Claudepierre, P.; Saraux, A.; Dougados, M.; Feydy, A. 2014: SAT0196Scoring of Spinal Lesions Compatible with Axial Spondyloarthritis on MRI in Clinical Practice by Local Radiologist or Rheumatologist in Desir; Comparison with Central Reading. Annals of the Rheumatic Diseases 73(Suppl 2): 660.3-661

Coutinho, M.; Duarte, C.; Ferreira, J.; Da Silva, J. 2014: SAT0197Ultrasound Guided Musculoskeletal Procedures under Peripheral Nerve Block: A Pilot Controlled Study in Rheumatic Patients. Annals of the Rheumatic Diseases 73(Suppl 2): 661.1-661

Montoro Alvarez, M.; Yew Chong, O.; Janta, I.; Serrano, B.; Mata, C.; Martinez, L.; Martinez-Barrio, J.; Hinojosa, M.; Bello, N.; Ovalles, J.; Nieto, J.; Valor, L.; Lopez-Longo, F.; Monteagudo, I.; Gonzalez, C.; Garrido, J.; Rosman, A.; Ing Soo, L.; Naredo, E.; Carreño, L. 2014: SAT0198Relation of Doppler Ultrasound Synovitis versus Clinical Synovitis with Changes in Native Complement Component Levels in Rheumatoid Arthritis Patients Treated with Biologic Disease-Modifying Antirheumatic Drugs:. Annals of the Rheumatic Diseases 73(Suppl 2): 661.2-661

Perez, M.O.; Aquila, L.; Medeiros, A.C.; Bonfiglioli, K.; Domiciano, D.; Guedes, L.N.; Gonçalves, C.R.; Laurindo, I.M.M. 2014: SAT0199Diagnosis of Early Rheumatoid Arthritis: is There A Best Classification Criteria?. Annals of the Rheumatic Diseases 73(Suppl 2): 661.3-662

Ishikawa, M.; Ito, H.; Furu, M.; Hashimoto, M.; Fuji, T.; Matsuda, S.; Mimori, T. 2014: SAT0200Clinical Application of the Soluble Lectin-Like Oxidized LDL Receptor-1 (SLOX-1) in Rheumatoid Arthritis: from Bench to Bedside. Annals of the Rheumatic Diseases 73(Suppl 2): 662.1-662

Witt, M.; Müller, F.; Leipe, J.; Proft, F.; Neumann, C.; Schulze-Koops, H.; Grunke, M. 2014: SAT0201The Relevance of Flexor Tendon Tenosynovitis to Small Joint Tenderness and Swelling: Data from A Prospective Early RA Cohort. Annals of the Rheumatic Diseases 73(Suppl 2): 662.2-662

Amengual, O.; Forastiero, R.; Sugiura-Ogasawara, M.; Oku, K.; Otomo, K.; Alves, J.; Favas, C.; Žigon, P.; Ambrožič, A.; Tomšič, M.; Ruiz-Irastorza, G.; Ruiz-Arruza, I.; Bertolaccini, M.L.; Norman, G.L.; Shums, Z.; Arai, J.; Atsumi, T. 2014: SAT0202International Multi-Centre Study to Evaluate the Clinical Significance of Phosphatidylserine-Dependent Antiprothrombin Antibodies for the Diagnosis of Antiphospholipid Syndrome. Annals of the Rheumatic Diseases 73(Suppl 2): 662.3-663

Roettger, D.; Vicente, J.; Hinton, M.; Kubassova, O.; Taylor, P. 2014: SAT0203A Novel Mri-Based Analysis Workflow for Spinal Lesions in Ankylosing Spondylitis. Annals of the Rheumatic Diseases 73(Suppl 2): 663.1-663

Bakker, P.; van den Berg, R.; de Hooge, M.; van Gaalen, F.; Reijnierse, M.; Huizinga, T.; van der Heijde, D. 2014: SAT0204Do Bone Marrow Edema Lesions in the Sacroiliac Joint Change into Fatty Lesions over A 1-Year Period in Patients with Axial Spondyloarthritis or Possible Spondyloarthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 663.2-664

Hanova, P.; Zavada, J.; Hurnakova, J.; Klein, M.; Olejarova, M.; Sleglova, O.; Senolt, L.; Komarc, M.; Pavelka, K. 2014: SAT0205 Potential of US 7 Score in Evaluating of Disease Activity of Patients with Rheumatoid Arthritis in the State of Remission. Annals of the Rheumatic Diseases 73(Suppl 2): 664-664

Brito Zeron, P.; Retamozo, S.; Bove, A.; Kostov, B.; Gheitasi, H.; Ligero, M. D. C.; Siso-Almirall, A.; Alos, L.; Ramos-Casals, M. 2014: SAT0206 Minimally-Invasive Technique for the Biopsy of Minor Salivary Glands: Searching for Systemic Infiltrative Diseases in Patients Presenting with SICCA Symptoms. Annals of the Rheumatic Diseases 73(Suppl 2): 664-664

Chakr, R.; Behar, M.; Mendonça, J.A.; Moro, A.L.; Zanchet, D.; Siqueira, I.; Hax, V.; Gasparin, A.; Palominos, P.; Kohem, C.; Brenol, C.; Monticielo, O.; Xavier, R.; Brenol, J.C.T. 2014: SAT0208Seven-Joint Power Doppler Ultrasound Score is Discordant to DAS28, SDAI and CDAI in Treatment Target Identification in Rheumatoid Arthritis Patients with Fibromyalgia. Annals of the Rheumatic Diseases 73(Suppl 2): 665.1-665

Mueller, R.; Kaegi, T.; Haile, S.R.; von Kempis, J. 2014: SAT0209The Clinical and Radiographic Course of Early Undifferentiated Arthritis under Treatment is not Dependent on the Amount of Erosions at Diagnosis. Results from the Swiss Prospective Observational Cohort. Annals of the Rheumatic Diseases 73(Suppl 2): 665.2-665

Kadavath, S.; Chittalae, S.; Nidal Shuaib, O.; Soon Goh, K.; Tosic, M.; Giles, J.; Efthimiou, P. 2014: SAT021114-3-3 ETA Protein: A Novel Biomarker for the Diagnosis of Rheumatoid Arthritis:. Annals of the Rheumatic Diseases 73(Suppl 2): 666.1-666

Falcao, S.; Castillo-Gallego, C.; Peiteado, D.; Branco, J.; Martín Mola, E.; de Miguel, E. 2014: SAT0212Can We Use Enthesis Ultrasound as an Outcome Measure of Disease Activity in Spondyloarthritis? A Study at Achilles Level. Annals of the Rheumatic Diseases 73(Suppl 2): 666.2-667

Guerin, A.; Saraux, A.; Cornec, D.; Gestin, S.; Bressollette, L.; Diallo, I.; Devauchelle-Pensec, V.; Quehe, P.; Marhadour, T.; Jousse-Joulin, S. 2014: SAT0213 Is Acoustic Radiation Force Impulse (ARFI) Quantification A Useful Noninvasive Method for Assessing Salivary Glands?. Annals of the Rheumatic Diseases 73(Suppl 2): 667-667

Lee, S. J.; Yoo, D. H.; Park, W.; Muller-Ladner, U.; Pyo, T. N. 2014: SAT0214 Statistical Evalution of Joint Damage Prgression in Patients with Rheumatoid Arthritis Treated with Infliximab or Biosimilar Infliximab (CT-P13) Anti-TNF Therapy: A Role of Sensitivity Analysis for Missing Data Evaluating Similarity. Annals of the Rheumatic Diseases 73(Suppl 2): 667-667

Krabbe, S.; Danielsen, M.A.; Østergaard, M.; Giard, M.-C.; Terslev, L. 2014: SAT0216Sensitivity and Specificity of Optical Spectral Transmission Imaging in Detecting Joint Inflammation in Rheumatoid Arthritis: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 668.1-668

Rashad, S.M.; Darwish, K.M.; Hassan, W.A.; Saad, S.A. 2014: SAT0217High Resolution Computed Tomography as A Diagnostic Determinant of Fibrotic Lung Changes in Connective Tissue Diseases. Annals of the Rheumatic Diseases 73(Suppl 2): 668.2-668

Woodworth, T.G.; Morgacheva, O.; Duan, L.; Pimienta, O.; Troum, O.; Barroso, N.; Ranganath, V.K.; Elashoff, D.; Furst, D.E. 2014: SAT0218Validating Responsiveness and Discrimination of the Rheumatoid Arthritis Magnetic Resonance Imaging SCORE (RAMRIS) A Meta-Analysis of Randomized Controlled Trials (RCTS) Identified in A Systematic Literature Review: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 669.1-669

Santiago, T.L.; Coutinho, M.; Salvador, M.J.; Del Galdo, F.; Redmond, A.; Da Silva, J. 2014: SAT0219Shear-Wave Elastography: A New Imaging Method for Evaluating Scleroderma Skin. Annals of the Rheumatic Diseases 73(Suppl 2): 669.2-669

Ohkawara, T.; Fujimoto, M.; Serada, S.; Naka, T. 2014: SAT0220Measurement of Serum Leucine-Rich Alpha-2 Glycoprotein, A Novel Disease Activity Biomarker in Rheumatoid Arthritis, for the Detection of Biologic-Associated Tuberculosis. Annals of the Rheumatic Diseases 73(Suppl 2): 670.1-670

Schmidt, W.A.; Schönau, V.; Reiche, B.E.; Ohrndorf, S.; Oberdorfer, P.D.; Backhaus, M. 2014: SAT0221Ultrasound Grading of Power Doppler Signals in Synovitis: Does IT Need an Update?. Annals of the Rheumatic Diseases 73(Suppl 2): 670.2-670

Győri, N.; Kisten, Y.; Rezaei, H.; Karlsson, A.; Romanus, C.; af Klint, E.; van Vollenhoven, R. 2014: SAT0223The Diagnostic Utility of Fluorescence Optical Imaging in Evaluating Synovitis of the Hands and Wrists. Annals of the Rheumatic Diseases 73(Suppl 2): 671.1-671

Gent, Y.; ter Wee, M.; den Uyl, D.; Voskuyl, A.; Hoekstra, O.; Lems, W.; van der Laken, C. 2014: SAT0224Macrophage Targeting by Positron Emission Tomography (PET) Imaging Detects Subclinical Synovitis in Hands and Wrists in Early RA Patients in Clinical Remission. Annals of the Rheumatic Diseases 73(Suppl 2): 671.2-671

Ortiz, A.M.; Rosario Lozano, M.P.; Martínez Fernández, C.; González-Άlvaro, I. 2014: SAT0225Is There A Difference in the Effectiveness in the Treatment of Rheumatoid Arthritis with Rituximab When Using A Dose of 1 or 2 Grams per Cycle? A Systematic Review. Annals of the Rheumatic Diseases 73(Suppl 2): 671.3-672

Burmester, G.; Blanco, R.; Keiserman, M.; Rigby, W.; van Vollenhoven, R.F.; Dimonaco, S.M.; Grzeschik, S.M.; Mitchell, N. 2014: SAT0226Tocilizumab (TCZ) as Combination Therapy and as Monotherapy VS Methotrexate (MTX) in MTX-Naive Patients with Early Rheumatoid Arthritis: Patient-Reported Outcomes (PROS) from A Randomized, Placebo-Controlled Trial. Annals of the Rheumatic Diseases 73(Suppl 2): 672.1-672

Nüβlein, H.; Alten, R.; Galeazzi, M.; Lorenz, H.-M.; Nurmohamed, M.; Bensen, W.; Burmester, G.-R.; Peter, H.-H.; Pavelka, K.; Chartier, M.; Poncet, C.; Rauch, C.; Le Bars, M. 2014: SAT0227Two-Year Retention and Effectiveness of IV Abatacept Monotherapy and Combination in PTS with RA Previously Treated with at Least One Biologic Agent in A Real-Life Setting: Subgroup Analysis from the Action Study. Annals of the Rheumatic Diseases 73(Suppl 2): 672.2-673

Ancuta, I.; Codreanu, C.; Ionescu, R.; Balanescu, A.; Rezus, E.; Suta, M.; Ciurea, P.; Milicescu, M.; Nemes, D.; Ancuta, C.; Bojinca, M.; Parvu, M.; Popoviciu, H. 2014: SAT0228Sustained Clinical Benefit with Multiple Courses of Rituximab in Second Line for ALL Rheumatoid Arthtritis Patients Irrespective to the Inhibitor of Tumour Necrosis Factor Previously Used: 3-Year Data from REPEAT Study. Annals of the Rheumatic Diseases 73(Suppl 2): 673-673

Chatzidionysiou, K.; Lie, E.; Nasonov, E.; Lukina, G.; Hetland, M.L.; Tarp, U.; Pavelka, K.; Gabay, C.; Nordström, D.C.; Canhão, H.; Tomsic, M.; van Riel, P.L.; Gomez-Reino, J.; Ancuta, I.; Kvien, T.K.; van Vollenhoven, R.F. 2014: SAT0229Effectiveness of Repeated Courses of Rituximab in RA Results from the Cererra Collaboration. Annals of the Rheumatic Diseases 73(Suppl 2): 674.1-674

Silva-Fernandez, L.; Lunt, M.; Watson, K.D.; Dixon, W.G.; Control Centre Consortium, B.; Symmons, D.P.; Hyrich, K.L. 2014: SAT0230The Influence of Anti-TNF or Rituximab on Cancer Incidence in Patients with Rheumatoid Arthritis Who Have HAD A Prior Malignancy:. Annals of the Rheumatic Diseases 73(Suppl 2): 674.2-674

Sala, L.; Arredondo, M.; Llorente, I.; Tomero, E.; Lopez Bote, J.P.; García de Vicuña, R.; Gonzalez, I.; Άlvaro Gracia, J.M. 2014: SAT0231Analysis of Monotherapy with BIOLOGICS in Rheumatoid Arthritis in Daily Clinical Practice. Annals of the Rheumatic Diseases 73(Suppl 2): 674.3-675

Galeazzi, M.; Bazzichi, L.; Sebastiani, G.; Neri, D.; Giovannoni, L.; Bacchion, F.; Wilton, J.; Garcia Gonzalez, E.; Ruffini, P.; Bardelli, M.; Baldi, C.; Selvi, E.; Minisola, G.; Caporali, R.; Prisco, E.; Bombardieri, S. 2014: SAT0232A Phase IB Clinical Trial in Rheumatoid Arthritis of Dekavil (F8-IL10), A Novel Anti-Inflammatory Immunocytokine. Annals of the Rheumatic Diseases 73(Suppl 2): 675-676

Hochberg, M.; Janssen, K.; Broglio, K.; Walsem, A. V.; Nadkarni, A. 2014: SAT0233 Comparison of Abatacept and Other Biologic DMARDS for the Treatment of Rheumatoid Arthritis Patients: A Systematic Literature Review and Network Meta-Analysis. Annals of the Rheumatic Diseases 73(Suppl 2): 676-676

Höhle, M.; Maas, R. 2014: SAT0235Bone Mineral Density under Tolicizumab Therapy Results of A Prospective 5-Year Analysis. Annals of the Rheumatic Diseases 73(Suppl 2): 676.3-677

Truchetet, M.-E.; Poursac, N.; Barnetche, T.; Shipley, E.; Bannwarth, B.; Richez, C.; Schaeverbeke, T. 2014: SAT0236Maintenance and Efficacy of Abatacept Monotherapy Compared to Abatacept + Conventional Synthetic DMARD in Patients with Rheumatoid Arthritis: Data from ORA Registry. Annals of the Rheumatic Diseases 73(Suppl 2): 677.1-677

Hanabayashi, M.; Kojima, T.; Takahashi, N.; Kida, D.; Funahashi, K.; Hirabara, S.; Asai, S.; Yoshioka, Y.; Ishiguro, N. 2014: SAT0237The Clinical Efficacy and Safety of Abatacept for Rheumatoid Arthritis from Japanese Multi-Center Registry: 2-Year Outcomes. Annals of the Rheumatic Diseases 73(Suppl 2): 677.2-677

Scarsi, M.; Colombo, E.; Piantoni, S.; Ottaviani, R.; Allegri, F.; Tincani, A.; Airò, P. 2014: SAT0240IL-22 Levels after Abatacept Treatment in Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 678.3-679

Takahashi, N.; Kojima, T.; Funahashi, K.; Hanabayashi, M.; Hirabara, S.; Asai, S.; Ishiguro, N. 2014: SAT0243Impact of Concomitant Methotrexate on the Enhanced Clinical Efficacy of Abatacept after 24 Weeks in Rheumatoid Arthritis Patients. Annals of the Rheumatic Diseases 73(Suppl 2): 680.1-680

Alten, R.; Nüβlein, H.; Galeazzi, M.; Lorenz, H.-M.; Nurmohamed, M.; Bensen, W.; Burmester, G.-R.; Peter, H.-H.; Pavelka, K.; Chartier, M.; Poncet, C.; Rauch, C.; Le Bars, M. 2014: SAT0245Decreased Use of Glucocorticoids in PTS with RA Who Initiated IV Abatacept and Previously Failed at Least One Biologic Agent: Results from the 2-Year Action Study. Annals of the Rheumatic Diseases 73(Suppl 2): 681.1-681

Faraawi, R.; Malik, S.; Roth, K. 2014: SAT0247 Safety of RAPID Rituximab Infusion in Rheumatoid Arthritis in A Single Community Practice. Annals of the Rheumatic Diseases 73(Suppl 2): 682-682

Smith, R.; Cole, Z.; Coy, A.; Carvalho, S. 2014: SAT0248Biologic Therapy Improves the Number of Patients Who Maintain Employment and Improves Their Overall Function. Annals of the Rheumatic Diseases 73(Suppl 2): 682.2-682

Provan, S.A.; Berg, I.J.; Semb, A.G.; Mathiessen, A.; Hammer, H.B.; Kvien, T.K. 2014: SAT0250Cardiovascular Risk Predictors under Non-Tnf Biological DMARD Treatment. A 12-Month Longitudinal Study. Annals of the Rheumatic Diseases 73(Suppl 2): 683.1-683

Manders, S.; Kievit, W.; Adang, E.; Brus, H.; Bernelot Moens, H.; Hartkamp, A.; Schilder, A.; Vonkeman, H.; Brouwer, E.; Westhovens, R.; Visser, H.; van de Laar, M.; van Riel, P. 2014: SAT0253Cost-Effectiveness of Abatacept, Rituximab or A TNFI after Failure of the First TNFI Treatment in RA: Results of A Multi-Centered Pragmatic RCT in the DREAM Registry. Annals of the Rheumatic Diseases 73(Suppl 2): 684.2-684

Daniluk, S.; Skrumsager, B. K.; Leszczynski, P. 2014: SAT0254 Safety and Tolerability of the Anti-C5ar Humanised Monoclonal Antibody NNC0151-0000 in Patients with Rheumatoid Arthritis: A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Trial. Annals of the Rheumatic Diseases 73(Suppl 2): 684-685

Huizinga, T. W.; Conaghan, P. G.; Martin-Mola, E.; Schett, G.; Amital, H.; Xavier, R. M.; Troum, O.; Aassi, M.; Bernasconi, C.; Dougados, M. 2014: SAT0255 Clinical and Radiographic Outcomes at 2 Years and the Effect of TOCILIZUMAB Discontinuation following Sustained Remission in the Second and Third Year of the ACT-RAY Study. Annals of the Rheumatic Diseases 73(Suppl 2): 685-685

Born, T.; Fung, V. 2014: SAT0256Analytical and Functional Assessments When Developing Biosimilar Candidates. Annals of the Rheumatic Diseases 73(Suppl 2): 685.2-686

Varisco, V.; Viganò, M.; Batticciotto, A.; Lampertico, P.; Marchesoni, A.; Gibertini, P.; Pellerito, R.; Rovera, G.; Caporali, R.; Todoerti, M.; Covelli, M.; Notarnicola, A.; Sarzi-Puttini, P. 2014: SAT0258Low Risk of Hepatitis B Virus Surface Antigen Seroreversion in Hbsag Negative, Anti-Hbc Positive Carriers Undergoing Rituximab for Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 686.2-687

Ruiz-Esquide, V.; González-Navarro, A.; Yagüe, J.; Ramírez, J.; Hernández, M.V.; Cabrera-Villalba, S.; Inciarte-Mundo, J.; Cañete, J.D.D.; Sanmarti, R. 2014: SAT0259Serum Levels of TOCILIZUMAB and Its Relationship with Disease Activity and Drug Dosage in Patients with Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 687.1-687

Horai, Y.; Takatani, A.; Nishino, A.; Nakashima, Y.; Suzuki, T.; Fujikawa, K.; Tsukada, T.; Tsuboi, M.; Matsuoka, N.; Migita, K.; Aramaki, T.; Ueki, Y.; Kawashiri, S.-Y.; Iwamoto, N.; Ichinose, K.; Tamai, M.; Nakamura, H.; Origuchi, T.; Kawakami, A. 2014: SAT0261Abatacept is A Suitable Biologic Disease Modifying Anti-Rheumatic Drugs in Patients with Anti-Ss-A Antibodies-Positive Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 687.3-688

Hattori, Y.; Kaneko, A.; Kida, D.; Takahashi, N.; Ishikawa, H.; Kanda, H.; Sato, T.; Kojima, T.; Ishiguro, N. 2014: SAT0262Comparison of Serum Matrix Metalloproteinase-3 Levels in Rheumatoid Arthritis after Treatment with Biologic Agents for 24 Weeks. Annals of the Rheumatic Diseases 73(Suppl 2): 688.1-688

Pers, Y.-M.; Schaub, R.; Fortunet, C.; Constant, E.; Lambert, J.; Godfrin-Valnet, M.; Pallot-Prades, B.; Wendling, D.; Gaudin, P.; Marotte, H.; Maillefert, J.-F.; Jorgensen, C. 2014: SAT0264Efficacy and Safety of TOCILIZUMAB in Elderly Patients with Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 689.1-689

Jancova, E.; Hruskova, Z.; Lanska, V.; Svojanovsky, J.; Sedova, L.; Zamboch, K.; Klaboch, J.; Kodeda, M.; Hanzal, V.; Jílek, D.; Valkovsky, I.; Tesar, V. 2014: SAT0265Characteristics and Outcomes of Patients with Anca-Associated Vasculitis (AAV) in the Czech Population. Annals of the Rheumatic Diseases 73(Suppl 2): 689.2-689

Alaoui, F.-Z.; Moudatir, M.; Echchilali, K.; Benamour, S.; El Kabli, H. 2014: SAT0266Behcet's Disease in Morocco: Report of 1484 Cases. Annals of the Rheumatic Diseases 73(Suppl 2): 689.3-689

Pearce, F.; Lanyon, P.; Watts, R.A. 2014: SAT0267Epidemiology of ANCA Associated Vasculitis in A Multi-Ethnic Urban Population. Annals of the Rheumatic Diseases 73(Suppl 2): 689.4-690

Muratore, F.; Boiardi, L.; Restuccia, G.; Cavazza, A.; Macchioni, P.; Germanò, G.; Pipitone, N.; Salvarani, C. 2014: SAT0268Comparison of Histopathological Findings with Clinical Manifestations in A Large Single Center Cohort of Patients with Biopsy-Proven GIANT Cell Arteritis. Annals of the Rheumatic Diseases 73(Suppl 2): 690.1-690

Vallet, H.; Riviere, S.; Lambert, M.; Deroux, A.; Bielfeld, P.; Seve, P.; Fraison, J.B.; Perard, L.; Schoindre, Y.; Papo, T.; Kaplanski, G.; Sellam, J.; Le Hoang, T.; Fain, O.; Marie, I.; Sene, D.; Mariette, X.; Blaison, G.; Hachulla, E.; Perlat, A.; Wechsler, B.; Cacoub, P.; Bodaghi, B.; Saadoun, D. 2014: SAT0269Efficacy and Safety of Anti-TNF Alpha in BehEt Disease: Preliminary Results of A French Multicenter Registry of 92 Patients. Annals of the Rheumatic Diseases 73(Suppl 2): 690.2-690

Moon, J.; Park, J.K.; Choi, I.A.; Lee, E.Y.; Song, Y.W.; Lee, E.B. 2014: SAT0270The Outcomes of Surgical and Percutaneous Vascular Intervention for Takayasu Arteritis in South Korea. Annals of the Rheumatic Diseases 73(Suppl 2): 690.3-691

Jakobsson, K.; Jacobsson, L.; Mohammad, A.J.; Nilsson, J.-Å.; Warrington, K.J.; Matteson, E.L.; Turesson, C. 2014: SAT0271The Impact of Clinical Features and Corticosteroids on Biopsy Findings in GIANT Cell Arteritis. Annals of the Rheumatic Diseases 73(Suppl 2): 691.1-691

Ahmad, K.; Bukhari, M. 2014: SAT0272The Use of Rituximab in Anca-Associated Vasculitides: Systematic Review. Annals of the Rheumatic Diseases 73(Suppl 2): 691.2-692

van der Geest, K.; Abdulahad, W.; Lorencetti, P.; Horst, G.; Boots, A.; Brouwer, E. 2014: SAT0273 Increased IL-6 Production by Effector B Cells in GIANT Cell Arteritis and Polymyalgia Rheumatica. Annals of the Rheumatic Diseases 73(Suppl 2): 692-692

Pan, L.; Wang, T. 2014: SAT0274IL-9-Producing TH 9 Cells May Participate in Pathogenesis of Takayasu's Arteritis. Annals of the Rheumatic Diseases 73(Suppl 2): 692.2-693

Petelytska, L.; Iaremenko, O.; Iaremenko, K. 2014: SAT0275Serum Proteins as Biomarkers of Systemic Necrotizing Vasculitis (SNV). Annals of the Rheumatic Diseases 73(Suppl 2): 693.1-693

Di Chio, M.C.; Sartorelli, S.; Tombetti, E.; Aiello, P.; Manfredi, A.; Sabbadini, M.G.; Baldissera, E. 2014: SAT0276High Prevalence of Inflammatory Comorbidities in a 70 Cases-Cohort of Takayasu Arteritis: not Only by Chance?: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 693.2-693

Yokoe, M. 2014: SAT0278 The Comparison of Diagnostic Accuracy between Eular/Acr Provisional Classification for PMR and Other Criterion. Annals of the Rheumatic Diseases 73(Suppl 2): 694-694

Loricera, J.; Blanco, R.; Castañeda, S.; Humbría, A.; Ortego-Centeno, N.; Narváez, J.; Mata, C.; Melchor, S.; Aurrecoechea, E.; Calvo-Alén, J.; Lluch, P.; Moll, C.; Mínguez, M.; Herrero-Beaumont, G.; Bravo, B.; Rubio, E.; Freire, M.; Peirό, E.; González-Vela, M.C.; Rueda-Gotor, J.; Pina, T.; Calvo-Río, V.; Ortiz-Sanjuán, F.; González-Gay, M.A. 2014: SAT0279Tocilizumab in Refractory Aortitis: Study on 16 Patients and Literature Review. Annals of the Rheumatic Diseases 73(Suppl 2): 694.2-694

Faurschou, M.; Mellemkjaer, L.; Voss, A.; Keller, K.K.; Hansen, I.T.; Baslund, B. 2014: SAT0280Prolonged Risk of Specific Malignancies following Cyclophosphamide-Therapy among Patients with Granulomatosis with Polyangiitis (WEGENER'S). Annals of the Rheumatic Diseases 73(Suppl 2): 694.3-695

Bély, M.; Apáthy, Ά. 2014: SAT0281Prevalence of Amyloidosis in Polymyalgia Rheumatica and in Temporal Arteritis. Annals of the Rheumatic Diseases 73(Suppl 2): 695.1-695

Saleh, M.; Turesson, C.; Englund, M.; Merkel, P.A.; Mohammad, A.J. 2014: SAT0282Clinical and Laboratory Characteristics Associated with Visual Complications in Patients with Biopsy-Proven GIANT Cell Arteritis. Annals of the Rheumatic Diseases 73(Suppl 2): 695.2-695

Potočnik, N.; Rotar, Ž.; Hočevar, A.; Pižem, J.; Hawlina, M.; Fakin, A.; Tomšič, M. 2014: SAT0283The Incidence of GIANT Cell Arteritis in Slovenia. Annals of the Rheumatic Diseases 73(Suppl 2): 696.1-696

Naderi, N.; Mohammad, A.J.; Turesson, C. 2014: SAT0284Large Vessel Involvement in GIANT Cell Arteritis - Incidence, Distribution and Predictors. Annals of the Rheumatic Diseases 73(Suppl 2): 696.2-696

Dolezalova, P.; Wilkinson, N.; Brogan, P. A.; Anton, J.; Benseler, S. M.; Brunner, J.; Cabral, D. A.; Cimaz, R.; O'Neil, K. M.; Ozen, S.; Luqmani, R. 2014: SAT0286 Paediatric Vasculitis Damage Index: A New Tool for Standardised Disease Assessment. Annals of the Rheumatic Diseases 73(Suppl 2): 696-697

Brier, R.; Borg, F. A.; Patil, P.; Dejaco, C.; Dasgupta, B. 2014: SAT0287 Association between Temporal Artery Ultrasound "Halo Score" and Biopsy in Newly Diagnosed GIANT Cell Arteritis. Annals of the Rheumatic Diseases 73(Suppl 2): 697-697

Solans-Laqué, R.; Fraile, G.; Castillo, M.J.; Solanich, X.; Caminal, L.; Rodriguez, M.; Rios, J.J.; Zamora, M.; Calleja, J.L.; Fanlo, P.; Garcia, I.; Saez, L.; Oristrell, J.; Abdilla, M.; Pasquau, F.; Lopez-Dupla, M.; Perez, A.; Fonseca, E.; Sopeña, B. 2014: SAT0288Eosinophilic Granulomatosis with Poliangeitis (EGPA): Clinical Features and Outcome in A Large Serie of Spanish Patients. Annals of the Rheumatic Diseases 73(Suppl 2): 697.2-698

Goel, R.; Mohan, H.; Kabeerdoss, J.; Jayaseelan, V.; Jude, J.; Joseph, G.; Danda, D. 2014: SAT0289Serum Soluble HLA E: A Biomarker of Disease Activity and Coronary Arteritis in Takayasu Arteritis. Annals of the Rheumatic Diseases 73(Suppl 2): 698.1-698

Wade, S.; Connolly, M.; O'Neill, L.; Mc Cormick, J.; Veale, D.; Murphy, C.; Molloy, E.; Fearon, U. 2014: SAT0290Altered Microrna Expression and Regulation in GIANT Cell Arteritis. Annals of the Rheumatic Diseases 73(Suppl 2): 698.2-698

Elsideeg, S.; Borg, F.A.; Williams, M.; Patil, P.; Dasgupta, B. 2014: SAT0293Association between Clinical Presentation and Blindness in Gca, and Effects of Gca-Related Visual Loss on Morbidity, Mortality and Quality of Life. Annals of the Rheumatic Diseases 73(Suppl 2): 699.1-699

Youngstein, T.; Quinn, M.; Peters, J.; Mason, J.C. 2014: SAT0294Longitudinal Analysis Suggests Clinical Outcomes in Takayasu Arteritis Are Improved by Early Combination Immunosuppression with Serial Non-Invasive Imaging. Annals of the Rheumatic Diseases 73(Suppl 2): 699.2-699

Cobankara, V.; Topaloglu, M.; Balkarlı, A.; Karabulut, N.; Akkoyunlu, N.; Karabulut, A. 2014: SAT0295Determining the Prevalance of Sacroiliitis in Behcet's Disease by Magnetic Resonance Imaging. Annals of the Rheumatic Diseases 73(Suppl 2): 699.3-700

Lumetti, F.; Serra, V.; Mozzani, F.; Delsante, G.; Ariani, A. 2014: SAT0296European Society of Cardiology/European Respiratory Society Guidelines and Detect Algorithm Right Heart Catheterisation Recommendations: A Real-Life Comparison: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 700.1-700

Vacca, A.; Civolani, A.; Devigus, A.; Fadda, L.; Floris, A.; Porru, G.; Garau, P.; Ibba, V.; Piga, M.; Sorbello, O.; Demelia, L.; Mathieu, A. 2014: SAT0297Non-Invasive Assessment of Silent Liver Fibrosis in Patients with Systemic Sclerosis. Annals of the Rheumatic Diseases 73(Suppl 2): 700.2-700

Khelkovskaya, A.; Antelava, O.; Olunin, U.; Koneva, O.; Nikonorova, N.; Aleksandrova, E.; Lopatina, N.; Nasonov, E. 2014: SAT0299Rituximab Treatment of the Antisynthetase Syndrome. Annals of the Rheumatic Diseases 73(Suppl 2): 701.1-701

Nordin, A.; Björnådal, L.; Roubi, E.; Jensen-Urstad, K.; Svenungsson, E. 2014: SAT0300Microcirculation and Macrovascular Disease in Systemic Sclerosis A Nailfold Capillary Study. Annals of the Rheumatic Diseases 73(Suppl 2): 701.2-701

Van Roon, A.M.; Smit, A.J.; van Roon, A.M.; Bootsma, H.; Mulder, D.J. 2014: SAT0301Vasospastic Severity and Digital Ischemia during Cooling is Related to Nail-Fold Capillaroscopic Pattern in Patients with Secondary Raynaud Phenomenon and Systemic Sclerosis. Annals of the Rheumatic Diseases 73(Suppl 2): 701.3-702

Notarnicola, A.; Iannone, F.; Giannini, M.; Paolotti, S.; Scardapane, A.; Salvarani, C.; Pipitone, N. 2014: SAT0302 Does MRI Have an Added Value over CK in Assessing Disease Activity in the Idiopathic Inflammatory Myopathies?. Annals of the Rheumatic Diseases 73(Suppl 2): 702-702

Peregud-Pogorzelska, M.; Bobrowska-Snarska, B.; Wielusiński, M.; Kiedrowicz, R.; Brzosko, M.; Kaźmierczak, J.; Kornacewicz-Jach, Z. 2014: SAT0303Assessment of ECG and Holter Parameters among Patients with Polimyositis and Dermatomyositis. Annals of the Rheumatic Diseases 73(Suppl 2): 702.2-702

Ruaro, B.; Sulli, A.; Elisa, A.; Ferrari, G.; Cimmino, M.A.; Cutolo, M. 2014: SAT0304Correlation between Three Different Methods to Evaluate Dermal Thickness in Different Skin Areas of Systemic Sclerosis Patients. Annals of the Rheumatic Diseases 73(Suppl 2): 702.3-703

Alhaddad, B.; O'Rourke, C.; Alalwani, M.; Zraik, B.; Yadav, R.; Chatterjee, S. 2014: SAT0305Interstitial Lung Disease (ILD) in Patients with Anti-Jo-1 Syndrome (AJS): A Descriptive Analysis. Annals of the Rheumatic Diseases 73(Suppl 2): 703.1-703

Oliveira-Cardoso, E.A.; Garcia, J.T.; Dias, J.E.B.; Moraes, D.A.; Stracieri, A.B.; Simões, B.P.; Oliveira, M.C.; Santos, M.A. 2014: SAT0306Quality of Life in Systemic Sclerosis Patients before and after Autologous Hematopoietic Stem Cell Transplantation. Annals of the Rheumatic Diseases 73(Suppl 2): 703.2-703

Kalinova, D.; Todorova, E.; Kyurkchiev, D.; Rashkov, R. 2014: SAT0307Overlap Myositis the Most Common Form of Autoimmune Myositis. Annals of the Rheumatic Diseases 73(Suppl 2): 703.3-704

Delis, K.; Daoussis, D.; Gizas, V.; Davlouros, P.; Alexopoulos, D.; Andonopoulos, A.P. 2014: SAT0308Effective Suppression of Adp-Dependent Platelet Activation by Clopidogrel May Result in Clinical Stabilization in Patients with Systemic Sclerosis. Results of an Open Label, Proof of Concept Study. Annals of the Rheumatic Diseases 73(Suppl 2): 704.1-704

Rizzi, M.; Atzeni, F.; Battellino, M.; Antivalle, M.; Boccassini, L.; Sarzi-Puttini, P. 2014: SAT0309Reduced Pulmonary Diffusion Capacity May BE an Early Indicator of Exercise-Induced Desaturation in Systemic Sclerosis Patients with Ild. Annals of the Rheumatic Diseases 73(Suppl 2): 704.2-704

Furini, F.; Bagnari, V.; Silvagni, E.; Lo Monaco, A.; La Corte, R.; Govoni, M. 2014: SAT0310Overlap Syndrome Systemic Sclerosis-Rheumatoid Arthritis and Pulmonary Involvement: Description of A Monocentric Series. Annals of the Rheumatic Diseases 73(Suppl 2): 704.3-705

De Luca, G.; Bosello, S.L.; Berardi, G.; Rucco, M.; Canestrari, G.; Di Mario, C.; Forni, F.; Ferraccioli, G. 2014: SAT0311Tumor Associated Antigens in Systemic Sclerosis Patients with Lung Involvement: Association with Lung Function and Cancer Risk. Annals of the Rheumatic Diseases 73(Suppl 2): 705.1-705

Berardi, G.; Rucco, M.; De Luca, G.; Parisi, F.; Bosello, S.L.; Ferraccioli, G. 2014: SAT0312Efficacy and Safety of High Dose Steroid Pulse Therapy in Early Progressive Systemic Sclerosis: the Risk of Renal Crisis is with Older Age. Annals of the Rheumatic Diseases 73(Suppl 2): 705.2-705

Abignano, G.; Bissell, L.-A.; Britton, J.; Lettieri, G.; Woods, D.; Buch, M.H.; McGonagle, D.; Emery, P.; Del Galdo, F. 2014: SAT0313Longitudinal Assessment of Scleroderma Skin by Optical Coherence Tomography: Preliminary Validation of Sensitivity to Change Over-Time. Annals of the Rheumatic Diseases 73(Suppl 2): 705.3-706

Pinal-Fernandez, I.; Selva-O'Callaghan, A.; Fernandez-Codina, A.; Martinez-Gomez, X.; Rodrigo-Pendas, J.A.; Perez-Lopez, J.; Vilardell-Tarres, M. 2014: SAT0314Pregnancy in Adult-Onset Idiopathic Inflammatory Myopathy. Report from A Cohort of Myositis Patients from A Single Center. Annals of the Rheumatic Diseases 73(Suppl 2): 706.1-706

Pinal-Fernandez, I.; Pineda-Sanchez, V.; Pallisa Núñez, E.; Simeόn-Aznar, C.P.; Selva-O'Callaghan, A. 2014: SAT0315Comparison of Fast 1.5T Chest MRI with HRCT Scan in the Assessment of Interstitial Lung Disease Extension Secondary to Systemic Sclerosis. Annals of the Rheumatic Diseases 73(Suppl 2): 706.2-706

Avouac, J.; Meune, C.; Chenevier-Gobeaux, C.; Borderie, D.; Lefevre, G.; Kahan, A.; Allanore, Y. 2014: SAT0316Key Role of Cardiac Biomarkers in the Assessment of Systemic Sclerosis: Contribution of High Sensitivity Cardiac Troponin. Annals of the Rheumatic Diseases 73(Suppl 2): 706.3-707

Martínez-Barrio, J.; Hinojosa, M.; Lopez-Longo, J.; Ovalles-Bonilla, J.G.; Bello, N.; Mata Martínez, C.; Serrano, B.; Nieto Gonzalez, J.C.; Martínez Estupiñan, L.; Gonzalez, C.; Montoro, M.; Valor, L.; Monteagudo, I.; Naredo, E.; Carreño, L. 2014: SAT0318Antisynthetase Syndrome: Clinical and Serological Characteristics at Disease Onset: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 707.2-707

Keogh, K.A.; Kane, G.C. 2014: SAT0319Role of Spirometry in Survival Prediction in Scleroderma Related Pulmonary Arterial Hypertension. Annals of the Rheumatic Diseases 73(Suppl 2): 707.3-708

Tsuchida, K.; Yamada, H.; Yamasaki, Y.; Ooka, S.; Suzuki, K.; Akashi, Y.; Ozaki, S. 2014: SAT0320Coexistence of Left Heart Diseases is Common among Patients with Connective Tissue Diseases-Associated Pulmonary Arterial Hypertension. Annals of the Rheumatic Diseases 73(Suppl 2): 708.1-708

Bissell, L.-A.; Abignano, G.; Del Galdo, F.; Buch, M.H. 2014: SAT0321The Absence of SSC Pattern at NFC Carries A 90% Negative Predictive Value for the Classification of Very Early or Established SSC in an Unselected Cohort of Patients with Raynaud's Phenomenon; Experience from A Single Tertiary Centre: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 708.2-708

Mouthon, L.; Carpentier, P.; Lok, C.; Clerson, P.; Gressin, V.; Hachulla, E.; Bérezné, A.; Diot, E.; Khau Van Kien, A.; Jego, P.; Agard, C.; Modeste Duval, A.-B.; Sparsa, A.; Puzenat, E.; Richard, M.-A. 2014: SAT0323Improvement of Digital Ulcerative Disease in Patients with Systemic Sclerosis is Associated with Better Functional Prognosis. Annals of the Rheumatic Diseases 73(Suppl 2): 709.1-709

Saez-Comet, L.; Perez-Conesa, M.; Vallejo-Rodriguez, C.; Fonollosa-Pla, V.; Colunga-Arguelles, D.; Egurbide-Arberas, M. V.; Mari-Alfonso, B.; Vargas-Hitos, J. A.; Freire-Dapena, M. C.; Simeon-Aznar, C. P. 2014: SAT0324 Comparison of ACR 1980'S and Acr/Eular 2013'S Systemic Sclerosis Classification Criteria in the RESCLE Cohort. Annals of the Rheumatic Diseases 73(Suppl 2): 709-709

Rubio-Rivas, M.; Fonollosa-Pla, V.; Corbella-Virόs, X.; Tolosa-Vilella, C.; Colunga-Argüelles, D.; Egurbide-Arberas, M.V.; Vargas-Hitos, J.A.; Ríos-Blanco, J.J.; Trapiella-Martínez, L.; Simeόn-Aznar, C.P. 2014: SAT0325Changes in the Pattern of Death in Systemic Sclerosis: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 710.1-710

Gutierrez, M.; Pineda, C.; Navarro, C.; Salaffi, F.; Hernandez, C.; Ventura, L.; Carotti, M.; Grassi, W. 2014: SAT0326Validity of Ultrasound in the Assessment of Pulmonary Fibrosis in Systemic Sclerosis: Correlation with High Resolution Computed Tomography, Pulmonary Function Test and Histological Findings. Annals of the Rheumatic Diseases 73(Suppl 2): 710.2-710

Marot, M.; Valéry, A.; Estève, E.; Bens, G.; Müller, A.; Rist, S.; Lespessailles, E. 2014: SAT0327Study of the Prevalence and Predicting Factors of Osteoporosis in Patients with Systemic Sclerosis: A Case-Control Study. Annals of the Rheumatic Diseases 73(Suppl 2): 710.3-710

Muratore, M.; Carati, D.; Quarta, L.; Quarta, E.; Grimaldi, A.; Costanza, D.; Tinelli, A. 2014: SAT0328Treatment of Vaginal Dryness in Women Affected by Systemic Sclerosis and Effects on Sexual Discomfort. Annals of the Rheumatic Diseases 73(Suppl 2): 710.4-711

Freire, M.; Gόmez-Sousa, J.; Val, N.; Baroja, A.; Alonso, M.; Sousa, A.; Soto, A.; Rivera, A.; Sopeña, B. 2014: SAT0329Scleroderma in Men in Northwestern Spain: Differentiating Clinical Features. Annals of the Rheumatic Diseases 73(Suppl 2): 711.1-711

Baron, M.; Hudson, M.; Foeldvari, I.; Tatibouet, S. 2014: SAT0330Juvenile Onset Raynaud's Predicts Good Survival in the Canadian Scleroderma Research Group Cohort. Annals of the Rheumatic Diseases 73(Suppl 2): 711.2-711

Villalba Yllan, A.; Plasencia, C.; Pascual-Salcedo, D.; Peiteado, D.; Nuño, L.; Bonilla, G.; del Moral, R.; Balsa, A.; Martin Mola, E. 2014: SAT0331Effect of Methotrexate on the Immnunogenicity of TNF Inhibitors in Spondyloartrhitis Patients. Annals of the Rheumatic Diseases 73(Suppl 2): 711.3-712

Plasencia, C.; Wolbink, G.; Kneepkens, E.; Krieckaert, C.; l'Ami, M.; Peiteado, D.; Nuno, L.; Arribas, F.; Nurmohamed, M.; Martín-Mola, E.; Balsa, A.; Pascual-Salcedo, D. 2014: SAT0334Comparison of Clinical Outcomes between Spondyloarthritis Patients Treated with TNF Inhibitors in Daily Clinical Practise: Tapering versus Standard Therapy: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 713.1-713

Choquette, D.; Raynauld, J.-P.; Bessette, L.; Fortin, I.; Haraoui, B.; Pelletier, J.-P.; Sauvageau, D.; Villeneuve, E.; Coupal, L. 2014: SAT0335Use of Monotherapy Anti-TNF Agents in Ankylosing Spondylitis Patients from the Rhumadata Registry: 8-Year Comparative Effectiveness of Adalimumab, Etanercept and Infliximab. Annals of the Rheumatic Diseases 73(Suppl 2): 713.2-713

Choquette, D.; Starr, M.; Khraishi, M.; Bensen, W.; Shaikh, S.; Rodrigues, J.; Sholter, D.; Sheriff, M.; Vaillancourt, J.; Sampalis, J.S.; Lehman, A.; Otawa, S.; Nantel, F.; Shawi, M. 2014: SAT0336Change over Time in the Profile of Ankylosing Spondylitis Patients Treated with Infliximab in A REAL World Routine Care. Annals of the Rheumatic Diseases 73(Suppl 2): 713.3-714

Hernández Flόrez, D.; Valor, L.; Nieto, J.C.; Martinez, L.; de la Torre, I.; del Río, T.; Gonzalez, C.; Lopez-Longo, J.; Monteagudo, I.; Naredo, E.; Montoro, M.; Carreño Perez, L. 2014: SAT0340Infliximab Levels and Anti-Infliximab Antibodies Comparison between Two Comercial ELISA Versions in Patients with Ankylosing Spondylitis. Annals of the Rheumatic Diseases 73(Suppl 2): 715.2-716

Van den Bosch, F.; Mease, P.; Sieper, J.; Baeten, D.L.; Karunaratne, P.M.; Song, I.-H.; Pangan, A.L. 2014: SAT0342Arthritis and Enthesitis Remission during Adalimumab Treatment in Peripheral Spondyloarthritis: Year-2 Results from Ability-2:. Annals of the Rheumatic Diseases 73(Suppl 2): 716.2-716

Maas, F.; Spoorenberg, A.; Brouwer, E.; Bos, R.; Efde, M.; Chaudhry, R.N.; Veeger, N.J.; Bootsma, H.; van der Veer, E.; Arends, S. 2014: SAT0343Spinal Radiographic Progression during 6 Years of Tnf-Alpha Blocking Therapy in Patients with Ankylosing Spondylitis: Results from the GLAS Cohort. Annals of the Rheumatic Diseases 73(Suppl 2): 716.3-717

Bartoli, F.; Fiori, G.; Peruzzi, F.; Guidi, G.; Pfanner, S.; Ceruso, M.; Matucci Cerinic, M. 2014: SAT0344Intravenous Bisphosphonate Reduces Rapidly Pain in Complex Regional Pain Syndrome (CRPS). Annals of the Rheumatic Diseases 73(Suppl 2): 717.1-717

Saygin, C.; Uzunaslan, D.; Hatemi, G.; Hamuryudan, V. 2014: SAT0345Patient Perceptions, Attitudes and Concerns about Anti-TNF Drugs:. Annals of the Rheumatic Diseases 73(Suppl 2): 717.2-717

Kim, H.J.; Hwang, J.; Kim, I.; Jeong, H.; Lee, J.; Jeon, C.H.; Koh, E.-M.; Cha, H.-S. 2014: SAT0346Anti-Drug Antibodies as A Predictor for the Discontinuation of Anti-TNF Agents in Patients with Spondyloarthrtis. Annals of the Rheumatic Diseases 73(Suppl 2): 717.3-718

Kalyoncu, U.; Karadag, O.; Kilic, L.; Bilgen, S.A.; Akdogan, A.; Kiraz, S.; Ertenli, I. 2014: SAT0347Patients with Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis HAD Similar TNFI Drug Survival: HR-BO REAL Life Results. Annals of the Rheumatic Diseases 73(Suppl 2): 718.1-718

Gaydukova, I.; Rebrov, A.; Nikitina, N.; Nam, I. 2014: SAT0348Efficacy and Safety of Different Schemes of Etoricoxib Administration in Patients with Axial Spondyloarthritis - Results of A 12-Week, Prospective, Open-Label Study: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 718.2-718

Sieper, J.; Drescher, E.; Rosa, J.; Pedersen, R.; Bonin, R.; Vlahos, B.; Bukowski, J.; Kotak, S. 2014: SAT0350Quality of Life with Etanercept in Early Non-Radiographic Axial Spondyloarthritis: 24 and 48-Week Data from A Randomized, Double-Blind, Placebo-Controlled Trial. Annals of the Rheumatic Diseases 73(Suppl 2): 719.2-719

Sieper, J.; Rudwaleit, M.; van der Heijde, D.; Maksymowych, W.; Dougados, M.; Mease, P.J.; Braun, J.; Deodhar, A.; Hoepken, B.; Nurminen, T.; Landewé, R. 2014: SAT0351Long-Term Safety and Efficacy of Certolizumab Pegol in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 96-Week Outcomes of the Rapid-Axspa Trial. Annals of the Rheumatic Diseases 73(Suppl 2): 719.3-720

Karlsson, J.A.; Kapetanovic, M.C.; Petersson, I.F.; Geborek, P.; Kristensen, L.-E. 2014: SAT0352Comparison of Nonradiographic Axial Spondyloarthritis and Ankylosing Spondylitis Patients Baseline Characteristics and Development of Clinical Variables during Three Years of Anti-TNF Therapy in Clinical Practice. Annals of the Rheumatic Diseases 73(Suppl 2): 720-720

Callhoff, J.; Sieper, J.; Weiß, A.; Zink, A.; Listing, J. 2014: SAT0353Meta-Analysis Comparing the Efficacy of Tnf-Blockers in as and Nr-Axspa Patients. Annals of the Rheumatic Diseases 73(Suppl 2): 721.1-721

Carbo, M.J.; Arends, S.; Brouwer, E.; Bos, R.; Efde, M.; Leijsma, M.K.; Bootsma, H.; van der Veer, E.; Spoorenberg, A. 2014: SAT0354Nsaid Use in Patients with Ankylosing Spondylitis Treated with and without Tnf-Alpha Blocking Therapy during 2-Year Follow-Up in Daily Clinical Practice. Annals of the Rheumatic Diseases 73(Suppl 2): 721.2-721

Rudwaleit, M.; Landewe, R.; Marzo-Ortega, H.; Sieper, J.; van der Heijde, D.; Rosenbaum, J.; Davies, O.; Stach, C.; Nurminen, T.; Deodhar, A. 2014: SAT0355 Observed Incidence Rates of Uveitis following Certolizumab Pegol Treatment in Patients with Axial Spondyloarthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 721-722

Dougados, M.; Wood, E.; Gossec, L.; van der Heijde, D.; Dubanchet, A.; Logeart, I. 2014: SAT0356Discriminant Capacity of Clinical Efficacy Measures, Alone or in Combination with NSAID Intake, in Detecting Anti-TNF Treatment Effect in Spondyloarthritis: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 722.1-722

Dougados, M.; Wood, E.; Combe, B.; Miceli-Richard, C.; Berenbaum, F.; Koppiker, N.; Dubanchet, A.; Logeart, I. 2014: SAT0357Evaluation of the Nonsteroidal Anti-Inflammatory Drug-Sparing Effect of Etanercept in Axial Spondyloarthritis: Results of the Multicenter Randomized, Double-Blind, Placebo-Controlled SPARSE Trial. Annals of the Rheumatic Diseases 73(Suppl 2): 722.2-723

Behrens, F.; Köhm, M.; Arndt, U.; Wittig, B.; Greger, G.; Thaci, D.; Scharbatke, E.; Tony, H.-P.; Burkhardt, H. 2014: SAT0358Impact of Methotrexate on Anti-TNF Treatment in Psoriatic Arthritis? an In-Depth Analysis of A Large Prospective Observational Study with Adalimumab. Annals of the Rheumatic Diseases 73(Suppl 2): 723.1-723

Van Der Weijden, M.; van Denderen, C.J.; Lems, W.W.; Nurmohamed, M.M.; Dijkmans, B.B.; van der Horst-Bruinsma, I.I. 2014: SAT0359Etanercept Increases Bone Mineral Density in Ankylosing Spondylitis, but Does not Prevent Vertebral Fractures. Annals of the Rheumatic Diseases 73(Suppl 2): 723.2-723

Protopopov, M.; Lapshina, S.; Aphanasieva, M.; Myasoutova, L. 2014: SAT0360Combined Therapy with Rituximab and NSAIDS in Treatment of Active Ankylosing Spondylitis: Better than NSAIDS Alone, Worse than Combination of Tnf-Inhibitors and Nsaids. Annals of the Rheumatic Diseases 73(Suppl 2): 724.1-724

Cetin, P.; Kalyoncu, U.; Solmaz, D.; Sari, I.; Karadag, O.; Kilic, L.; Birlik, M.; Kiraz, S.; Onen, F.; Ertenli, I.; Akkoc, N. 2014: SAT0361Short Term Efficacy of Tumor Necrosis Factor Inhibitors in Patients with NonRadiographic Axial Spondylarthritis and Ankylosing Spondylitis; Results from TURKBIO Registry: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 724.2-724

Mease, P.J.; Dougados, M.; Davies, O.; Nurminen, T.; Sieper, J. 2014: SAT0362Certolizumab Pegol Rapidly Reduces Peripheral Enthesitis and the Incidence of Tender and Swollen Joints in Patients with Active Axial Spondyloarthritis, Including Both Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 724.3-725

Rahman, P.; Choquette, D.; Khraishi, M.; Bensen, W.; Shaikh, S.; Sholter, D.; Sheriff, M.; Rampakakis, E.; Sampalis, J.S.; Nantel, F.; Otawa, S.; Lehman, A.; Shawi, M. 2014: SAT0363Validation of the Ankylosing Spondylitis Disease Activity SCORE (ASDAS) and Effectiveness of Infliximab in the Treatment of Ankylosing Spondylitis over 4 Years. Annals of the Rheumatic Diseases 73(Suppl 2): 725.1-725

Wu, R. 2014: SAT0364Efficacy and Safety of Intra-Articular Therapy with Methotraxate in Large Glucose Injection Volume on Knee Synovitis in Patients with Ankylosing Spondylitis. Annals of the Rheumatic Diseases 73(Suppl 2): 725.2-725

Dadoun, S.; Kossi, S.; Guillaume, G.; Dougados, M.; Gossec, L. 2014: SAT0365Who Are the Spondyloarthritis Patients with A Primary Inefficacy of A First TNF Blocker? A Monocenter Systematic Study. Annals of the Rheumatic Diseases 73(Suppl 2): 725.3-726

Forejtova, S.; Jarosova, K.; Votavova, M.; Uher, M.; Hejduk, K.; Pavelka, K. 2014: SAT0366Effect of First-Line Anti-TNF Therapy on Fatigue in Patients with Ankylosing Spondylitis Results from the Czech BIOLOGICS Registry Attra. Annals of the Rheumatic Diseases 73(Suppl 2): 726.1-726

Kalyoncu, U.; Karadag, O.; Kilic, L.; Ertenli, I.; Bilgen, S.A.; Akdogan, A.; Kiraz, S. 2014: SAT0367Frequency of Radiological Hip Involvement and Total Hip Replacement in A Large Single Center Spondyloarthritis Cohort with Biological Treatments: HR-BO REAL Life Results: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 726.2-726

Kim, T.-H.; Shin, J.H.; Kim, S.-K.; Joo, K.B.; Lee, S.; Kim, T.-J. 2014: SAT0368Tumor Necrosis Factor Inhibitor Has NO Influence on Radiographic Damage in Ankylosing Spondylitis: Observation Study of Korean Spondyloarthropathy Registry (OSKAR) Data. Annals of the Rheumatic Diseases 73(Suppl 2): 726.3-727

Donmez, U.; Ozturk, C.; Kocanaogullari, H.; Gucenmez, S.; Hepguler, S. 2014: SAT0369 Do Pyhsical Therapy Modalities Have Additional Benefit over Exercise Therapy in the Management of Ankylosing Spondylitis? A Randomized Controlled Trial. Annals of the Rheumatic Diseases 73(Suppl 2): 727-727

Kalyoncu, U.; Kilic, L.; Karadag, O.; Bilgen, S. A.; Akdogan, A.; Kiraz, S.; Ertenli, I. 2014: SAT0370 Retention Rate of TNF Blockers is Greater in CASE of Advanced Spinal Ankylosis in Axial Spondyloarthritis: Data from the HUR-BIO Registry. Annals of the Rheumatic Diseases 73(Suppl 2): 727-727

Maksymowych, W.P.; van der Heijde, D.; Dougados, M.; Sieper, J.; Braun, J.; Citera, G.; Miceli-Richard, C.; Wei, J. C.-C.; Pedersen, R.; Bonin, R.; Logeart, I.; Wajdula, J.; Rahman, M.U.; Vlahos, B.; Bukowski, J. 2014: SAT0372Clinical and Imaging Efficacy of Etanercept in Early Non-Radiographic Axial Spondyloarthritis: 48-Week Treatment Data: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 728.1-728

Pedersen, S.J.; Wichuk, S.; Chiowchanwisawakit, P.; Lambert, R.G.; Maksymowych, W.P. 2014: SAT0373Anti-Tumor Necrosis Factor Therapy May Influence Structural Progression in the Sacroiliac Joints of Patients with Axial Spondyloarthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 728.2-729

Baraliakos, X.; Kiltz, U.; Heldmann, F.; Appel, H.; Dybowski, F.; Igelmann, M.; Kalthoff, L.; Krause, D.; Menne, H.-J.; Saracbasi, E.; Schmitz-Bortz, E.; Braun, J. 2014: SAT0374Do Patients with Non-Radiographic Axial Spondyloarthritis and Ankylosing Spondylitis Respond Similarly Well to Nsaids? A Prospective Study Including Magnetic Resonance Imaging. Annals of the Rheumatic Diseases 73(Suppl 2): 729.1-729

Baraliakos, X.; Hermann, K.-G.; Xu, S.; Hsu, B.; Braun, J. 2014: SAT0375The Distribution of Inflammatory Lesions in the Anterior and Posterior Structures of the Spine in Patients with Active Ankylosing Spondylitis and the Effect of Tnf-Alpha -Blockade. Annals of the Rheumatic Diseases 73(Suppl 2): 729.2-729

Baraliakos, X.; Hermann, K.-G.; Xu, S.; Hsu, B.; Braun, J. 2014: SAT0376Spinal Mobility in the Cervical and the Lumbar Spine Correlates with Magnetic Resonance Imaging Findings in Patients with Ankylosing Spondylitis More Results from the GO-RAISE Trial. Annals of the Rheumatic Diseases 73(Suppl 2): 730.1-730

Adebajo, A.; Wells, A.; Edwards, C.; Kivitz, A.; Bird, P.; Shah, K.; Hu, C.; Stevens, R.; Aelion, J. 2014: SAT0377Long-Term Safety and Tolerability of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: A Phase 3, Randomized, Controlled Trial. Annals of the Rheumatic Diseases 73(Suppl 2): 730.2-730

Kibari, A.; Cohen, A.; Bitterman, H.; Shalom, G.; Feldhamer, I.; Batat, E.; Comanesther, D.; Greenberg-Dotan, S.; Zisman, D. 2014: SAT0378Cardiac and Cardiovascular Morbidities in Patients with Psoriatic Arthritis: A Population-Based Cohort Study. Annals of the Rheumatic Diseases 73(Suppl 2): 730.3-731

Szentpetery, A.; Heffernan, E.; Haroon, M.; Gallagher, P.; Baker, A.-M.; Cooney, M.; FitzGerald, O. 2014: SAT0379Effects of Abatacept on Synovitis as Assessed by Magnetic Resonance Imaging (MRI) in Psoriatic Arthritis - Preliminary Analysis from A Single Centre, Placebo-Controlled, Crossover Study. Annals of the Rheumatic Diseases 73(Suppl 2): 731.1-731

Szentpetery, A.; Haroon, M.; O'Flynn, E.; Gallagher, P.; Alraqi, S.; FitzGerald, O. 2014: SAT0380Do Patients Know Best? Reliability of Electronic Patient Self-Evaluation of Swollen and Tender Joints in Psoriatic Arthritis: A Comparison Study with B-Mode Ultrasonography, Physician and Nurse Assessments. Annals of the Rheumatic Diseases 73(Suppl 2): 731.2-731

Gulati, A.M.; Haugeberg, G.; Semb, A.G.; Romunstad, P.R.; Kavanaugh, A.; Gulati, S.; Rollefstad, S.C.; Hoff, M. 2014: SAT0381On the Hunt for Cardiovascular Risk Factors and Disease in Patients with Psoriatic Arthritis Results from the Norwegian Hunt Study. Annals of the Rheumatic Diseases 73(Suppl 2): 731.3-732

Wells, A.; Edwards, C.; Adebajo, A. O.; Kivitz, A. J.; Bird, P.; Shah, K.; Hu, C.; Stevens, R. M.; Aelion, J. A. 2014: SAT0382 Palace 4, A Phase 3, Randomized, Controlled TRIAL of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Treatment of Psoriatic Arthritis: Long-Term (52-WEEK) Improvements in Physical Function. Annals of the Rheumatic Diseases 73(Suppl 2): 732-732

Pana, C.; Ramazan, A.-M.; Muflic, L.; Suta, M. 2014: SAT0383The Functionl Impact of Asymptomatic Axial Involvement in Psoriatic Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 732.2-733

Abou-Raya, A.; Abou-Raya, S.; Helmii, M. 2014: SAT0384 Metformin: A Valid ADD-ON Drug in the Treatment of Psoriatic Arthritis - Randomized Controlled Trial. Annals of the Rheumatic Diseases 73(Suppl 2): 733-733

Michelsen, B.; Diamantopoulos, A.; Kavanaugh, A.; Haugeberg, G. 2014: SAT0385Lack of Correlation between Clinical and Ultrasonographic Evidence of Disease Activity in Psoriatic Arthritis:. Annals of the Rheumatic Diseases 73(Suppl 2): 733.2-733

Van Dongen, C.; Agca, R.; Trivino, L.; Vogelzang, E.; Nurmohamed, M. 2014: SAT0388Effect of Etanercept Therapy on Lipid Profile in Patients with Psoriatic Arthritis:. Annals of the Rheumatic Diseases 73(Suppl 2): 734.2-735

Edwards, C.; Wells, A.; Adebajo, A.; Kivitz, A.; Bird, P.; Shah, K.; Hu, C.; Stevens, R. M.; Aelion, J. 2014: SAT0389 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-Term (52-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Results from the Palace 4 Phase 3, Randomized, Controlled Trial. Annals of the Rheumatic Diseases 73(Suppl 2): 735-735

Zhang, F.; Tencer, T.; Li, S. 2014: SAT0392Work Productivity Improvement Associated with Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results of A Phase 3, Randomized, Controlled Trial. Annals of the Rheumatic Diseases 73(Suppl 2): 736.1-736

De Marco, G.; Cattaneo, A.; Battafarano, N.; Carrera, C.G.; Marchesoni, A. 2014: SAT0393Distinguishing Spinal Diseases from Spondylitis among Psoriatic Subjects: the Performance of ASAS Inflammatory Back Pain Definition in A Mono-Centric CASE Series. Annals of the Rheumatic Diseases 73(Suppl 2): 736.2-736

Park, J.W.; Lee, J.M.; Lee, J.; Song, Y.W.; Shin, K. 2014: SAT0394Prevalence of Psoriatic Arthritis Based on an Algorithm beyond ICD-10 Codes Using National Health Insurance Claims Data in Korea. Annals of the Rheumatic Diseases 73(Suppl 2): 736.3-737

Kavanaugh, A.; Puig, L.; Gottlieb, A.; Ritchlin, C.; Li, S.; Wang, Y.; Mendelsohn, A.M.; Song, M.; Rahman, P.; McInnes, I. 2014: SAT0396Efficacy and Safety of Ustekinumab in Patients with Active Psoriatic Arthritis: 2-Year Results from A Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study. Annals of the Rheumatic Diseases 73(Suppl 2): 737.2-738

Tam, L.-S.; Shang, Q.; Li, E.; Wong, P.; Zhu, T.; Li, T.; Pui, M.; Leung, K.; Kun, E.; Yu, C.-M. 2014: SAT0397Serum Apolipoprotein B is Associated with Increased Risk of the Presence and Progression of Carotid Atherosclerosis in Patients with Psoriatic Arthritis: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 738.1-738

Gossec, L.; de Wit, M.; Heiberg, T.; Maccarone, M.; Balanescu, A.; Balint, P.; Niedermayer, D.; Canete, J.D.; Helliwell, P.; Kalyoncu, U.; Braun, J.; Kiltz, U.; Otsa, K.; Veale, D.; de Vlam, K.; Scrivo, R.; Stamm, T.; Smolen, J.S.; Kvien, T.K. 2014: SAT0398Fatigue in Psoriatic Arthritis is Related to Disease Activity Rather than to Demographic Characteristics an Ancillary Analysis of the Cross-Sectional International PSAID Study of 246 Patients. Annals of the Rheumatic Diseases 73(Suppl 2): 738.2-738

Kilic, L.; Karadag, O.; Gossec, L.; Apras Bilgen, S.; Akdogan, A.; Kiraz, S.; Ertenli, I.; Kalyoncu, U. 2014: SAT0399The Patient-Derived PSA Impact of Disease (PSAID) Questionnaire Correlates with Other Outcome Measures: HR-BO REAL Life Results. Annals of the Rheumatic Diseases 73(Suppl 2): 739.1-739

Khraishi, M.; Aslanov, R. 2014: SAT0400Prevalence of Comorbidities in Patients with Psoriatic Arthritis and their Impact on Cardiovascular Risk and Quality of Life. Annals of the Rheumatic Diseases 73(Suppl 2): 739.2-739

Salaffi, F.; Ciapetti, A.; Carotti, M.; Gasparini, S.; Gutierrez, M. 2014: SAT0401Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in A Real-World. Annals of the Rheumatic Diseases 73(Suppl 2): 739.3-739

Schafer, P.; Chen, P.; Fang, L.; Wang, A.; Chopra, R. 2014: SAT0402Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pharmacodynamic Results of A Phase 3, Randomized, Controlled Trial (PALACE 1). Annals of the Rheumatic Diseases 73(Suppl 2): 739.4-740

Helliwell, P.; Mease, P.J.; Nurminen, T.; FitzGerald, O. 2014: SAT0403Further Analysis of Psoriatic Arthritis Disease Activity Score (PASDAS) and Composite Psoriatic Disease Activity Index (CPDAI) Using Data from A Placebo-Controlled TRIAL of Certolizumab Pegol in Psoriatic Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 740.1-740

Coates, L.C.; Helliwell, P.S. 2014: SAT0406Low Level of Erosive Change is Found in Early Psoriatic Arthritis:. Annals of the Rheumatic Diseases 73(Suppl 2): 741.2-742

Helliwell, P.; Jones, H.; Szumski, A.; Marshall, L. 2014: SAT0407Baseline Characteristics in Psoriasis Patients with Polyarthritis or Oligoarthritis: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 742.1-742

Mease, P. J.; Kavanaugh, A.; Gladman, D.; Adebajo, A. O.; Gomez-Reino, J. J.; Wollenhaupt, J.; Cutolo, M.; Schett, G.; Lespessailles, E.; Shah, K.; Hu, C.; Stevens, R.; Edwards, C.; Birbara, C. 2014: SAT0408 Long-Term Safety and Tolerability of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of Three Phase 3, Randomized, Controlled Trials. Annals of the Rheumatic Diseases 73(Suppl 2): 742-743

Queiro, R.; Acasuso, B.; Rodríguez, S.; Cabezas, I.; Morante, I.; Tejόn, P.; Arboleya, L.; Riestra, J.L. 2014: SAT0410Determinants of Hypertension in Patients with Psoriatic Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 743.2-743

Reddy, S.M.; Scher, J.U.; Swearingen, C.J.; Yazici, Y. 2014: SAT0411Gender Differences in Disease Activity in A Psoriatic Arthritis Routine Care Cohort: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 743.3-744

Kalyoncu, U.; Karadag, O.; Kilic, L.; Bilgen, S.A.; Akdogan, A.; Kiraz, S.; Ertenli, I. 2014: SAT0412Patients with Psoriatic Arthritis HAD Better TNFI Survival than Ankylosing Spondylitis: HR-BO REAL Life Results. Annals of the Rheumatic Diseases 73(Suppl 2): 744.1-744

Zhu, Y.; Griffith, J.F.; Qin, L.; Hung, V.W.; Fong, T.-N.; Au, S.-K.; Tang, X.-L.; Kwok, A.W.; Leung, P.-C.; Li, E.K.; Tam, L.-S. 2014: SAT0413A Case-Control Study of Density and Microstructure at the Distal Radius in Patients with Psoriatic Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 744.2-744

Leung, Y.Y.; Ho, K.-W.; Li, E. K.-M.; Li, M.; Kwok, L.-W.; Wong, P.C.; Li, T.K.; Zhu, T.Y.; Kun, E.E.; Tam, L.-S. 2014: SAT0414Predictors of Functional Deterioration in Chinese Patients with Psoriatic Arthritis: A Longitudinal Study. Annals of the Rheumatic Diseases 73(Suppl 2): 744.3-745

Orsolini, G.; Idolazzi, L.; Rossini, M.; Viapiana, O.; Fracassi, E.; Povino, M.; Risoli, M.; Gatti, D.; Adami, S. 2014: SAT0415Effects of Intra-Articular Clodronate in the Treatment of Knee Osteoarthritis: Results of A Double-Blind, Randomised Placebo-Controlled Trial. Annals of the Rheumatic Diseases 73(Suppl 2): 745.1-745

Starodubtseva, I.; Vasilieva, L.; Nikitin, A. 2014: SAT0416Risk Factors of Developing Secondary Osteoarthritis of the Knee in Patients with Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 745.2-745

Sellam, J.; Rat, A.-C.; Fellahi, S.; Bastard, J.-P.; Bernard, L.; Ea, H.K.; Chevalier, X.; Richette, P.; Capeau, J.; Guillemin, F.; Berenbaum, F. 2014: SAT0418The Serum Leptin/Adiponectin Ratio, A Useful Estimate of Insulin Resistance, is Associated with Clinical Symptoms in Hip Osteoarthritis: Results of the Population-Based French Khoala Cohort. Annals of the Rheumatic Diseases 73(Suppl 2): 746.1-746

Siebuhr, A.S.S.; Bierma-Zeinstra, S.M.; Uitterlinden, A.G.; Karsdal, M.A.; Bay-Jensen, A.C.; Van Meurs, J.B. 2014: SAT0419Mmp-Dependent Tissue-Inflammation Predicts the Risk of Osteoarhritis-Progression after Five Years. Annals of the Rheumatic Diseases 73(Suppl 2): 746.2-746

Garrido-Castro, J. L.; Gil-Cabezas, J.; Perez-Guijo, V.; Gonzalez-Navas, C.; Font-Ugalde, P.; Collantes-Estevez, E. 2014: SAT0420 Ground Reaction Forces in Patients with Knee Osteoarthritis after Intra-Articular Treatments. Annals of the Rheumatic Diseases 73(Suppl 2): 746-747

Louati, K.; Berenbaum, F.; Sellam, J. 2014: SAT0421Association between Diabetes Mellitus and Osteoarthritis: A Systematic Literature Review and Meta-Analysis. Annals of the Rheumatic Diseases 73(Suppl 2): 747.1-747

Takahashi, K.; Hashimoto, S.; Mori, A.; Sato, A.; Mochizuki, Y.; Nakamura, H.; Takai, S. 2014: SAT0422Medial Meniscal Posterior Root/Horn Radial Tears Are A Strong Predisposing Factor for Cartilage Degeneration Observed on T1 Relaxation Mapping. Annals of the Rheumatic Diseases 73(Suppl 2): 747.2-747

Aljarallah, K.F.; Shehab, D.; Abdulla, N.; Al Mohamedy, H. 2014: SAT0423Knee Osteoarthritis in Type 2 Diabetes Mellitus: Does Insulin Therapy Retard the Osteophyte Formation?. Annals of the Rheumatic Diseases 73(Suppl 2): 747.3-748

Grypdonck, L.; Luyten, F.; Hermens, R.; Vankrunkelsven, P. 2014: SAT0424Barriers in Primary Care to Use Guidelines for Osteoarthritis of the Knee. Annals of the Rheumatic Diseases 73(Suppl 2): 748.1-748

Lourido, L.; Fernandez-Tajes, J.; Calamia, V.; Fernández, C.; Rocha, B.; Fuentes, M.; Blanco, F.J.; Ruiz-Romero, C. 2014: SAT0425Serum Autoantibody Profiling in Rheumatic Diseases by Nucleid Acid Programmable Protein Arrays. Annals of the Rheumatic Diseases 73(Suppl 2): 748.2-748

Sapundzhiev, L.; Lambova, S.; Staykova, M.; Batalov, A. 2014: SAT0426The Place of Intraarticular Corticosteroids in the Therapeutic Approach of Hip Osteoarthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 748.3-749

Hochberg, M.; Martel-Pelletier, J.; Monfort, J.; Moller, I.; Castillo, J.- R.; Arden, N.; Berenbaum, F.; Conaghan, P.; Pap, T.; Richette, P.; Sawitzke, A.; du Souich, P.; Pelletier, J.- P. 2014: SAT0427 Multicentric Osteoarthritis Intervention Study with Sysadoa (MOVES): Effects of Combined Glucosamine Hydrochloride and Chondroitin Sulfate VS Celecoxib for Painful Knee Osteoarthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 749-749

Mayán, M.D.; Carpintero, P.; Gago, R.; Varela-Eirin, M.; Goldberg, G.; Blanco, F.J. 2014: SAT0428Lectins That Target Sialic Acid Modified Receptors May Hold Therapeutic Potential for Degenerative Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 749.2-749

Van Middelkoop, M.; Arden, N.; Atchia, I.; Birrell, F.; Chao, J.; Lambert, R.; Ravaud, P.; Bijlsma, J.W.; Doherty, M.; Dziedzic, K.; Lohmander, S.; McAlindon, T.; Zhang, W.; Bierma-Zeinstra, S. 2014: SAT0429The OA TRIAL Bank: Meta-Analysis of Individual Patient Data Show That Patients with Severe Pain or with Inflammatory Signs Detected by Ultrasound Especially Benefit from Intra-Articular Glucocorticoids for Knee or Hip Oa. Annals of the Rheumatic Diseases 73(Suppl 2): 749.3-750

Van Der Leeden, M.; Koeckhoven, E.; Dekker, J.; Roorda, L. D.; van der Esch, M.; Lems, W. F. 2014: SAT0430 Association between Serum 25-Hydroxy (OH) Vitamin D Level and Muscle Strength in Patients with Knee Osteoarthritis: Results of the AMS-OA Cohort. Annals of the Rheumatic Diseases 73(Suppl 2): 750-750

Rizamukhamedova, M.Z.; Boboev, N.M.; Karimov, H.Y.; Ibragimov, Z.Z.; Rezvanov, A.S.; Boboev, K.T. 2014: SAT0432Study of Polymorphism of 1377 C>T Calcitonin Receptor Gene in Patients with Osteoarthritis and with Osteoporosis. Annals of the Rheumatic Diseases 73(Suppl 2): 750.3-750

Ruiz-Iban, M. Ά.; Oteo, Ά.; Macule, F.; Torne, P.; Gil-Garay, E.; Lόpez-Millán, J.M.; Díaz-Heredia, J.; Loza, E. 2014: SAT0433Consensus Statement on the Management of Preoperative Pain in Patients with Total Knee And/Or Hip Replacement. Annals of the Rheumatic Diseases 73(Suppl 2): 751.1-751

Nuñez, M.; Sastre, S.; Nuñez, E.; Saulό, A.; Segur, J.M.; Maurits, N.M.; Moreno, M.; Cabestany, J.; Segarra, J.; Segura, V.; Lozano, L.; Alemany, X.; Maculé, F.; Suso, S. 2014: SAT0435Knee Osteoarthritis and Periarticular Structure Quantified by Ultrasound. A Case-Control Study. Annals of the Rheumatic Diseases 73(Suppl 2): 751.3-751

Karsdal, M.A.; Bay-Jensen, A.-C.; Bihlet, A.; Byrjalsen, I.; Alexandersen, P.; Christiansen, C. 2014: SAT0436Association between Joint SPACE Width, Kellgren-Lawrence Score, Pain and Progression in Osteoarthritis Subjects from Two Phase III Studies A Clinical Study Reference Database. Annals of the Rheumatic Diseases 73(Suppl 2): 752.1-752

Tsvetkova, E.; Ionichenok, N.; Karusinov, P.; Smirnov, A.; Denisov, L.; Nasonov, E. 2014: SAT0437Meaning and the Prevalence of Different MRI Structural Changes in Knee Osteoarthritis (KOA). Annals of the Rheumatic Diseases 73(Suppl 2): 752.2-752

Addimanda, O.; Cavallari, C.; Pignotti, E.; Pulsatelli, L.; Mancarella, L.; Punzi, L.; Fioravanti, A.; Meliconi, R. 2014: SAT0438Radiographic Involvement of Metacarpophalangeal Joints in Hand Osteoarthritis: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 752.3-752

Frallonardo, P.; Oliviero, F.; Peruzzo, L.; Lorenzin, M.; Ortolan, A.; Punzi, L.; Ramonda, R. 2014: SAT0439Ultrasensitive Detection of Calcium Crystals in Synovial Fluid of Patients with Knee Osteoarthritis. Relation with Clinical, Instrumental, Laboratory Assessment in Different Phases of Disease. Annals of the Rheumatic Diseases 73(Suppl 2): 753.1-753

Szulc, P.; Estublier, C.; Bertholon, C.; Marchand, F.; Chapurlat, R. 2014: SAT0440Serum Sclerostin is Higher in Men with Severe Osteophytes at the Spine the Minos Study. Annals of the Rheumatic Diseases 73(Suppl 2): 753.2-753

Geusens, P.; Pavelka, K.; Rovensky, J.; Vanhoof, J.; Vanden Berghe, D. 2014: SAT0441 Effect of Choline-Stabilized Orthosilicic Acid on Symptoms of Knee Osteoarthritis in A Randomized, Double-Blind, Placebo-Controlled Trial. Annals of the Rheumatic Diseases 73(Suppl 2): 753-754

Klose-Jensen, R.; Hartlev, L.B.; Boel, L.W.T.; Laursen, M.B.; Keller, K.K.; Hauge, E.-M. 2014: SAT0442Subchondral Bone Remodeling, but not Bone Mass, is Increased in Local Early Stage Lesions of the Osteoarthritic Human Hip Joint as Studied by Stereological Histology. Annals of the Rheumatic Diseases 73(Suppl 2): 754.1-754

Cheleschi, S.; Cantarini, L.; Pascarelli, N.A.; Lucherini, O.M.; Guidelli, G.M.; Collodel, G.; Galeazzi, M.; Fioravanti, A. 2014: SAT0443In Vitro Effects of Canakinumab on Human Osteoarthritic Chondrocytes. Annals of the Rheumatic Diseases 73(Suppl 2): 754.2-754

Muraki, S.; Akune, T.; Tanaka, S.; Kawaguchi, H.; Nakamura, K.; Oka, H.; Yoshimura, N. 2014: SAT0444Does Osteophytosis at the Knee PREDICT Health-Related Quality of Life Decline? A 3-Year Follow-Up of the ROAD Study. Annals of the Rheumatic Diseases 73(Suppl 2): 754.3-755

Eeg, I. K.; Rollefstad, S.; Haugen, I. K.; Olsen, I. C.; Osteras, N.; Slatkowsky-Christensen, B.; Hammer, H. B.; Nordsletten, L.; Natvig, B.; Kvien, T. K.; Semb, A. G. 2014: SAT0445 Risk of Cardiovascular Disease in Patients with Osteoarthritis: Results from the Must-Heart Study. Annals of the Rheumatic Diseases 73(Suppl 2): 755-755

Stebbings, S.; Gray, A.; Schneiders, A.; Sansom, A. 2014: SAT0446A Novel Green-Lipped Mussel Lipid Extract (BIOLEX) for the Treatment of Pain in Osteoarthritis of the Hip and Knee: A Randomized Double-Blind, Placebo Controlled Trial. Annals of the Rheumatic Diseases 73(Suppl 2): 755.2-755

Goss, S.; Wang, S.; Klein, C.; Medema, J.; Awni, W. 2014: SAT0447Safety, Tolerability and Pharmacokinetics of Abt-981, an IL-1A and IL-1b Dual Target Biologic Drug in Development for Osteoarthritis, following Single Dose Administration in Healthy Subjects. Annals of the Rheumatic Diseases 73(Suppl 2): 755.3-756

Wang, S.X.; Medema, J.K.; Kosloski, M.P.; Liu, W.; Saltarelli, M.J.; Karsdal, M. 2014: SAT0448Interleukin-1 Dual Variable Domain Immunoglobulin Reduces Multiple Imflammatory Markers in Knee Osteoarthritis Patients. Annals of the Rheumatic Diseases 73(Suppl 2): 756.1-756

Abou-Raya, S.; Abou-Raya, A. 2014: SAT0449Cognitive Behavioural Therapy for Treatment of Insomnia in Older Adults with Symptomatic Knee Osteoarthritis: A Randomized Trial. Annals of the Rheumatic Diseases 73(Suppl 2): 756.2-756

Abou-Raya, S.; Abou-Raya, A.; Khadrawe, T. 2014: SAT0450Efficacy of Hydroxychloroquine in the Treatment of Symptomatic Knee Osteoarthritis in Older Adults: A Randomized Placebo-Controlled Trial. Annals of the Rheumatic Diseases 73(Suppl 2): 756.3-757

Bieler, T.; Magnusson, S.P.; Kjaer, M.; Beyer, N. 2014: SAT0451Supervised Strength Training, NORDIC Walking or Unsupervised Home Based Exercise in Older People with Hip Osteoarthritis? A Randomized Trial. Annals of the Rheumatic Diseases 73(Suppl 2): 757.1-757

Salaru, V.; Mazur-Nicorici, L.; Revenco, N.; Lozan, O.; Sadovici, V.; Mazur, M. 2014: SAT0452Direct and Indirect Costs of Osteoarthritis the Republic of Moldova. Annals of the Rheumatic Diseases 73(Suppl 2): 757.2-757

Liu, R.; Damman, W.; Reijnierse, M.; Kloppenburg, M. 2014: SAT0453Mri Signs of Inflammation in Hand Osteoarthritis: Its Association with Pain. Annals of the Rheumatic Diseases 73(Suppl 2): 757.3-758

Jaremko, J.; McDougall, D.; Lambert, R.G.; Maksymowych, W.P. 2014: SAT0454Comparative Validation of an Electronic Overlay Enhanced Target-Lesion Based Methodology with the Volumetric Based MRI Osteoarthritis Knee Score for Scoring Bone Marrow Lesions in Osteoarthritis of the Knee: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 758.1-758

Damman, W.; Liu, R.; Kaptein, A.; Rosendaal, F.; Kloppenburg, M. 2014: SAT0455Negative Illness Perceptions Are Associated with Short-Term Disability in Patients with Hand Osteoarthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 758.2-758

Marques, A.A.; Lourenço, O.; Da Silva, J. 2014: SAT0456The Consumption of Health-Care Resources Due to Hip Fractures in Portugal Mainland A Two Years Study: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 758.3-759

Zebaze, R.M.; Libanati, C.; McClung, M.R.; Zanchetta, J.R.; Kendler, D.L.; Høiseth, A.; Wang, A.; Ghasem-Zadeh, A.; Seeman, E. 2014: SAT0457Reduced Hip Cortical Porosity with Denosumab (DMAB) Treatment in Women with Osteoporosis. Annals of the Rheumatic Diseases 73(Suppl 2): 759.1-759

Krishna, A.; Mellström, D.; Li, Z.; Fan, C.-P.S.; Salomonsson, S.; Waern, E. 2014: SAT0459Characteristics, Treatments, and Quality of Life of Patients in A Swedish Osteoporosis Patient Registry. Annals of the Rheumatic Diseases 73(Suppl 2): 760.1-760

Seriolo, B.; Brizzolara, R.; Soldano, S.; Casabella, A.; Molfetta, L.; Paolino, S.; Cimmino, M.A.; Botticella, G.; Cutolo, M. 2014: SAT0460Low Bone Mass in Patients with Systemic Sclerosis: Relationships with Dickkopf-1 Levels and 25-Hydroxyvitamin D Status. Annals of the Rheumatic Diseases 73(Suppl 2): 760.2-760

Haouichat, C.; Hammoumraoui, N.; Lehtihet, S.; Djoudi, H. 2014: SAT0461Prevalence of Postmenopausal Osteoporosis in Algerian Women. Annals of the Rheumatic Diseases 73(Suppl 2): 760.3-760

Lee, C.-H.; Oh, J.-M.; Yoo, W.-H.; Beak, S.-H.; Choi, J.-J.; Choi, S.-W.; Yeon, J.-T.; Lee, W.-S.; Lee, M.-S. 2014: SAT0462Overexpression of Prohibitin-1 Inhibits Rankl-Induced Activation of P38-Elk-1-Sre Signaling Axis Blocking MKK6 Activity. Annals of the Rheumatic Diseases 73(Suppl 2): 761.1-761

Roux, C.; Papapoulos, S.; Lippuner, K.; Lin, C.J.; Kendler, D.; Lewiecki, E.M.; Brandi, M.L.; Czerwinski, E.; Franek, E.; Lakatos, P.; Mautalen, C.; Minisola, S.; Reginster, J.-Y.; Jensen, S.; Daizadeh, N.; Wang, A.; Gavin, M.; Wagman, R.B.; Bone, H.G. 2014: SAT0463Effect of Eight Years of Denosumab Treatment in Postmenopausal Women with Osteoporosis: Five-Year Results from the Freedom Extension. Annals of the Rheumatic Diseases 73(Suppl 2): 761.2-761

Jauregui, E.; Galvis, M.; Moncaleano, V.; Aldana, C.; Munoz, Y. 2014: SAT0464 Bone Mineral Density Reference Value by Densitometry (DXA) and Prevalence of Osteoporosis in A Healthy Adult Population from Bogota, Colombia. Annals of the Rheumatic Diseases 73(Suppl 2): 761-762

Malyuta, E.; Korchuganov, P.; Voronkina, A.; Raskina, T.; Averkieva, J.; Kokov, A.; Barbarash, O. 2014: SAT0465Osteopenic Syndrome and Atherosclerosis of Extracranial Arteries among Males with Coronary Heart Disease. Annals of the Rheumatic Diseases 73(Suppl 2): 762.1-762

Casado, E.; Malouf, J.; Salas, E.; Caamano, M.; Castaneda, S.; Sanchez-Burson, J. M.; Herrero-Beaumont, G. 2014: SAT0466 Bisphosphonate Drug Holiday: Results from the ESTRATOS Survey. Annals of the Rheumatic Diseases 73(Suppl 2): 762-762

Delgado Frías, E.; Ferraz-Amaro, I.; Hernández-Hernández, V.; Gόmez Rodríguez-Bethencourt, M.; González-Díaz, A.; Muñiz, J.; de Vera-González, A.; González-Rivero, A.; Díaz-González, F. 2014: SAT0467Relationship of Body Composition and Abdominal Adiposity with Bone Mineral Density in Patients with Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 762.3-763

Conversano, F.; Pisani, P.; Greco, A.; Soloperto, G.; Muratore, M.; Casciaro, S. 2014: SAT0468An Innovative Ultrasound-Based Method for the Estimation of Osteoporotic Fracture Risk. Annals of the Rheumatic Diseases 73(Suppl 2): 763.1-763

Kageyama, G.; Okano, T.; Yamamoto, Y.; Sugiyama, D.; Tsuji, G.; Tsuda, K.; Takahashi, S.; Nishida, M.; Akashi, K.; Nishimura, K.; Sendo, S.; Kogata, Y.; Saegusa, J.; Kawano, S.; Kumagai, S.; Morinobu, A. 2014: SAT0469Ineffective Fracture Prevention by Bisphosphonate in Patients Undergoing High Dose Glucocorticoid Therapy with A Frax Ten Year Probability Greater than 5.8%. Annals of the Rheumatic Diseases 73(Suppl 2): 763.2-763

Kishimoto, H.; Nishiyama, S.; Yoshinaga, Y.; Aita, T.; Ohashi, K.; Miyawaki, S.; Miyoshi, S.; Yoshihara, Y.; Toda, M.; Tsuno, M. 2014: SAT0470Matrix Metalloproteinase-3 (MMP-3) Correlates with Low Bone Mineral Density (BMD) at the Lumbar Spine, but not at the Femoral Neck in Patients with Systematic Lupus Erythematosus (SLE). Annals of the Rheumatic Diseases 73(Suppl 2): 763.3-764

Jiménez-Moleόn, I.; Morales, P.; Juarez, M.; Raya, E. 2014: SAT0471Cathepsin K is A Bone Remodelling Marker in Females with Postmenopausal Osteoporosis. Annals of the Rheumatic Diseases 73(Suppl 2): 764.1-764

Fowler, J.; Mitchell, K.; Bukhari, M. 2014: SAT0472The Effect of Aromatase Inhibitors on Different Sites of the Human Skeleton an Observational Case-Control Study. Annals of the Rheumatic Diseases 73(Suppl 2): 764.2-764

Fowler, J.; Mitchell, K.; Bukhari, M. 2014: SAT0473Predictive Factors of Longitudinal Bone Loss in Patients Treated with Aromatase Inhibitors for Breast Cancer. Annals of the Rheumatic Diseases 73(Suppl 2): 764.3-765

Cotton, J.; Bukhari, M.; Oldroyd, A. 2014: SAT0474Predictors of Bone Loss in Men Treated with Androgen Deprivation Therapy for Prostate Cancer: an Observational Study: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 765.1-765

Borges, J.; Fernandes, S.; Gonçalves, I.; Cardoso, A.; Simão, R.; Fernandes, R.; Vila, I.; Pires, G.; Barcelos, F.; Cunha-Miranda, L.; Santos, H.; Leitão, R.; Coelho, P.; Parente, M.; Simões, E.; Vaz Patto, J. 2014: SAT0475Serum Protein Levels, Fall Occurrence, Bone Fractures and Nutrition in Rheumatic Patients is There Any Relationship?. Annals of the Rheumatic Diseases 73(Suppl 2): 765.2-765

Valero Sanz, J.L.; Grau Garcia, E.; Molina Almela, C.; Chalmeta Verdejo, I.; Martinez Cordellat, I.; Feced Olmos, C.; Negueroles Albuixech, R.; Gonzalez Puig, L.; Muñoz Guillen, M.L.; Nuñez-Cornejo Piquer, C.; Alcañiz Escandell, C.; Ivorra Cortes, J.; Roman Ivorra, J.A. 2014: SAT0476Vitamin D Supplementation in Liver Transplant Patients: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 765.3-766

Sunmboye, K.O.; Sheldon, P. 2014: SAT0477A Fracture-Liaison Service at Zero Cost? A University Teaching Hospital Experience. Annals of the Rheumatic Diseases 73(Suppl 2): 766.1-766

Gifre, L.; Vidal, J.; Portell, E.; Monegal, A.; Muxi, A.; Guañabens, N.; Peris, P. 2014: SAT0478Effect of Complete Spinal Cord Injury on Bone Turnover and Bone Mineral Density (BMD) Evolution. A One Year Follow-Up Study. Annals of the Rheumatic Diseases 73(Suppl 2): 766.2-766

Geller, M.; Wagman, R.; Ho, P.; Siddhanti, S.; Stehman-Breen, C.; Watts, N.; Papapoulos, S. 2014: SAT0479Early Findings from Prolia Post-Marketing Safety Surveillance for Atypical Femoral Fracture, Osteonecrosis of the Jaw, Severe Symptomatic Hypocalcemia, and Anaphylaxis. Annals of the Rheumatic Diseases 73(Suppl 2): 766.3-767

Ushikubo, M.; Kuda, H.; Ito, H.; Izumi, K.; Tamaki, S.; Akiya, K.; Tanaka, I.; Oshima, H. 2014: SAT0481Clinical Factors for Incident Vertebral Fractures Treated with Bisphosphonates in Glucocorticoid-Induced Osteoporosis. Who Needs to Use Other Anti-Osteoporotic Agents?. Annals of the Rheumatic Diseases 73(Suppl 2): 767.2-767

Bernad, M.; Garcés, M.; Martín Mola, E. 2014: SAT0483Denosumab Compared with Alendronate in Osteoporotic Postmenopausal Women Previously Treated with Alendronate. Annals of the Rheumatic Diseases 73(Suppl 2): 768.1-768

Bernardes, M.; Machado, J.C.; Vieira, T.; Gonçalves, D.; Vieira, R.; Fonseca, R.; Madureira, P.; Abelha-Aleixo, J.; Bernardo, A.; Pereira, J.G.; Martins, M.J.; Costa, L.; Simões-Ventura, F. 2014: SAT0484Bsmi VDR Gene Polymorphism is Associated with Bone Mineral Density and Bone Metabolism in Established Rheumatoid Arthritis Patients. Annals of the Rheumatic Diseases 73(Suppl 2): 768.2-768

Ishibashi, M.; Watanabe, M.; Ochi, K.; Furuya, T.; Inoue, E.; Ishida, O.; Yano, K.; Sakuma, Y.; Yoshida, S.; Ikari, K.; Taniguchi, A.; Yamanaka, H.; Momohara, S. 2014: SAT0485Risk Factors for Proximal Humerus Fracture in Japanese Patients with Rheumatoid Arthritis: A Prospective Observational Cohort Study. Annals of the Rheumatic Diseases 73(Suppl 2): 768.3-769

Guañabens, N.; Filella, X.; Monegal, A.; Gomez-Vaquero, C.; Bonet, M.; Buquet, D.; Casado, E.; Cerda, D.; Erra, A.; Martinez, S.; Montala, N.; Pitarch, C.; Kanterewicz, E.; Sala, M.; Suris, X.; Torres, F. 2014: SAT0486Reference Intervals for Bone Turnover Markers in Spanish Premenopausal Women. Annals of the Rheumatic Diseases 73(Suppl 2): 769.1-769

Dempster, D.; Kendler, D.L.; Boonen, S.; Bolognese, M.; Chapurlat, R.; Goemaere, S.; Hyldstrup, L.; Lewiecki, E.M.; Miller, P.; Yang, Y.-C.; Wagman, R.; Langdahl, B. 2014: SAT0487Denosumab (DMAB) Effect on Bone Histology and Histomorphometry in Men with Low Bone Mineral Density (BMD): Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 769.2-769

Vieira, R.; Araújo, F.; Costa, L.; Lopes, C.; Lucas, R. 2014: SAT0488Clinical Screening Tools to Identify Men with Low Bone Mass: A Systematic Review. Annals of the Rheumatic Diseases 73(Suppl 2): 769.3-770

Vieira, R.; Severo, M.; Costa, L.; Lopes, C.; Lucas, R. 2014: SAT0489Upper Arm Circumference Measurement Improves Screening for Low Bone Mineral Density in Men. Annals of the Rheumatic Diseases 73(Suppl 2): 770.1-770

Paolino, S.; Seriolo, B.; Casabella, A.; Sulli, A.; Pizzorni, C.; Botticella, G.; Meroni, M.; Cutolo, M. 2014: SAT0490Vitamin D Serum Levels Correlate with Bone Mass Values in Postmenopausal Systemic Sclerosis Patients. Annals of the Rheumatic Diseases 73(Suppl 2): 770.2-770

Casciaro, S.; Conversano, F.; Franchini, R.; Casciaro, E.; Chiriacò, F.; Renna, M.D.; Muratore, M. 2014: SAT0491Accuracy of A New Ultrasonic Method for Osteoporosis Diagnosis on Lumbar Spine. Annals of the Rheumatic Diseases 73(Suppl 2): 770.3-771

Stoica, S.; Zugravu, G. 2014: SAT0492Risedronate for Prevention of Steroid Induced Osteoporosis in Rheumatoid Arthritis Pacients. Annals of the Rheumatic Diseases 73(Suppl 2): 771.1-771

Novkovic, S.; Marinkovic, G.; Prodanovic, S.; Panic, M.; Terek, M. 2014: SAT0493The Relation of Age, Bone Microarhitecture Index (TBS), and Bone Mineral Density (BMD) in Healthy Women in Menopause. Annals of the Rheumatic Diseases 73(Suppl 2): 771.2-771

Fernandes, S.; Borges, J.; Goncalves, I.; Cardoso, A.; Fernandes, R.; Simao, R.; Vila, I.; Pires, G.; Barcelos, F.; Cunha-Miranda, L.; Santos, H.; Leitao, R.; Coelho, P.; Parente, M.; Simoes, E.; Vaz Patto, J. 2014: SAT0494 Protein Intake and Body Composition Relationship in A Rheumatic Patient Population. Annals of the Rheumatic Diseases 73(Suppl 2): 771-771

Vardanyan, V.; Ginosyan, K.; Simonyan, A.; Matsakyan, G. 2014: SAT0496 Efficacy of Strontium Ranelate in the Treatment of Glucocorticoid- Induced Osteoporosis. Annals of the Rheumatic Diseases 73(Suppl 2): 772-772

Lee, W.S.; Min, I.-S.; Choi, Y.-J.; Lee, C.-H.; Lee, M.-S.; Yoo, W.-H. 2014: SAT0497Effect of Raloxifene on Osteoporosis and Disease Activity in Postmenopausal Female with Rheumatic Diseases. Annals of the Rheumatic Diseases 73(Suppl 2): 772.3-772

Naito, Y.; Wakabayashi, H.; Nakagawa, T.; Iino, T.; Sudo, A. 2014: SAT0498Alendronate Inhibits Hyperalgesia and Suppresses Neuropeptide Markers of Pain in A Mouse Model of Osteoporosis. Annals of the Rheumatic Diseases 73(Suppl 2): 772.4-773

Farah, Z.; Sbai, M.; Reddy, V. 2014: SAT0499Falling Standards and Breaking Bad Habits: an Evaluation of Clinical Practice. Annals of the Rheumatic Diseases 73(Suppl 2): 773.1-773

Balkarlı, A.; Tepeli, E.; Çobankara, V. 2014: SAT0500Frequency of MEFV Gene Mutation and Correlatin of MEVF Gene Mutation with Clinical Symptoms in Patients with Gout. Annals of the Rheumatic Diseases 73(Suppl 2): 773.2-773

Scirè, C.A.; Carrara, G.; Manara, M.; Cimmino, M.; Govoni, M.; Salaffi, F.; Punzi, L.; Montecucco, C.; Matucci-Cerinic, M.; Minisola, G. 2014: SAT0501Clinical Predictors of Functional Disability in Patients with Gout: Analysis from A Multicentre Observational Study of the Italian Society for Rheumatology:. Annals of the Rheumatic Diseases 73(Suppl 2): 774.1-774

Guillen Astete, C.A.; Boteanu, A.; Zea, A. 2014: SAT0502Comparison between Oral or Intra-Articular Corticoids in the Management of Acute Gout Flare in Patients with Chronic Renal Failure. Annals of the Rheumatic Diseases 73(Suppl 2): 774.2-774

Kuo, C.-F.; Grainge, M.J.; Mallen, C.; Zhang, W.; Doherty, M. 2014: SAT0503Eligibility for Urate-Lowering Treatment around the Time of Diagnosis in Gout Patients: A Nationwide Population Study. Annals of the Rheumatic Diseases 73(Suppl 2): 774.3-775

Cosso, C.; Barbieri, F.; Franconeri, A.; Piccazzo, R.; Fabbro, E.; Seriolo, B.; Garlaschi, G.; Cutolo, M.; Cimmino, M.A. 2014: SAT0504Mri Bone Marrow Oedema is A Frequent Feature in Patients with Gout. Annals of the Rheumatic Diseases 73(Suppl 2): 775.1-775

Mikhnevich, E.; Artichevskaja, N. 2014: SAT0505Factors Associated with Destabilized Hypertension during the Treatment of Gouty Arthritis with Nsaids. Annals of the Rheumatic Diseases 73(Suppl 2): 775.2-775

Contant, E.; Ornetti, P.; Bohm, A.; Fortunet, C.; Maillefert, J.F. 2014: SAT0506Interest of Musculoskeletal Ultrasound in the Diagnosis of Calcium Pyrophosphate Dihydrate Deposition Disease. Annals of the Rheumatic Diseases 73(Suppl 2): 775.3-775

Sheng, F.; Fang, W.; Zeng, X. 2014: SAT0507The Analysis of Factors Associated with Treatment Adherence of Gout: A Patient Survey in China. Annals of the Rheumatic Diseases 73(Suppl 2): 776.1-776

Perez-Ruiz, F.; Castillo, E.; Chinchilla, S.P.; Herrero-Beites, A.M. 2014: SAT0508Coexistence of Gout and Pyrophosphate Arthritis in Two Large Cohorts: Hyperuricemia as A Factor for Clinical Misdiagnosis. Annals of the Rheumatic Diseases 73(Suppl 2): 776.2-776

Filippou, G.; Adinolfi, A.; Carta, S.; Santoro, P.; Bertoldi, I.; Ferrata, P.; Galeazzi, M.; Frediani, B. 2014: SAT0510Ultrasound versus Synovial Fluid Analysis for the Diagnosis of Calcium Pyrophosphate Dihydrate Deposition Disease: is IT Cppd? Ask Us!. Annals of the Rheumatic Diseases 73(Suppl 2): 776.4-777

Ko, J.-Y.; Im, G.-I. 2014: SAT0511Osteogenic Differentiation of Human Induced Pluripotent Stem Cells. Annals of the Rheumatic Diseases 73(Suppl 2): 777.1-777

Im, G.-I.; Kim, K.-I. 2014: SAT0512Influence of Cocultured Adipose-Derived Stem Cells on Osteogenic Differentiation and Angiogenesis of Bone Marrow Stem Cells. Annals of the Rheumatic Diseases 73(Suppl 2): 777.2-777

Ea, H.K.; Maravic, M. 2014: SAT0513Hospital Burden of Gout, Pseudogout and Other Crystal Arthropathies in France from 2009 to 2011:. Annals of the Rheumatic Diseases 73(Suppl 2): 777.3-778

Ea, H.K.; Rat, A.C.; Sellam, J.; Fellahi, S.; Bastard, J.-P.; Bernard, L.; Chevalier, X.; Capeau, J.; Berenbaum, F.; Guillemin, F.; Richette, P. 2014: SAT0514Does Hyperuricemia Worsen Pain and Function in Patients with Knee or Hip OA? Results from the Khoala Cohort. Annals of the Rheumatic Diseases 73(Suppl 2): 778.1-778

Gharsallah, I.; Laanani, A.; Dhahri, R.; Ajili, F.; Metoui, L.; Boussetta, N.; Ben Abdelhafidh, N.; Louzir, B.; Othmani, S. 2014: SAT0515 Brucellosis: Clinical Manifestations Complications and Treatment (42 CASES). Annals of the Rheumatic Diseases 73(Suppl 2): 778-778

Kim, I.Y.; Park, E.-J.; Jung, H.; Kim, H.; Jeon, C.H.; Kim, J.; Lee, J.; Koh, E.-M.; Cha, H.-S. 2014: SAT0517Prognostic Value of Long-Term Cumulative Uric Acid Level on Cardiovascular Diseases in Gout Patients with Treatment. Annals of the Rheumatic Diseases 73(Suppl 2): 779.1-779

Arnada Arreola, E.; Pelaez Ballestas, I.; Alvarez Hernandez, E.; Rull Gabayet, M.; Pascual, V.; Burgos-Vargas, R.; Vazquez Mellado, J. 2014: SAT0518Coping Patterns and Associated Factors in an Inception Cohort of Patients with Gout:. Annals of the Rheumatic Diseases 73(Suppl 2): 779.2-779

Singh, J.A. 2014: SAT0520The Impact of Gout on Patient's Lives and Differences by Race and Gender: A Patient Perspective. Annals of the Rheumatic Diseases 73(Suppl 2): 779.4-780

Tan, P. K.; Hyndman, D.; Miner, J. N. 2014: SAT0521 Lesinurad, an Inhibitor of the Uric Acid Transporter URAT1 and A Potential Therapy for Gout, Requires URAT1 Phenylalanine 365 for High Affinity Inhibition. Annals of the Rheumatic Diseases 73(Suppl 2): 780-780

Oh, J.S.; Choi, S.W.; Ku, B.S.; Hong, S.C.; Kim, Y.J.; Koo, B.S.; Kim, Y.-G.; Lee, C.-K.; Yoo, B. 2014: SAT0522The Association between Uric Acid Level and Urolithiasis on Ultrasonography. Annals of the Rheumatic Diseases 73(Suppl 2): 780.2-780

Song, J.S.; Choi, S.T.; Park, E.H. 2014: SAT0523The Usefulness of Procalcitonin for Differentiating Acute Gout Arthritis from Infectious Disease. Annals of the Rheumatic Diseases 73(Suppl 2): 780.3-781

Audet, M.- C.; Beaudoin, C.; Guay-Belanger, S.; Dumont, J.; Brown, J. P.; Michou, L. 2014: SAT0525 Environmental Factors Associated with Paget's Disease of Bone or with the Sqstm1/P392l Mutation Carriage. Annals of the Rheumatic Diseases 73(Suppl 2): 781-781

Eliseev, M.; Vladimirov, S.; Nasonov, E. 2014: SAT0526The Frequency of Calcium Pyrophosphate Deposition Disease in Patients with Acute Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 781.3-782

Schlesinger, N.; Etzel, C. J.; Greenberg, J. D.; Kremer, J. M.; Harrold, L. R. 2014: SAT0527 Gout Flare Prophylaxis Evaluated According to the 2012 American College of Rheumatology (ACR) Guidelines: Analysis from the Corrona Gout Registry. Annals of the Rheumatic Diseases 73(Suppl 2): 782-782

Dalbeth, N.; Gamble, G.D.; Horne, A.; Reid, I.R. 2014: SAT0529Relationship between Changes in Serum Urate and Bone Mineral Density during Treatment with Thiazide Diuretics: Secondary Analysis from A Randomised Controlled Trial. Annals of the Rheumatic Diseases 73(Suppl 2): 782.3-782

Aati, O.; Taylor, W.; Seigert, R.; Horne, A.; House, M.; Tan, P.; Drake, J.; Stamp, L.; Dalbeth, N. 2014: SAT0530Development of A Patient Reported Outcome Measure of Tophus Burden: the Tophus Impact Questionnaire (TIQ-20). Annals of the Rheumatic Diseases 73(Suppl 2): 783.1-783

Richette, P.; Doherty, M.; Pascual, E.; Barskova, V.; Becce, F.; Coyfish, M.; Janssens, H.; Jansen, T.; Liote, F.; Mallen, C.; Nuki, G.; Perez-Ruiz, F.; Pimentao, J.; Piwell, T.; Punzi, L.; So, A.; Tausche, A.- K.; Uhlig, T.; Zavada, J.; Zhang, W.; Tubach, F.; Bardin, T. 2014: SAT0531 Updated Eular Evidence-Based Recommendations for the Management of Gout. Annals of the Rheumatic Diseases 73(Suppl 2): 783-783

Richette, P.; Pascual, E.; Doherty, M.; Barskova, V.; Becce, F.; Coyfish, M.; Janssens, H.; Jansen, T.; Liote, F.; Mallen, C.; Nuki, G.; Perez-Ruiz, F.; Pimentao, J.; Piwell, T.; Punzi, L.; So, A.; Tausche, A.- K.; Uhlig, T.; Zavada, J.; Zhang, W.; Tubach, F.; Bardin, T. 2014: SAT0532 Updated Eular Evidence-Based Recommendations for the Diagnosis of Gout. Annals of the Rheumatic Diseases 73(Suppl 2): 783-784

Fabreguet, I.; So, A.; Dumusc, A.; Aubry-Rozier, B.; Zufferey, P. 2014: SAT0533Utility of Joint Ultrasonography in the Diagnosis of Suspected Acute Crystal Arthritis Results of A Prospective Controlled Study of 90 Patients: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 784.1-784

Gow, P.; He, J. 2014: SAT0534How Healthy Are Our Patients with Gout? A Study of Health Status and Management of Patients with Gout at Two Primary Heath Care Practices. Annals of the Rheumatic Diseases 73(Suppl 2): 784.2-784

Juge, P.-A.; Ottaviani, S.; Aubrun, A.; Palazzo, E.; Dieudé, P. 2014: SAT0535Sensitivity and Reproducibility of Ultrasonography in Calcium Pyrophosphate Crystal Deposition: A Case-Control Study. Annals of the Rheumatic Diseases 73(Suppl 2): 784.3-785

Alten, R.; Schlesinger, N.; So, A.; Schumacher, H.R.; Bloch, M.T.; Machein, U.; Richard, D.; Lheritier, K.; Bardin, T. 2014: SAT0537Long-Term Safety and Efficacy of Canakinumab VS Triamcinolone Acetonide in Patients with Frequent Acute Gouty Arthritis Attacks Who Are Contraindicated, Intolerant or Unresponsive to NSAIDS And/Or Colchicine. Annals of the Rheumatic Diseases 73(Suppl 2): 785.2-785

Gancheva, R.N.; Kundurdjiev, A.; Ivanova, M.; Rashkov, R.; Kundurdjiev, T.; Kolarov, Z. 2014: SAT0538Ultrasonographic Examination of Target Organs in Gout. Annals of the Rheumatic Diseases 73(Suppl 2): 785.3-786

Warrell, R. P.; Klukovits, A.; Barnes, K.; Satyanarayana, C.; Cheeseman, C.; Piwinski, J. 2014: SAT0539 Novel Bifunctional Inhibitors of Xanthine Oxidase and URAT1 Induce Profound Hypouricemia in Human Subjects. Annals of the Rheumatic Diseases 73(Suppl 2): 786-786

Wood, R.; Johnson, J.; Morlock, R.; Baumgartner, S.; Ramachandran, S. 2014: SAT0540Gout Patients Treated with Conventional Urate-Lowering Therapy: Association between Disease Control and Work Productivity. Annals of the Rheumatic Diseases 73(Suppl 2): 786.2-786

Wood, R.; Johnson, J.; Morlock, R.; Baumgartner, S.; Ramachandran, S. 2014: SAT0541Gout Patients Treated with Conventional Urate-Lowering Therapy: Association between Disease Control and Health-Related Quality of Life. Annals of the Rheumatic Diseases 73(Suppl 2): 786.3-787

Kim, S.-K.; Choe, J.-Y.; Park, S.-H.; Lee, H. 2014: SAT0542Oxidative Stress by Monosodium Urate Crystals Promotes Renal Cell Apoptosis through Mitochondrial Caspase-Dependent Pathway in Human Embryonic Kidney 293 Cells. Annals of the Rheumatic Diseases 73(Suppl 2): 787.1-787

Liu, S.; Hyndman, D.; Cravets, M.; Miner, J.N. 2014: SAT0543A Novel Equation to Effectively Estimate 24-Hour Urinary Uric Acid Excretion. Annals of the Rheumatic Diseases 73(Suppl 2): 787.2-787

Bardin, T.; Bouée, S.; Clerson, P.; Chalès, G.; Doherty, M.; Flipo, R.-M.; Lambert, C.; Lioté, F.; Poiraud, T.; Schaeverbeke, T.; Richette, P. 2014: SAT0544Prevalence of Gout in the Adult Population of France in 2013. Annals of the Rheumatic Diseases 73(Suppl 2): 787.3-788

Leturc, T.; Ea, H.K.; Mehsen, N.; Truchetet, M.-E.; Parlier, C.; Hamze, B.; Hauger, O.; Laredo, J.-D.; Orcel, P.; Schaeverbeke, T.; Bousson, V. 2014: SAT0545Efficacy of Bisphosphonate in 17 Cases of Osteoid Osteoma. Annals of the Rheumatic Diseases 73(Suppl 2): 788.1-788

Youssef, A. A.-R.; Afifi, A.E.A.; Abd El Ghaffar, H.A.; El-Basuny, S.R.; Gharbia, O.M.; El hawary, A.K.; Mansour, A.L.; Abd el hamid, A.E.; Ezzat, A.A. 2014: SAT0546The Regenerative Effect of Human Umbilical Cord Blood Mesenchymal Stem Cells in A Rabbit Model of Osteoarthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 788.2-789

Torrent, A.; Montell, E.; Vergés, J.; Ruhí, R.; Meilin, S.; Sonego, H.; Mainil-Varlet, P. 2014: SAT0547Chondroprotective Activity of Acti-Joint, A Combination of Chondroitin Sulphate, Glucosamine and A Natural Ingredient Rich in Hyaluronic Acid. Annals of the Rheumatic Diseases 73(Suppl 2): 789.1-789

Puchner, A.; Blüml, S.; Saferding, V.; Goncalves-Alves, E.; Leiss, H.; Hayer, S.; Smolen, J.; Redlich, K. 2014: SAT0549Osteoclast Precursors Are Reugulated by Proinflammatory Cytokines and Arise before Clinical Onset of Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 789.3-790

Harvey, B.P.; Kaymakcalan, Z. 2014: SAT0550Inhibition of Tnf-Enhanced Human Osteoclast Function by Adalimumab is Influenced by Complex Formation in the Absence of FC Receptor Binding. Annals of the Rheumatic Diseases 73(Suppl 2): 790.1-790

Relier, M.; Touraine, S.; Bouhadoun, H.; Engelke, K.; Laredo, J.-D.; Chappard, C. 2014: SAT0551Location Dependence of the Microstructure of Cartilage and of Subchondral Cortical and Trabecular Bone Microstructure in Knees with NO or Mild OA Assessed by High Resolution Micro-Computed Tomography. Annals of the Rheumatic Diseases 73(Suppl 2): 790.2-790

Byrne, R.; von Dalwigk, K.; Steiner, G.; Holinka, J.; Windhager, R.; Smolen, J.S.; Kiener, H.; Scheinecker, C. 2014: SAT0552Fibroblast-Like Synovial Cells and Monocytes TEAM up in the Organization and the Dynamic Modeling of the Synovial Tissue. Annals of the Rheumatic Diseases 73(Suppl 2): 790.3-791

Sagar, D.R.; Markides, H.; Burston, J.J.; Kehoe, O.; El Haj, A.J.; Chapman, V. 2014: SAT0554Intra-Articular Injection of Mesenchymal Stem Cells Improves Pain Behaviour in A Model of OA Pain. Annals of the Rheumatic Diseases 73(Suppl 2): 791.2-791

Neumann, E.; Zimmermann, B.; Köppert, S.; Rehart, S.; Müller-Ladner, U. 2014: SAT0555Transmigration and Mobility of Rheumatoid Arthritis Synovial Fibroblasts is Dependent on Distinct Interaction Processes with Endothelial Cells. Annals of the Rheumatic Diseases 73(Suppl 2): 791.3-792

Im, G.-I.; Kim, E.-A.; Lee, J.-M.; Ahn, J.-M. 2014: SAT0556Transcription Factor SPB-X is A Key Molecule Inducing Hypertrophy of Differentiated Chondrocyte from Msc. Annals of the Rheumatic Diseases 73(Suppl 2): 792.1-792

Scholtysek, C.; Ipseiz, N.; Djouad, F.; Schett, G.; Krönke, G. 2014: SAT0557Osteoblast-Specific Expression of the Nuclear Receptor Ppar-Delta Controls Bone and Glucose Homeostasis. Annals of the Rheumatic Diseases 73(Suppl 2): 792.2-792

Kim, H.R.; Kim, H.-H.; Lee, S.-H. 2014: SAT0558Vegf Promotes RANKL Expression and Osteoclastogenesis in Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 792.3-792

Bleil, J.; Appel, H.; Maier, R.; Sieper, J.; Syrbe, U. 2014: SAT0559High Expression of Cyclooxygenase-2, Prostaglandin E2 and Prostaglandin E2 Receptor Ep4 in Zygapophyseal Joints of Patients with Ankylosing Spondylitis: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 792.4-793

Valverde-Franco, G.; Hum, D.; Lussier, B.; Matsuo, K.; Pelletier, J.-P.; Kapoor, M.; Martel-Pelletier, J. 2014: SAT0560The in Vivo Role of Bone Specific Ephb4 Receptor Overexpression in Osteoarthritic Synovial Membrane. Annals of the Rheumatic Diseases 73(Suppl 2): 793.1-793

Valverde-Franco, G.; Lussier, B.; Hum, D.; Wu, J.; Pelletier, J.-P.; Kapoor, M.; Martel-Pelletier, J. 2014: SAT0561In Vivo Cartilage-Specific Deletion of Ephrin-B2 in Mice Results in Bone Development Leading to Osteoarthritis Features. Annals of the Rheumatic Diseases 73(Suppl 2): 793.2-794

Fujioka, K.; Kishida, T.; Kukida, Y.; Nagahara, H.; Fujii, W.; Murakami, K.; Seno, T.; Yamamoto, A.; Kohno, M.; Mazda, O.; Kawahito, Y. 2014: SAT0562Directly Reprogrammed Osteoblasts Genetically Engineered to Produce Interleukin-10 Significantly Suppress Osteoclastgenesis. Annals of the Rheumatic Diseases 73(Suppl 2): 794.1-794

Rauwolf, K.; Beckmann, D.; Hansen, U.; Kronenberg, D.; Gullberg, D.; Korb-Pap, A.; Pap, T. 2014: SAT0563Integrin a11b1 is Induced in Synovial Fibroblasts of Arthritic Htnftg Mice. Annals of the Rheumatic Diseases 73(Suppl 2): 794.2-794

Schönbeck, K.; Tran, C.L.; Strehl, C.; Gaber, T.; Jakstadt, M.; Röhner, E.; Burmester, G.R.; Buttgereit, F.; Hoff, P. 2014: SAT0564Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) Expressed in Human Mesenchymal Stromal Cells. Annals of the Rheumatic Diseases 73(Suppl 2): 794.3-794

Pleštilová, L.; Aradi, B.; Filková, M.; Šenolt, L.; Ciurea, A.; Gay, R.E.; Vencovský, J.; Neidhart, M.; Gay, S.; Jüngel, A. 2014: SAT0565The Expression and Regulation of the Argonaute Protein Family Member PIWIL4 in RA. Annals of the Rheumatic Diseases 73(Suppl 2): 795.1-795

Lourido, L.; Calamia, V.; Fernández-Puente, P.; Mateos, J.; Rocha, B.; Fernández-Costa, C.; Blanco, F.J.; Ruiz-Romero, C. 2014: SAT0566Protein Profiling of Cartilage Secretome to Identify A Novel Panel of OA Biomarkers. Annals of the Rheumatic Diseases 73(Suppl 2): 795.2-795

Kondo, M.; Yamaoka, K.; Sonomoto, K.; Nakano, K.; Tanaka, Y. 2014: SAT0568IL-6-Stat3-Signaling Enhances Chondrogenic Differentiation of Human Mesenchymal Stem Cells. Annals of the Rheumatic Diseases 73(Suppl 2): 796.1-796

Hafsia, N.; Poirier, F.; Delacour, D.; Reboul, P.; Côme, D.; Van Lent, P.; Cohen-Solal, M.; Lioté, F.; Ea, H.K. 2014: SAT0569Galectin 3 Exerts A Protective Role in A Murine Model of Osteoarthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 796.2-796

Perniola, S.; Lacarpia, N.; Bizzoca, R.; Natuzzi, D.; Notarnicola, A.; Moretti, B.; Lapadula, G.; Iannone, F. 2014: SAT0571Role of Obesity in the Expression of Cytokines and Metalloproteinases in Human Osteoarthritis Chondrocytes. Annals of the Rheumatic Diseases 73(Suppl 2): 797.1-797

Machida, T.; Nishida, K.; Hashizume, K.; Nakahara, R.; Ozawa, M.; Harada, R.; Ozaki, T. 2014: SAT0572The Effect of Interleukin-4 on Mechanical Stress-Induced Protease Expressions by Human Chondrocytes. Annals of the Rheumatic Diseases 73(Suppl 2): 797.2-797

Geurts, J.; Pippenger, B.; Hirschmann, M.T.; Müller-Gerbl, M.; Valderrabano, V.; Hügle, T. 2014: SAT0573Spatial Association of Subchondral Osteosclerosis and Immune Cell Infiltration in Osteoarthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 797.3-798

Calamia, V.; Lourido, L.; Mateos, J.; Fernández-Puente, P.; Fernández, C.; Rocha, B.; Blanco, F.J.; Ruiz-Romero, C. 2014: SAT0574Peptidomic Analysis of Cartilage Secretome for the Discovery of Early OA Biomarkers. Annals of the Rheumatic Diseases 73(Suppl 2): 798.1-798

Sagawa, A.; Funahashi, K.; Matsubara, T.; Izumihara, T.; Adachi, M.; Iwahasi, M.; Oyama, T.; Nishioka, Y.; Hashimoto, K.; Oribe, M.; Takahashi, Y. 2014: SAT0575Ra Patients' Expectations of Treatment - Comparison with the Result of Surveys in Multi-Cohort-. Annals of the Rheumatic Diseases 73(Suppl 2): 798.2-798

Cividino, A.; Bakowsky, V.; Bessette, L.; Homik, J.; Khalidi, N.; Pineau, C.A.; Pope, J.; Robinson, D.; Shojania, K. 2014: SAT0576Creating New Rheumatologists: the Canadian Experience. Annals of the Rheumatic Diseases 73(Suppl 2): 798.3-799

Ferdman, A.S.; Bleasel, J.F.; Richards, B.L. 2014: SAT0577Attracting Australian Basic Physician Trainees to Rheumatology How Are We Doing?. Annals of the Rheumatic Diseases 73(Suppl 2): 799.1-799

Rat, A.-C.; Fautrel, B.; Flipon, E.; Gossec, L.; Marguerie, L.; Nataf, H.; Pallot Prades, B.; Poilvert, R.M.; Royant, V.; Sadji, F.; Sordet, C.; Thevenot, C.; Beauvais, C. 2014: SAT0578Patients with Rheumatoid Arthritis, Spondyloarthritis and Psoriatic Arthritis Treated with BIOLOGICS Use Similar Coping Strategies: A Study of 671 Patients:. Annals of the Rheumatic Diseases 73(Suppl 2): 799.2-799

Trouvin, A.-P.; Menard, J.-F.; Hugon, N.; Previnaire, A.-S.; Selle, S.; Lecomte, B.; Chambellan, S.; Daragon, A.; Vittecoq, O.; Pouplin, S. 2014: SAT0579Assessing the Value of an Educational Program in A Rehabilitation Program over A Week in Chronic Low Back Pain. Annals of the Rheumatic Diseases 73(Suppl 2): 799.3-800

Ahmed, A.; Balendra, S.; Collins, D.; Price, E.; Williamson, L. 2014: SAT0580Improving Patient Understanding of Combination DMARD Therapy Using Pictorial Leaflets. Annals of the Rheumatic Diseases 73(Suppl 2): 800.1-800

Ciurtin, C.; Fitz-Clarence, H.; Leandro, M. 2014: SAT0581Rheumatology Patients' Knowledge about Clinical Research. Annals of the Rheumatic Diseases 73(Suppl 2): 800.2-800

Yilmaz, S.; Kendirlioglu, S.; Kaba, K.; Ozdemir, U.; Ozturk, M.; Simsek, I. 2014: SAT0583The CASE of Case Reports in Rheumatology Literature. Annals of the Rheumatic Diseases 73(Suppl 2): 801.1-801

Viguier, M.; Rist, S.; Aubin, F.; Leccia, M.-T.; Richard, M.-A.; Gaudin, P.; Pham, T.; Richette, P.; Wendling, D.; Tubach, F. 2014: SAT0584Impact of an Online Training on Skin Cancer Diagnosing in Rheumatologists, A Nationwide Randomized Web-Based Survey. Annals of the Rheumatic Diseases 73(Suppl 2): 801.2-801

Antivalle, M.; Battellino, M.; Ditto, M.C.; Varisco, V.; Chevallard, M.; Rigamonti, F.; Batticciotto, A.; Atzeni, F.; Sarzi-Puttini, P. 2014: SAT0585Evaluation of Wikipedia Rheumatology Articles as A Learning Resource for Medical Students. Annals of the Rheumatic Diseases 73(Suppl 2): 801.3-802

Das, P.; Moorthy, A.; Makda, S.; Wells, P. 2014: SAT0586Diagnosing and Managing Inflammatory Back Pain- How Good Are Our GP Trainees?. Annals of the Rheumatic Diseases 73(Suppl 2): 802.1-802

Das, P.; Moorthy, A.; Maksymowych, W.; Pope, J. 2014: SAT0587A Comparative Study of Rheumatology Specialist Training across UK and Canada. Annals of the Rheumatic Diseases 73(Suppl 2): 802.2-802

Fischer, J.; Geurts, J.; Valderrabano, V.; Hügle, T. 2014: SAT0588Educational Quality of Knee Arthrocentesis Videos on Youtube. Annals of the Rheumatic Diseases 73(Suppl 2): 803-803

Creaser, C.; Harrison, T.; Martin, L.; Barnabe, C. 2014: SAT0589-HPRBody Mass Index and Its Relationship to Disease Activity in Early Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 1210.3-1211

Gόmez Gόmez, D.; Colόn Lόpez de Dicastillo, A.; Ochagavía Sufrategui, M.; Arnaiz de las Revillas Almajano, F.; Valero Domínguez, M. 2014: SAT0590-HPREconomic Evaluation of Biological Therapies in Rheumatic Diseases. Annals of the Rheumatic Diseases 73(Suppl 2): 1211.1-1211

Hackett, K.L.; Deane, K.; Deary, V.; Rapley, T.; Newton, J.L.; Ng, W.-F. 2014: SAT0592-HPRNon-Pharmacological Interventions for Primary SjGren's Syndrome: A Systematic Review of the Evidence. Annals of the Rheumatic Diseases 73(Suppl 2): 1211.3-1212

Willems, L.M.; Redmond, A.C.; Stamm, T.A.; Boström, C.; Decuman, S.; Tyrrell Kennedy, A.; Brozd, J.; Roškar, S.; Smith, V.; van den Ende, C.H. 2014: SAT0593-HPRNon-Pharmacological Care Provided in Clinical Practice to Treat Patients with Systemic Sclerosis: an International Survey Conducted on Behalf of the Eular Scleroderma Health Professionals Network (EUSHNET). Annals of the Rheumatic Diseases 73(Suppl 2): 1212.1-1212

Bao, Y.; Ganguli, A.; De, G.; Kelkar, S.; Curtis, J.R. 2014: SAT0595-HPRReal-World Risk of Fall-Related Injuries among Rheumatoid Arthritis (RA) Patients Treated with Tumor Necrosis Factor Inhibitors (ANTI-TNFS) or Methotrexate (MTX). Annals of the Rheumatic Diseases 73(Suppl 2): 1213-1213

Lirman, D.; Thyberg, T.; Santos, R.; Schopmeyer, S.; Drury, C.; Collado-Vides, L.; Bellmund, S.; Serafy, J. 2014: SAV Communities of Western Biscayne Bay, Miami, Florida, USA: Human and Natural Drivers of Seagrass and Macroalgae Abundance and Distribution Along a Continuous Shoreline. Estuaries and Coasts 37(5): 1243-1255

Pierdicca, N; Guerriero, L; Giusto, R; Brogioni, M; Egido, A 2014: SAVERS: A Simulator of GNSS Reflections From Bare and Vegetated Soils. IEEE Transactions on Geoscience and Remote Sensing 52(10): 6542-6554

Asgarzadeh, H; Mosaddeghi, M Reza; Nikbakht, A Mohammad 2014: SAWCal: A user-friendly program for calculating soil available water quantities and physical quality indices. Computers and Electronics in Agriculture 109: 86-93

Orujalipoor, I; Aytimur, A; Tükel, C; İde, S; Uslu, İbrahim 2014: SAXS and WAXS analysis of MgO doped ZnO nanostructured ceramics grown on Si and glass substrate. Journal of Sol-Gel Science and Technology 70(1): 125-132

Chakraborty, S.K.; Chatterjee, S.; DasGupta, A. 2014: SBAS operation in the Indian sector under simultaneous scintillation on different GNSS links. Journal of Atmospheric and Solar-Terrestrial Physics 114: 50-57

Wahl, D.R.; Stenmark, M.H.; Pollom, E.; Tao, Y.; Lee, O.E.; Schipper, M.J.; Caoili, E.M.; Ben-Josef, E.; Lawrence, T.S.; Feng, M. 2014: SBRT Provides Equivalent Local Control Compared to RFA for the Treatment of Hepatocellular Carcinoma With Minimal Toxicity. International Journal of Radiation Oncology*biology*physics 90(1): S378-S379

Duma, M.; Kroll, L.; Oechsner, M.; Andratschke, N.; Molls, M. 2014: SBRT for Lung Metastases: Should We, Should We Not?. International Journal of Radiation Oncology*biology*physics 90(5): S30-S31

Herman, M.P.; Dagan, R.; Yeung, A.R.; Bryant, C.; Morris, C.G.; Okunieff, P. 2014: SBRT for Oligometastatic Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*biology*physics 90(1): S609-S610

Su, Z.; Mamalui-Hunter, M.; Huh, S.N.; Lee, S.; Dagan, R.; Hoppe, B.S.; Nichols, R.; Bryant, C.; Li, Z. 2014: SBRT/SRS Experience Using a Vero Linac for Oligometastases. International Journal of Radiation Oncology*biology*physics 90(1): S909-S910

Cutlip, D. E. 2014: SCAI Interventional Cardiology Board Review - Second Edition. Circulation 129(23): E647-E647

Bogaard, G; Meijer, E H.; Vrij, A; Broers, N J.; Merckelbach, H 2014: SCAN is largely driven by 12 criteria: results from sexual abuse statements. Psychology Crime and Law 20(5): 430-449

Winfield, I J. 2014: Scientific Writing for Impact Factor Journals - by E. Lichtfouse. Journal of Fish Biology 84(4): 1268-1269

Mohammad Golbabaee, A Alahi… 2014: SCOOP: A Real-Time Sparsity Driven People Localization Algorithm. Journal of Mathematical Imaging and Vision 48(1): 160-175

Ayazpoor, U 2014: SCS-Therapie mit Burst-Stimulation. Info Neurologie and Psychiatrie 16(9): 68-69

Giannotti, E; Longo, M; Messina, M; Ghiglieri, A; Launay, D 2014: SCYX-7158: Reproductive toxicity studies. Toxicology Letters 229: S90-S91

Chung, E S.; Penn, M S.; Sherman, W; Anderson, R. David; Mendelsohn, F O.; Fisher, S J.; Pastore, J M.; Aras, R; Miller, L; Patel, A N. 2014: SDF-1 Plasmid Attenuates Adverse Remodeling in Ischemic Heart Failure Patients in a Randomized Phase II Trial. Journal of Cardiac Failure 20(8): S9-S10

Armstrong, E L.; Fernandes, H B.F.; Woodley, M A. 2014: SDIE and other differentiation effects in Italy and Spain. Personality and Individual Differences 68: 189-194

De Montis, A; Ledda, A; Caschili, S; Ganciu, A; Barra, M 2014: SEA effectiveness for landscape and master planning: An investigation in Sardinia. Environmental Impact Assessment Review 47: 1-13

Pangman, P; Blythe, N 2014: SEAM Update. Leading Edge 33(3): 234-236

Hiraoki, R; Fukuzumi, H; Ono, Y; Saito, T; Isogai, A 2014: SEC-MALLS analysis of TEMPO-oxidized celluloses using methylation of carboxyl groups. Cellulose 21(1): 167-176

Habersack, H; Blamauer, B; Villwock, H; Prenner, D; Hauer, C 2014: SED_AT – Feststoffhaushalt, Sedimenttransport und Flussmorphologie im Rahmen des Nationalen Gewässerbewirtschaftungsplans. Österreichische Wasser- und Abfallwirtschaft 66(9-10): 327-339

Posey, C 2014: SEG Denver 2014 online registration: SEG sees numerous improvements in exposition registration process. Leading Edge 33(8): 918-920

Sprunt, E; House, N; Capello, M Angela 2014: SEG survey on dual-career couples and women: Implications for the future of our Society. Leading Edge 33(4): 460-462

Sprunt, E; House, N; Capello, M Angela 2014: SEG survey on dual-career couples and women: The hidden diversity of dual-career couples. Leading Edge 33(7): 812-816

Chelidze, T.; Zhukova, N.; Matcharashvili, T. 2014: SEISMOTOOL: An Easy Way to See, Listen, and Analyze Seismograms. Seismological Research Letters 85(4): 889-895

Singthongla, P; Kanasri, N Rompurk 2014: SEL Series Expansion and Generalized Model Construction for the Real Number System via Series of Rationals. International Journal of Mathematics and Mathematical Sciences 2014: 1-8

Banerjee, B; Dutta, J K. 2014: SELP: A general-purpose framework for learning the norms from saliencies in spatiotemporal data. Neurocomputing 138: 41-60

Otsuka, T; Nakamura, M; Yamashita, K-ichi; Hara, M; Timischl, F; Honda, K; Kudo, M; Kitamura, S-ichi 2014: SEM Image Observation Using an Electron Energy and Electron Take-off Angle Filtered Detector. Microscopy and Microanalysis 20(S3): 36-37

Leonard, D.N.; Gardiner, D. S.; Thomas, R. L. 2014: SEM Through Dielectric Membranes: Secondary Electron Contrast Reversal. Microscopy and Microanalysis 20(S3): 24-25

Szczepanowska, H M.; Goreva, Y S. 2014: SEM and ToF-SIMS Ion Imaging Applied to Characterization of Fungal Biodeterioration of Paper in the Context of Cultural Heritage Collections. Microscopy and Microanalysis 20(S3): 2036-2037

Suarez-Alcantara, K.; Martínez-Casillas, D.C.; Zheng, K.B.; Zhu, Q.; Abdellah, M.; Haase, D.; Pullerits, T.; Solorza-Feria, O.; Canton, S.E. 2014: SEM and XAS characterization at beginning of life of Pd-based cathode electrocatalysts in PEM fuel cells. International Journal of Hydrogen Energy 39(10): 5358-5370

Musselman, I.H.; Panapitiya, N.P.; Bushdiecker, D.K.; Tomasek, M.P.; Miller, C.K.; Gilpin, C.J.; Balkus, K.J.; Ferraris, J.P. 2014: SEM, TEM, and AFM Analyses of Phase-Separated Polymer Blend Membranes for Gas Separations. Microscopy and Microanalysis 20(S3): 2064-2065

Danuso, F; Rocca, A 2014: SEMoLa: A simple and easy modelling language. Ecological Modelling 285: 54-77

Agarwal, N. R.; Tommasini, M.; Fazio, E.; Neri, F.; Ponterio, R. C.; Trusso, S.; Ossi, P. M. 2014: SERS activity of silver and gold nanostructured thin films deposited by pulsed laser ablation. Applied Physics A: Materials Science and Processing 117(1): 347-351

Luo, Y; Wen, G; Dong, J; Liu, Q; Liang, A; Jiang, Z 2014: SERS detection of trace nitrite ion in aqueous solution based on the nitrosation reaction of rhodamine 6G molecular probe. Sensors and Actuators B, Chemical 201: 336-342

Kiran, M Syamala; Itoh, T; Abe, H; Fujita, Y; Tomimoto, K; Biju, V; Kavitha, S; Ganamani, A; Ishikawa, M 2014: SERS microscopic imaging as novel tool for assessing viability and enumerating yeast cells at various stages of cell cycle in lag, log, exponential and stationary phases of growth in culture. Journal of Experimental Nanoscience 9(10): 1003-1014

Nishijima, Y; Hashimoto, Y; Rosa, L; Khurgin, J B.; Juodkazis, S 2014: SERS scaling rules. Applied Physics A: Materials Science and Processing 117(2): 647-650

Zhang, J; Huang, Q; Yao, G; Ke, Z; Zhang, H; Lu, Y 2014: SERS study of transformation of phenylalanine to tyrosine under particle irradiation. Journal of Molecular Structure 1072: 195-202

Polavarapu, L; Porta, A La; Novikov, S M.; Coronado-Puchau, M; Liz-Marzán, L M. 2014: SERS: Pen-on-Paper Approach Toward the Design of Universal Surface Enhanced Raman Scattering Substrates (Small 15/2014). Small 10(15): 3064-3064

Prajapati, P; Agrawal, Y.K. 2014: SFCMS/MS for identification and simultaneous estimation of the isoniazid and pyrazinamide in its dosage form. Journal of Supercritical Fluids 95: 597-602

Plassart, M; Shearmur, R 2014: SFIC et innovation : Les dynamiques gographiques de l'innovation Qubec. Canadian Geographer / le Géographe Canadien 58(2): 244-262

Sasvári, Ágoston; Baharev, A 2014: SG2PS (structural geology to postscript converter) A graphical solution for brittle structural data evaluation and paleostress calculation. Computers and Geosciences 66: 81-93

Li, L; Boucher, A; Caers, J 2014: SGEMS-UQ: An uncertainty quantification toolkit for SGEMS. Computers and Geosciences 62: 12-24

&na;, 2014: SGNAS 41ST ANNUAL COURSE May 26, 2014 | Nashville, Tennessee. Gastroenterology Nursing 37(1): 80-107

Campbell, B A.; Putzig, N E.; Foss, F J.; Phillips, R J. 2014: SHARAD Signal Attenuation and Delay Offsets Due to the Martian Ionosphere. IEEE Geoscience and Remote Sensing Letters 11(3): 632-635

Kumar, P; Saxena, N; Chandra, R; Gao, K; Zhou, S; Agarwal, A; Singh, F; Gupta, V; Kanjilal, D. 2014: SHI induced enhancement in green emission from nanocrystalline CdS thin films for photonic applications. Journal of Luminescence 147: 184-189

Thomazeau, H.; Raoul, T.; Pollet, S.; Albert, J.-D.; Kriegel, P.; Ropars, M. 2014: SHOULDER C-Test (SC-T): To evaluate shoulder function with a single goniometer. Revue de Chirurgie Orthopédique et Traumatologique 100(8): E5-E6

Zanetti, A.; Mazzucchelli, M.; Sinigoi, S.; Giovanardi, T.; Peressini, G.; Fanning, M. 2014: SHRIMP U-Pb Zircon Triassic Intrusion Age of the Finero Mafic Complex (Ivrea-Verbano Zone, Western Alps) and its Geodynamic Implications. Journal of Petrology 55(6): 1239-1240

Chen, X; Seitmuratova, E; Wang, Z; Chen, Z; Han, S; Li, Y; Yang, Y; Ye, B; Shi, W 2014: SHRIMP UPb and ArAr geochronology of major porphyry and skarn Cu deposits in the Balkhash Metallogenic Belt, Central Asia, and geological implications. Journal of Asian Earth Sciences 79: 723-740

Reid, A J.; Jagodzinski, E A.; Fraser, G L.; Pawley, M J. 2014: SHRIMP UPb zircon age constraints on the tectonics of the Neoarchean to early Paleoproterozoic transition within the Mulgathing Complex, Gawler Craton, South Australia. Precambrian Research 250: 27-49

Turniak, K; Mazur, Sław; Domańska-Siuda, J; Szuszkiewicz, A 2014: SHRIMP UPb zircon dating for granitoids from the Strzegom Sobtka Massif, SW Poland: Constraints on the initial time of Permo-Mesozoic lithosphere thinning beneath Central Europe. Lithos 208-209: 415-429

Da Silva Filho, A. F.; Guimarães, I. P.; Van Schmus, W. R.; Armstrong, R. A.; Rangel da Silva, J. M.; Osako, L. S.; Cocentino, L. M. 2014: SHRIMP UPb zircon geochronology and Nd signatures of supracrustal sequences and orthogneisses constrain the Neoproterozoic evolution of the Pernambuco Alagoas domain, southern part of Borborema Province, NE Brazil. International Journal of Earth Sciences 103(8): 2155-2190

Mohan, M. Ram; Sarma, D. Srinivasa; McNaughton, N J.; Fletcher, I R.; Wilde, S A.; Siddiqui, M. Alam; Rasmussen, B; Krapez, B; Gregory, C J.; Kamo, S L. 2014: SHRIMP zircon and titanite U-Pb ages, Lu-Hf isotope signatures and geochemical constraints for 2.56Ga granitic magmatism in Western Dharwar Craton, Southern India: Evidence for short-lived Neoarchean episodic crustal growth?. Precambrian Research 243: 197-220

Fournier, A.; Ficheux, M.; Boutemy, J.; Guillard, P.; Hurault de Ligny, B. 2014: SHU atypique chez un patient trait pour cancer de la prostate. La Revue de Médecine Interne 35: A97-A98

Asakai, T; Hioki, A 2014: SI traceable assay of periodate compounds. Accreditation and Quality Assurance 19(2): 105-109

King, A G. 2014: SIL determination: Recognising and handling high demand mode scenarios. Process Safety and Environmental Protection 92(4): 324-328

Wirtz, T.; Dowsett, D.; Eswara Moorthy, S.; Fleming, Y. 2014: SIMS Based Correlative Microscopy for High-Resolution High-Sensitivity Nano-Analytics. Microscopy and Microanalysis 20(S3): 966-967

Litvinov, V.A.,Koppe, V.T.… 2014: SIMS investigation of the processes of gas release from zirconium-based getter alloy. Bulletin of the Russian Academy of Sciences: Physics 78(6): 526-530

Vetter, L; Kozdon, R; Valley, J W.; Mora, C I.; Spero, H J. 2014: SIMS measurements of intrashell 13C in the cultured planktic foraminifer Orbulina universa. Geochimica et Cosmochimica Acta 139: 527-539

Morozov, S.N.,Kh, U.. Rasulev 2014: SIMS of silicon bombarded with Sbm+cluster ions. Bulletin of the Russian Academy of Sciences: Physics 78(6): 516-519

Tarocchi, M.; Marroncini, G.; Mello, T.; Polvani, S.; Tempesti, S.; Ceni, E.; Galli, A. 2014: SIRT1 activity in hepatic stellate cells during liver injury is a target for the modulation of the fibrogenic process. Digestive and Liver Disease 46: E30-E31

Harris, P S; Gomez, J D; Backos, D S; Fritz, K S 2014: SIRT3 Regulates ALDH2 Activity via Lysine Deacylation. Free Radical Biology and Medicine 76: S104-S105

Wepner, U 2014: SIT: Chance für Kinder auf dem allergischen Marsch. Allergo Journal 23(5): 52-52

Zakaria, M.A.; Parsons, A. 2014: SKYLA (Levonorgestrel-Releasing Intrauterine System) Use in a Case of Mullerian Uterine Anomaly. Journal of Minimally Invasive Gynecology 21(6): S186-S187

Granfeldt, J.; Agren, M. 2014: SLA developmental stages and teachers' assessment of written French: Exploring Direkt Profil as a diagnostic assessment tool. Language Testing 31(3): 285-305

Auat Cheein, F A.; Guivant, J 2014: SLAM-based incremental convex hull processing approach for treetop volume estimation. Computers and Electronics in Agriculture 102: 19-30

Kumar, V V.; Kunhi, M 2014: SLE with predominant hepatitis. Indian Journal of Rheumatology 9: S33-S34

Legrand, P. 2014: SMAO - La clinique suicidaire en Afrique sub-saharienne : de lanalyse sociologique la prvention. European Psychiatry 29(8): 640-641

Tago, J.; Metivier, L.; Virieux, J. 2014: SMART layers: a simple and robust alternative to PML approaches for elastodynamics. Geophysical Journal International 199(2): 700-706

Farash, M Sabzinejad; Attari, M Ahmadian 2014: SMC accepts use of Iluvien. Pharmacoeconomics and Outcomes News 697(1): 11-11

Guo, J; Wang, F; Zhang, X Sheng 2014: SMC publishes December 2013 decisions. Pharmacoeconomics and Outcomes News 694(1): 11-11

Conway, C 2014: SMEs competing in the food sector. International Journal of Entrepreneurship and Innovation 15(3): 219-220

Karel Nesmerak, A A. Toropov, A P. Toropova 2014: SMILES-based quantitative structureretention relationships for RP HPLC of 1-phenyl-5-benzylsulfanyltetrazoles. Structural Chemistry 25(1): 311-317

Munoz-Sabater, J; de Rosnay, P; Jimenez, C; Isaksen, L; Albergel, C 2014: SMOS Brightness Temperature Angular Noise: Characterization, Filtering, and Validation. IEEE Transactions on Geoscience and Remote Sensing 52(9): 5827-5839

Nyadjro, E S.; Subrahmanyam, B 2014: SMOS Mission Reveals the Salinity Structure of the Indian Ocean Dipole. IEEE Geoscience and Remote Sensing Letters 11(9): 1564-1568

Jalenques, I. 2014: SMP Diagnostic et traitement personnaliss : un paradigme davenir dans les troubles schizophrniques. European Psychiatry 29(8): 591-592

Cucu, H; Buzo, A; Besacier, L; Burileanu, C 2014: SMT-based ASR domain adaptation methods for under-resourced languages: Application to Romanian. Speech Communication 56: 195-212

Royers, T 2014: SNOES in het verpleeghuis. Denkbeeld 27(1): 25-25

Shao, C; Ma, X; Meng, Y 2014: SNP or RNA editing?. Journal of Plant Biochemistry and Biotechnology 23(2): 123-124

Villano, M 2014: SNR and Noise Variance Estimation in Polarimetric SAR Data. IEEE Geoscience and Remote Sensing Letters 11(1): 278-282

Kwak, K Tae; Choi, S Kyoung; Lee, B Gyou 2014: SNS flow, SNS self-disclosure and post hoc interpersonal relations change: Focused on Korean Facebook user. Computers in Human Behavior 31: 294-304

Menichelli, E; Almøy, T; Tomic, O; Olsen, N Veflen; Næs, T 2014: SO-PLS as an exploratory tool for path modelling. Food Quality and Preference 36: 122-134

Naja, M; Mallik, C; Sarangi, T; Sheel, V; Lal, S 2014: SO2 measurements at a high altitude site in the central Himalayas: Role of regional transport. Atmospheric Environment 99: 392-402

Conde, V; Bredemeyer, S; Duarte, E; Pacheco, J F.; Miranda, S; Galle, B; Hansteen, T H. 2014: SO2degassing from Turrialba Volcano linked to seismic signatures during the period 20082012. International Journal of Earth Sciences 103(7): 1983-1998

Iakovlev, M; You, X; van Heiningen, A; Sixta, H 2014: SO2ethanolwater (SEW) fractionation process: production of dissolving pulp from spruce. Cellulose 21(3): 1419-1429

Baba, A; Adachi, S 2014: SOC Estimation of HEV/EV Battery Using Series Kalman Filter. Electrical Engineering in Japan 187(2): 53-62

Niranjan Kumar, K.; Rao, C. Kanaka; Sandeep, A.; Rao, T. N. 2014: SODAR observations of inertia-gravity waves in the atmospheric boundary layer during the passage of tropical cyclone. Atmospheric Science Letters 15(2): 120-126

Minutillo, M.; Perna, A.; Jannelli, E. 2014: SOFC and MCFC system level modeling for hybrid plants performance prediction. International Journal of Hydrogen Energy 39(36): 21688-21699

Hackett, M.; Prawoko, I.; Janssen, W.E. 2014: SOP to master process record (MPR) to batch process record (BPR): a paradigm for optimizing cell processing documentation. CytoTherapy 16(4): S52-S53

Campbell's, B A; Baxters, D; Mitchell, D 2014: SOUPies: an old(er) urban phenomenon. Area 46(4): 443-445

Tanderup, K. 2014: SP-0005: PTV concept in BT - do we need it?. RadioTherapy and Oncology 111: S1-S2

Sourbron, S. 2014: SP-0007: Applications of DCE-MRI in radiotherapy. RadioTherapy and Oncology 111: S2-S3

Pötter, R. 2014: SP-0011: Austron - origin of today's ion beam setting in Europe. RadioTherapy and Oncology 111: S3-S4

Theys, J.; Habets, R.; Jutten, B.; Groot, A.; Paesmans, K.; Lambin, P.; Rouschop, K.; Vooijs, M. 2014: SP-0014: Radiation sensitivity and EMT in cancer: Role of the tumor microenvironment. RadioTherapy and Oncology 111: S4-S5

Stuschke, M.; Poettgen, C.; Gkika, E. 2014: SP-0018: Oesophageal cancer. RadioTherapy and Oncology 111: S5-S6

Andersen, M.H.; Moeller, D.S.; Knap, M.M.; Rasmussen, A.B.; Joergensen, M.K.; Khalil, A.A.; Boejen, A.; Hoffmann, L. 2014: SP-0032: RTT implementation of daily online soft tissue match for lung tumours. RadioTherapy and Oncology 111: S9-S10

Chalmers, A.; Carruthers, R. 2014: SP-0103: Combining PARP inhibitors with radiation and chemotherapy in early phase clinical trials. RadioTherapy and Oncology 111: S42-S43

Khoo, V. 2014: SP-0113: Do we need elective nodal irradiation in prostate cancer?. RadioTherapy and Oncology 111: S45-S46

Rades, D. 2014: SP-0116: Advances in radiotherapy of spinal metastases. RadioTherapy and Oncology 111: S46-S47

Bundschuh, R.A. 2014: SP-0120: Motion registration and compensation in PET imaging. RadioTherapy and Oncology 111: S47-S48

Geets, X. 2014: SP-0123: The clinical evidence for the dose-painting concept. RadioTherapy and Oncology 111: S48-S49

Ledsom, D. 2014: SP-0126: RTT-led OAR delineation for breast radiation therapy. RadioTherapy and Oncology 111: S49-S50

Maingon, P.M. 2014: SP-0146: New concepts for radiotherapy in anal canal cancers. RadioTherapy and Oncology 111: S56-S57

Gambacorta, M.A. 2014: SP-0196: Multi-disciplinary management of rectal cancer. RadioTherapy and Oncology 111: S78-S79

Breedveld, S. 2014: SP-0200: Automated multi-criterial treatment planning and Pareto navigation. RadioTherapy and Oncology 111: S79-S80

Thorwarth, D. 2014: SP-0203: Combined PET/MR Imaging for Radiation Oncology. RadioTherapy and Oncology 111: S80-S81

Balosso, J.; Estève, F.; Elleaume, H.; Bravin, A.; Adam, J.F.; Renier, M.; Nemoz, C.; Brochard, T.; Berkvens, P.; Le Bas, J.F. 2014: SP-0205: Monoenergetic synchrotron beams: first human experience for therapeutic purpose. RadioTherapy and Oncology 111: S81-S82

Hurkmans, C.W. 2014: SP-0216: Lung SBRT: Minimum requirements or complete standardisation?. RadioTherapy and Oncology 111: S84-S85

Lu, W. 2014: SP-0225: Non-voxel-based-broad-beam framework. RadioTherapy and Oncology 111: S87-S88

Van Os, M.J.H. 2014: SP-0243: The value of a multi-disciplinary approach in quality management. RadioTherapy and Oncology 111: S93-S94

De Bari, B. 2014: SP-0322: Experience of ESTRO fellows / exchange programmes. RadioTherapy and Oncology 111: S125-S126

Timmermann, B. 2014: SP-0325: Which 'clinical questions' are, and should be, addressed in hadron therapy?. RadioTherapy and Oncology 111: S126-S127

Järvinen, H.; Bly, R.; Malicki, J.; Jahnen, A.; Godet, J.L.; Valero, M.; Prieto, C.; Krengli, M.; Maingon, P. 2014: SP-0329: ACCIRAD: European guidelines on risk assesment in radiotherapy - results of expert consensus and final version. RadioTherapy and Oncology 111: S127-S128

Grosu, A. 2014: SP-0332: Role of re-irradiation in recurrent brain tumours/malignancies. RadioTherapy and Oncology 111: S128-S129

Bruland, O.S. 2014: SP-0336: Combination of radionuclides and EBRT from the clinical radiotherapy point of view. RadioTherapy and Oncology 111: S129-S130

Hellebust, T.P. 2014: SP-0339: Applicator reconstruction using 3D imaging. RadioTherapy and Oncology 111: S130-S131

Granton, P.V.; Lindsay, P.; Van Hoof, S.; Verhaegen, F. 2014: SP-0342: Challenges in precision small animal dose calculations. RadioTherapy and Oncology 111: S131-S132

De Jong, R. 2014: SP-0346: Development of IGRT protocols. RadioTherapy and Oncology 111: S132-S133

Alsner, J. 2014: SP-0350: How to write a successful grant application. RadioTherapy and Oncology 111: S133-S134

Ravkilde, T.; O'Brien, R.; Keall, P.J.; Poulsen, P.R. 2014: SP-0435: Real-time dose reconstruction during volumetric modulated arc therapy with dynamic MLC tracking. RadioTherapy and Oncology 111: S172-S173

Gallez, B. 2014: SP-0438: Imaging biomarkers to measure tumour oxygenation: towards clinical application in radiation oncology. RadioTherapy and Oncology 111: S173-S174

Maughan, T. 2014: SP-0440: Methodology of modern trials in Radiation Oncology: 5 foundational principles. RadioTherapy and Oncology 111: S174-S175

Verellen, D.; De Ridder, M. 2014: SP-0446: Challenges in adaptive planning. RadioTherapy and Oncology 111: S176-S177

Vos, P.H. 2014: SP-0450: Optimise resources to decrease waiting times. RadioTherapy and Oncology 111: S177-S178

Feron, O. 2014: SP-0452: Lactate transport inhibition as a new anticancer strategy to combine with radio- and chemotherapy. RadioTherapy and Oncology 111: S178-S179

Poortmans, P. 2014: SP-0455: The impact of oncoplastic surgery on volume delineation and side effects. RadioTherapy and Oncology 111: S179-S180

Rödel, C. 2014: SP-0459: Biomarker-driven personalised radiation therapy. RadioTherapy and Oncology 111: S180-S181

Cavedon, C. 2014: SP-0462: Motion management QA: From imaging to treatment delivery. RadioTherapy and Oncology 111: S181-S182

Pimpinella, M.; Consorti, R.; Falco, M.D.; Marinelli, M.; Verona-Rinati, G. 2014: SP-0467: Advances in synthetic diamond detectors dosimetry. RadioTherapy and Oncology 111: S182-S183

Brunenberg, E.J.L.; Kusters, J.M.A.M.; Van Kollenburg, P.G.M.; Braam, P.M. 2014: SP-0469: The development of a one-stop-shop palliative radiotherapy treatment using MR and CBCT. RadioTherapy and Oncology 111: S183-S184

Haie-Meder, C.; Mazeron, R.; Chargari, C.; Dumas, I. 2014: SP-0479: Adaptive brachytherapy in cervical cancer. RadioTherapy and Oncology 111: S187-S188

Fiorino, C.; Passoni, P. 2014: SP-0481: Efficient implementation of an adaptive boost strategy in the neoadjuvant treatment of rectal cancer. RadioTherapy and Oncology 111: S188-S189

Kaanders, J.; Bussink, J. 2014: SP-0527: Clinical interventions and biological stratification. RadioTherapy and Oncology 111: S207-S208

Haas, R.L.M. 2014: SP-0530: Limb sarcoma: Should the optimal timing sequence for radiotherapy be the same for all patients?. RadioTherapy and Oncology 111: S208-S209

Burnet, N.G.; Burton, K.E.; Scaife, J.E.; Harris, F.; Jefferies, S.J.; Jena, R. 2014: SP-0534: Do patients with glioblastoma benefit from IMRT?. RadioTherapy and Oncology 111: S209-S210

Widesott, L.; La Macchia, M.; Fellin, F.; Amichetti, M.; Cianchetti, M.; Lomax, A.J. 2014: SP-0537: Quantifying the performances of commercially available deformable registration tools in contouring OAR in ART. RadioTherapy and Oncology 111: S210-S211

Perchard-Rees, L. 2014: SP-0543: Radiotherapy information and support in the community, - as part of rehabilitation. RadioTherapy and Oncology 111: S212-S213

Illidge, T. 2014: SP-0556: Radiotherapy and immunotherapy combinations - unlocking the potential. RadioTherapy and Oncology 111: S217-S218

Kirova, Y.; Boersma, L. 2014: SP-0560: ESTRO guideline for treatment volume definition of the breast, boost and thoracic wall: questions and answers. RadioTherapy and Oncology 111: S218-S219

Major, T. 2014: SP-0562: Target volume delineation in partial breast brachytherapy. RadioTherapy and Oncology 111: S219-S220

Van der Schaaf, A. 2014: SP-0592: NTCP modelling: Fact or myth?. RadioTherapy and Oncology 111: S232-S233

Dunscombe, P. 2014: SP-0596: Health economics in Radiation Oncology. RadioTherapy and Oncology 111: S233-S234

Cozzarini, C. 2014: SP-0601: Radiation-related treatment effects across the age spectrum with a focus on prostate cancer. RadioTherapy and Oncology 111: S234-S235

De Jong, M.C.; Ten Hoeve, J.J.; Van den Brekel, M.W.M.; Verheij, M.; Begg, A.C. 2014: SP-0607: microRNAs and radioresistance in head and neck cancer. RadioTherapy and Oncology 111: S236-S237

Lievens, Y. 2014: SP-0614: Radiotherapy costs: Myths and facts. RadioTherapy and Oncology 111: S238-S239

Muren, L.P. 2014: SP-0619: Trends in the medical physics science and its dissemination. RadioTherapy and Oncology 111: S239-S240

Thörnqvist, S.; Hysing, L.B.; Zolnay, A.G.; Söhn, M.; Hoogeman, M.S.; Muren, L.P.; Heijmen, B.J.M. 2014: SP-0622: Statistical motion models for generating plan libraries. RadioTherapy and Oncology 111: S240-S241

Rosewall, T.; Dickie, C.; Huang, S.H.; Li, W.; Velec, M. 2014: SP-0624: Creating a research culture within clinical radiotherapy departments. RadioTherapy and Oncology 111: S241-S242

Van Luijk, P. 2014: SP-0627: Imaging-based scoring of toxicity: Quantification of local radiation-induced lung damage using CT. RadioTherapy and Oncology 111: S242-S243

Grantzau, T. 2014: SP-0630: Increased risk of second cancer after radiotherapy; A meta-analysis on 925,523 breast cancer patients. RadioTherapy and Oncology 111: S243-S244

Carrie, C. 2014: SP-0633: Is there a role for re-irradiation?. RadioTherapy and Oncology 111: S244-S245

Widder, J. 2014: SP-0638: Stereotactic ablative radiotherapy for oligometastatic disease: why and how?. RadioTherapy and Oncology 111: S246-S247

Elstrøm, U.V. 2014: SP-0642: Direct and indirect methods for CBCT-based dose calculations. RadioTherapy and Oncology 111: S247-S248

Coffey, M. 2014: SP-0645: ESTRO/IAEA initiaitive: Have we trained the RTT trainers?. RadioTherapy and Oncology 111: S248-S249

Cid, M.C. 2014: SP0002Pathogenic Mechanisms in Giant-Cell Arteritis. Annals of the Rheumatic Diseases 73(Suppl 2): 2.2-2

Pipitone, N. 2014: SP0003The Role of Imaging Modalities in the Diagnosis and Followup of GIANT Cell Arteritis. Annals of the Rheumatic Diseases 73(Suppl 2): 2.3-2

Gonzalez-Gay, M.A. 2014: SP0004The Old and the New in the Treatment of GIANT Cell Arteritis. Annals of the Rheumatic Diseases 73(Suppl 2): 3.1-3

Tan, A.L. 2014: SP0005Novel Imaging Markers for Oa: Costly or Effective?. Annals of the Rheumatic Diseases 73(Suppl 2): 3.2-3

Van Spil, W.E. 2014: SP0006Biochemical Markers for Osteoarthritis: Will the Holy Grail BE Found?. Annals of the Rheumatic Diseases 73(Suppl 2): 3.3-3

Gossec, L. 2014: SP0007The Total Knee Prosthesis as Ultimate (At Least Final) Outcome Measure in OA Trials. Annals of the Rheumatic Diseases 73(Suppl 2): 3.4-3

Calvo Alén, J. 2014: SP0008Critical Issues in the Management of Sle. Annals of the Rheumatic Diseases 73(Suppl 2): 3.5-4

Reis, P. 2014: SP0009Case Presentation: Igg4 Related Disease. Annals of the Rheumatic Diseases 73(Suppl 2): 4.1-4

Zwerina, J. 2014: SP0010 Igg4-Related Disease: A Clinical and Therapeutic Overview. Annals of the Rheumatic Diseases 73(Suppl 2): 4-4

Dalbeth, N. 2014: SP0012Magnitude and Sites of Urate Crystal Deposits and Its Evaluation. Annals of the Rheumatic Diseases 73(Suppl 2): 5.1-5

Addadi, L. 2014: SP0013Biomineralization: the Mechanism of Crystal Formation in Bone and Other Mineralized Tissues. Considerations on the Relevance to Gout. Annals of the Rheumatic Diseases 73(Suppl 2): 5.2-5

Cornell, P. 2014: SP0014The Challenges of Undertaking Ultrasound - Framework for Practice. A European Perspective on Commpetencies for HPS. Annals of the Rheumatic Diseases 73(Suppl 2): 5.3-5

Supp, G.M. 2014: SP0015Implementing Ultrasound into Rheumatology Clinical Practice - A Sucessful Model in Austria. Annals of the Rheumatic Diseases 73(Suppl 2): 5.4-5

Carmona, L. 2014: SP0016The ABC of Diagnostic and Prognostic Tests. Annals of the Rheumatic Diseases 73(Suppl 2): 5.5-5

Hermann, K.G. 2014: SP0018How to Use MRI in Low Back Pain. Annals of the Rheumatic Diseases 73(Suppl 2): 6.1-6

Østergaard, M. 2014: SP0019How to Use MRI in Inflammatory Arthritis in Clinical Practice. Annals of the Rheumatic Diseases 73(Suppl 2): 6.2-6

Terslev, L. 2014: SP0020How to Optimize Doppler Settings for Slow Flow. Annals of the Rheumatic Diseases 73(Suppl 2): 6.3-6

Schmidt, W.A. 2014: SP0021How to Optimize Doppler Settings for Fast Flow: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 6.4-6

Thorseng, H. 2014: SP0022Food as Therapy Supporting Healthy Choices. Annals of the Rheumatic Diseases 73(Suppl 2): 6.5-7

Christodoulou, V. 2014: SP0023Putting Knowledge into Practice: Psychological Barriers. Annals of the Rheumatic Diseases 73(Suppl 2): 7.1-7

Cutolo, M. 2014: SP0024Vitamin D and People with RMDS: How Much from Diet?. Annals of the Rheumatic Diseases 73(Suppl 2): 7.2-7

Betteridge, K. 2014: SP0025Food Challenges - Getting In; Getting IT On; Getting IT Off. Annals of the Rheumatic Diseases 73(Suppl 2): 7.3-7

Goncalves, J. 2014: SP0026In Search for Mab Biosimilarity: How to Overcome Obstacles?. Annals of the Rheumatic Diseases 73(Suppl 2): 7.4-7

Esplugues Mota, J.V. 2014: SP0027Biosimilars: Potential Clinical Differences and European Regulatory Aspects. Annals of the Rheumatic Diseases 73(Suppl 2): 7.5-8

Buchbinder, R. 2014: SP0028Personalised Treatment for Shoulder Pain. Annals of the Rheumatic Diseases 73(Suppl 2): 8.1-8

Revel, M. 2014: SP0029Phenotyping Neck Pain in Order to Personnalize the Treatment. Annals of the Rheumatic Diseases 73(Suppl 2): 8.2-8

Oddis, C. 2014: SP0030An Update on the Treatment and Assessment of Patients with Inflammatory Myopathy. Annals of the Rheumatic Diseases 73(Suppl 2): 8.3-9

Lorenz, H.-M. 2014: SP0031Biomarkers: the Future or Waste of Resources: the Evidence behind Laboratory Biomarkers. Annals of the Rheumatic Diseases 73(Suppl 2): 9.1-9

Mandl, P. 2014: SP0032The Race for Imaging Biomarkers. Annals of the Rheumatic Diseases 73(Suppl 2): 9.2-9

Maksymowych, W.P. 2014: SP0033What Makes A Good Biomarker?. Annals of the Rheumatic Diseases 73(Suppl 2): 9.3-9

Herrick, A. 2014: SP0034 Ways to Approach Primary Raynaud's Phenomenon. Annals of the Rheumatic Diseases 73(Suppl 2): 9-10

Sulli, A. 2014: SP0035Doctor I Have Cold Hands and Skin Lesions! What Can I Do?. Annals of the Rheumatic Diseases 73(Suppl 2): 10.1-10

Matteson, E.L. 2014: SP0036Where Does Polymyalgia Rheumatica Fit in the Spectrum of Inflammatory Rheumatic Disease?. Annals of the Rheumatic Diseases 73(Suppl 2): 10.2-10

Dasgupta, B. 2014: SP0037Eular ACR Guidelines for the Treatment of Polymyalgia Rheumatica. Annals of the Rheumatic Diseases 73(Suppl 2): 10.3-10

Dejaco, C. 2014: SP0038Review of the Key Evidence Supporting the New Treatment Guidelines in Polymyalgia Rheumatica. Annals of the Rheumatic Diseases 73(Suppl 2): 10.4-11

Ray, D. 2014: SP0039 Peripheral Clocks in Immunity and Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 11-11

Bowness, P. 2014: SP0041Vintage B27 (The Role of HLA-B27 in Ankylosing Spondylitis Pathogenesis). Annals of the Rheumatic Diseases 73(Suppl 2): 11.3-12

Aydin, S.Z. 2014: SP0042Does the Synovio-Entheseal Complex Resist Novel Conceptual Challenges?. Annals of the Rheumatic Diseases 73(Suppl 2): 12.1-12

Knittle, K. 2014: SP0043Promoting Important Behavioural Changes in Musculoskeletal Disease is Evidence Informing Practice?. Annals of the Rheumatic Diseases 73(Suppl 2): 12.2-12

Demmelmaier, I. 2014: SP0044Learning and Using Behavior Change Techniques to Promote Physical Activity in Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 12.3-13

Toes, R. 2014: SP0045What You Need to Know to Understand the Immune Targets in Biological Rheumatic Disease Treatment. Annals of the Rheumatic Diseases 73(Suppl 2): 13.1-13

Leavis, H. 2014: SP0046Why IT Could BE Relevant to Study the Microbiome in Rheumatic Diseases. Annals of the Rheumatic Diseases 73(Suppl 2): 13.2-13

Hachulla, E. 2014: SP0047Novel Learning through the Eular Online Courses in Rheumatology. Annals of the Rheumatic Diseases 73(Suppl 2): 13.3-13

Iagnocco, A. 2014: SP0048What Can Eular Offer to Teach Rheumatologists How to Use Ultrasound in Clinical Practice. Annals of the Rheumatic Diseases 73(Suppl 2): 13.4-14

Carlsson, A. 2014: SP0049 Strategy for Work for People with Rheumatic Diseases. Annals of the Rheumatic Diseases 73(Suppl 2): 14-14

Betteridge, N.J. 2014: SP0050The New Eular EU Public Affairs Strategy: Why IT Matters to People with RMDS. Annals of the Rheumatic Diseases 73(Suppl 2): 14.2-14

O'donnell, V. 2014: SP0051Activated Immune Cells Enzymatically Oxidize Membrane Lipids on Activation. Annals of the Rheumatic Diseases 73(Suppl 2): 14.3-14

Ioan, A. 2014: SP0052Lipids as Potent Modulators of Inflammation in the Rheumatic Joint. Annals of the Rheumatic Diseases 73(Suppl 2): 14.4-14

Moody, D.B. 2014: SP0053Human T Cells Recognize CD1A Antigen Presenting Molecules Bound to Lipid Autoantigens. Annals of the Rheumatic Diseases 73(Suppl 2): 15.1-15

Djouad, F. 2014: SP0054The Many Faces of Mesenchymal Stem Cell Immunomodulation. Annals of the Rheumatic Diseases 73(Suppl 2): 15.2-15

Lange, U. 2014: SP0055Physical Therapy in Rheumatology - Interesting Studies. Annals of the Rheumatic Diseases 73(Suppl 2): 15.3-15

Denton, C.P. 2014: SP0056Raynaud's Phenomenon and Systemic Sclerosis. Annals of the Rheumatic Diseases 73(Suppl 2): 15.4-16

Tumim, M.E. 2014: SP0057Telemedicine - the Role of Technology in Supporting Patients' Choice. Annals of the Rheumatic Diseases 73(Suppl 2): 16.1-16

Alten, R. 2014: SP0058Doctor-Patient Communication. Annals of the Rheumatic Diseases 73(Suppl 2): 16.2-16

Chinoy, H. 2014: SP0059Inflammatory Myositis in the 21St Century: Clinical Care and Management. Annals of the Rheumatic Diseases 73(Suppl 2): 16.3-16

Jakobsson, P.-J. 2014: SP0060Potential New Strategies for Inhibiting Prostaglandins. Annals of the Rheumatic Diseases 73(Suppl 2): 16.4-16

Häuser, W. 2014: SP0061Fibromyalgia What Really Works? from Ancient to Recent Managements. Annals of the Rheumatic Diseases 73(Suppl 2): 16.5-17

Naredo, E. 2014: SP0062Imaging Biomarkers in Psoriasis for Predicting Developing PSA. Annals of the Rheumatic Diseases 73(Suppl 2): 17.1-17

Østergaard, M. 2014: SP0063Imaging Biomarkers in Undifferentiated Arthritis. Are Mri/Us Useful Tools?. Annals of the Rheumatic Diseases 73(Suppl 2): 17.2-17

Manger, B. 2014: SP0064Imaging Biomarkers as A Useful Tool in Gout Disease. Annals of the Rheumatic Diseases 73(Suppl 2): 17.3-18

Strand, V. 2014: SP0065What is the Target for Ra? The Imaging Target. Annals of the Rheumatic Diseases 73(Suppl 2): 18.1-18

Porter, D. 2014: SP0066What is the Target in Ra? Pursuing the Optimal Clinical Target. Annals of the Rheumatic Diseases 73(Suppl 2): 18.2-18

Machado, P. 2014: SP0067How to Develop Meaningful Indices from Scratch (E.G. ASDAS). Annals of the Rheumatic Diseases 73(Suppl 2): 18.3-18

Seror, R. 2014: SP0068Developing Indices for SjGren's Syndrome. Annals of the Rheumatic Diseases 73(Suppl 2): 18.4-19

Souto, A. 2014: SP0070No ALL Night Sweats is Tuberculosis. Smoking is Bad for Your Health. Annals of the Rheumatic Diseases 73(Suppl 2): 19.2-19

Gomez-Reino, J.J. 2014: SP0071Is the Risk of Cancer after anti TNF Exposal Nule? Data from Worldwide Databases. Annals of the Rheumatic Diseases 73(Suppl 2): 19.3-20

Gattorno, M. 2014: SP0072Lessons Learned from the Eurofever Project. Annals of the Rheumatic Diseases 73(Suppl 2): 20.1-20

Lefebvre, V. 2014: SP0073Molecular Control of Cell Fate Determination in Cartilage and Joint Development. Annals of the Rheumatic Diseases 73(Suppl 2): 20.2-20

Beyaert, R. 2014: SP0075The Multifaceted Role of Ubiquitination in Inflammation. Annals of the Rheumatic Diseases 73(Suppl 2): 21.1-21

Ahmed, A. 2014: SP0076Proteasome as A Therapeutic Target in Osteoarthritis?. Annals of the Rheumatic Diseases 73(Suppl 2): 21.2-21

Klokkerud, M. 2014: SP0077Identifying Key Elements in the Structure, Process and Outcome of Rehabilitation in Chronic Pain. Annals of the Rheumatic Diseases 73(Suppl 2): 21.3-21

De Rooij, A. 2014: SP0078Cognitive Mechanisms of Change in Multidisciplinary Treatment of Patients with Chronic Widespread Pain. Annals of the Rheumatic Diseases 73(Suppl 2): 21.4-21

Jensen, M.P. 2014: SP0079Illness Beliefs as A Treatment Target in Chronic Pain. Annals of the Rheumatic Diseases 73(Suppl 2): 22.1-22

Vowles, K.E. 2014: SP0080Characteristics of Effective Treatments and Effective Treatment Environments. Annals of the Rheumatic Diseases 73(Suppl 2): 22.2-22

Allaart, C.F. 2014: SP0081Investigator-Initiated Clinical Trials - How to BE Successful. Annals of the Rheumatic Diseases 73(Suppl 2): 22.3-22

Iagnocco, A. 2014: SP0082Do We Need A Different US Joint Count for Diagnosing, Monitoring and Remission in Ra?. Annals of the Rheumatic Diseases 73(Suppl 2): 22.4-22

Jousse-Joulin, S. 2014: SP0083The Role of US for Diagnosing SjGren's Syndrome - Practical Aspects. Annals of the Rheumatic Diseases 73(Suppl 2): 23.1-23

Bosworth, A. 2014: SP0084Understanding the Importance of Transparency When Using Opportunities to Work with the Pharmaceutical Industry. Annals of the Rheumatic Diseases 73(Suppl 2): 23.2-23

Church, J. 2014: SP0085Building Successful Alliances with Other Stake Holders in the Field of Chronic Diseases. Annals of the Rheumatic Diseases 73(Suppl 2): 23.3-23

Dekker, J. 2014: SP0086Does Self Management save Costs in Health Care for People with RMDS?. Annals of the Rheumatic Diseases 73(Suppl 2): 23.4-23

Derksen, R. 2014: SP0087Systemic Lupus Erythematosus and the Antiphospholipid Syndrome. Annals of the Rheumatic Diseases 73(Suppl 2): 23.5-24

De Vita, S. 2014: SP0088 Advances in Systemic Vasculitis. Annals of the Rheumatic Diseases 73(Suppl 2): 24-24

Anaya, J.- M. 2014: SP0089 Trends in the Treatment of Rheumatoid Arthritis in Latin America. Annals of the Rheumatic Diseases 73(Suppl 2): 24-24

Saag, K. 2014: SP0090Similarities and Differences in RA Treatment Guidelines: the US View. Annals of the Rheumatic Diseases 73(Suppl 2): 24.3-24

Doherty, M. 2014: SP0091Gout Treatment: Does the Rate of Crystal Clearance Matter?. Annals of the Rheumatic Diseases 73(Suppl 2): 24.4-25

Peris, P. 2014: SP0092Osteoporosis. Whom, When and How to Treat. Annals of the Rheumatic Diseases 73(Suppl 2): 25.1-25

Bergman, S. 2014: SP0093Management of Pain - A Mechanism Based Approach. Annals of the Rheumatic Diseases 73(Suppl 2): 25.2-25

Dragoi, R.G. 2014: SP0094Patients' Needs. do We Meet Them?. Annals of the Rheumatic Diseases 73(Suppl 2): 25.3-25

Unger, J. 2014: SP0095Coverage of the Patient Perspective in Disease-Specific Quality of Life-Patient Reported Outcome Measures. Annals of the Rheumatic Diseases 73(Suppl 2): 25.4-26

Gallop, K. 2014: SP0096A Patient-Perspective Based Conceptual Model of Health-Related Quality of Life. Annals of the Rheumatic Diseases 73(Suppl 2): 26.1-26

Ernst, M. 2014: SP0097Completing Patient Reported Outcomes: Does IT Improve My Care?. Annals of the Rheumatic Diseases 73(Suppl 2): 26.2-26

Moutsopoulos, H.M. 2014: SP0098Etiology of SICCA Syndrome: the Forgotten Causes. Annals of the Rheumatic Diseases 73(Suppl 2): 26.3-26

Al Suwaidi, M. 2014: SP0099A Comorbid SjGren Patient: Which Organ Has Priority?. Annals of the Rheumatic Diseases 73(Suppl 2): 26.4-27

Fleck, M. 2014: SP0100A Comorbid SjGren Patient: Which Organ Has Priority?. Annals of the Rheumatic Diseases 73(Suppl 2): 27.1-27

Woolf, A. 2014: SP0101Raising Awareness - the Perspective of the Bone and Joint Decade. Annals of the Rheumatic Diseases 73(Suppl 2): 27.2-27

Kouloumas, M. 2014: SP0102Raising Awareness - the Perspective of Pare. Annals of the Rheumatic Diseases 73(Suppl 2): 27.3-27

Berenbaum, F. 2014: SP0103Raising Awareness - the Perspective of Eular. Annals of the Rheumatic Diseases 73(Suppl 2): 27.4-27

Hafler, D.A. 2014: SP0104The Molecular Basis of Autoimmune Disease. Annals of the Rheumatic Diseases 73(Suppl 2): 27.5-28

Meyaard, L. 2014: SP0105Prevention of Collateral Damage by Immune Inhibitory Receptors. Annals of the Rheumatic Diseases 73(Suppl 2): 28.1-28

Richardson, J. 2014: SP0106Ehealth Literacy on Rheumatic Diseases: Analysing the Power of the Internet: Health Talk Online - Patients' Experience of Gout. Annals of the Rheumatic Diseases 73(Suppl 2): 28.2-28

Van Der Vaart, R. 2014: SP0107 Ehealth Literacy among Patients with Rheumatic Diseases; Present and Future Perspectives. Annals of the Rheumatic Diseases 73(Suppl 2): 28-28

Ammerlaan, J. 2014: SP0108Patient Education to Adults with Rheumatic Diseases through the Internet: A Valuable Example. Annals of the Rheumatic Diseases 73(Suppl 2): 28.4-29

Ruperto, N. 2014: SP0110European Initiative in Pediatric Rheumatology. the Example of the Paediatric Rheumatology International Trials Organisation (PRINTO). Annals of the Rheumatic Diseases 73(Suppl 2): 29.2-29

Vojinovic, J. 2014: SP0111Pediatric Rheumatology in the Balkan Area. Annals of the Rheumatic Diseases 73(Suppl 2): 29.3-29

Herrick, A. 2014: SP0112Clinical Manifestations of Raynaud's Phenomenon during Different Ages. Annals of the Rheumatic Diseases 73(Suppl 2): 30.1-30

Smith, V. 2014: SP0113How to Differentiate Normal from Abnormal Capillaroscopic Patterns and Its Role in Distinguishing between Primary and Secondary Rp. Annals of the Rheumatic Diseases 73(Suppl 2): 30.2-30

Cutolo, M. 2014: SP0114The Predictive and Prognostic Power of the Capillaroscopic Analysis. Annals of the Rheumatic Diseases 73(Suppl 2): 30.3-30

Sulli, A. 2014: SP0115Manual and Semi Automatic Identification and Scoring of the Qualitative Capillaroscopic Patterns in Systemic Sclerosis. Annals of the Rheumatic Diseases 73(Suppl 2): 30.4-31

Hermann, W. 2014: SP0116How to Select the Most Appropriate Capillaroscopic Device: PROS and Cons. Annals of the Rheumatic Diseases 73(Suppl 2): 31.1-31

Terslev, L. 2014: SP0117 How to Optimize Doppler Settings for Slow Flow. Annals of the Rheumatic Diseases 73(Suppl 2): 31-31

Schmidt, W.A. 2014: SP0118How to Optimize Doppler Settings for Fast Flow: Table 1. Annals of the Rheumatic Diseases 73(Suppl 2): 31.3-32

Braun, J. 2014: SP0119Latest Update on Biosimilars - Chances and Risks. Annals of the Rheumatic Diseases 73(Suppl 2): 32.1-32

Mckenzie, A. 2014: SP0120Innate Lymphoid Cells and TH2 Immunity. Annals of the Rheumatic Diseases 73(Suppl 2): 32.2-32

Saris, D. 2014: SP0121Joint Homeostasis: Limitations and Advantages for Cartilage Repair in Oa. Annals of the Rheumatic Diseases 73(Suppl 2): 32.3-33

Andriacchi, T.P. 2014: SP0122Biomechanical Joint Homeostasis: Mechanisms in Health, Aging and Oa. Annals of the Rheumatic Diseases 73(Suppl 2): 33.1-33

Lems, W.F. 2014: SP0124Osteoporosis and Bone Diseases. Annals of the Rheumatic Diseases 73(Suppl 2): 34.1-34

Mckenna, F. 2014: SP0125Management of Fibromyalgia. Annals of the Rheumatic Diseases 73(Suppl 2): 34.2-34

Sieper, J. 2014: SP0126How to Treat (HOT) Spondyloarthritis?. Annals of the Rheumatic Diseases 73(Suppl 2): 34.3-34

Pascual-Salcedo, D. 2014: SP0127Basic Concepts: Analysis of Anti-Drug Antibodies and Serum Concentrations of Biologicals. Annals of the Rheumatic Diseases 73(Suppl 2): 35.1-35

Mulleman, D. 2014: SP0128Is Therapeutic Drug Monitoring Useful? A Review of the Literature. Annals of the Rheumatic Diseases 73(Suppl 2): 35.2-35

Haerle, P. 2014: SP0129How to Treat/Hot - Localized Rheumatic Syndromes. Annals of the Rheumatic Diseases 73(Suppl 2): 35.3-35

Doherty, M. 2014: SP0130How to Treat (HOT) Osteoarthritis an Evidence Based Overview. Annals of the Rheumatic Diseases 73(Suppl 2): 35.4-36

Buttgereit, F. 2014: SP0132How to Assess Glucocorticoid Confounding in the Context of Osteoporosis. Annals of the Rheumatic Diseases 73(Suppl 2): 36.2-36

Bombardieri, M. 2014: SP0133Raise for Impact: Epstein-Barr Virus in Rheumatic Patients. Annals of the Rheumatic Diseases 73(Suppl 2): 36.3-37

Cutolo, M. 2014: SP0134Glucocorticoids and the Rheumatic Organism: Sunset or Sunrise?. Annals of the Rheumatic Diseases 73(Suppl 2): 37.1-37

Mastbergen, S. 2014: SP0135From Small to Large Animal Models of Oa: Relevance to Clinical Practice. Annals of the Rheumatic Diseases 73(Suppl 2): 37.2-37

Kurowska-Stolarska, M. 2014: SP0137Mirs in Activation of Myeloid Cells in RA. Annals of the Rheumatic Diseases 73(Suppl 2): 37.4-37

Hewlett, S. 2014: SP0138Rheumatoid Arthritis Flare is More than a High Joint Count: Patient Perspectives on Flare. Annals of the Rheumatic Diseases 73(Suppl 2): 37.5-38

Fautrel, B. 2014: SP0139A Tool to Identify Past or Present Rheumatoid Arthritis Flare from Both Patient and Physician Perspective. Annals of the Rheumatic Diseases 73(Suppl 2): 38.1-38

Bartlett, S.J. 2014: SP0140Outcome Measures in Rheumatology (OMERACT): Status on the Flare Assessment Work. Annals of the Rheumatic Diseases 73(Suppl 2): 38.2-38

Andrén, C. 2014: SP0141Ask the Patient. Distinguishing Your Symptoms. Annals of the Rheumatic Diseases 73(Suppl 2): 38.3-38

Mandl, P. 2014: SP0142Developing Eular Recommendations for the Use of Imaging in Spondyloarthritis Clinical Practice: Background and Process. Annals of the Rheumatic Diseases 73(Suppl 2): 38.4-38

Terslev, L. 2014: SP0143Ten Eular Recommendations for Use of Imaging in Spondyloarthritis Clinical Practice. Annals of the Rheumatic Diseases 73(Suppl 2): 38.5-39

Naredo, E. 2014: SP0144Overview of Future Eular Projects in Musculosketal Imaging. Annals of the Rheumatic Diseases 73(Suppl 2): 39.1-39

Østergaard, M. 2014: SP0145Mri: Introduction to Image Acquisition and Basic Physics. Annals of the Rheumatic Diseases 73(Suppl 2): 39.2-39

Markus, B. 2014: SP0148The Network of Parents with Children Who Have Arthritis in Germany. Annals of the Rheumatic Diseases 73(Suppl 2): 40.1-40

O'shaughnessy, S. 2014: SP0149Growing up A Teenager with Juvenile Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 40.2-40

Backström, M. 2014: SP0150The Care of Teenagers with JIA - Efforts Done to Improve the Transition Process in Finland. Annals of the Rheumatic Diseases 73(Suppl 2): 40.3-40

Damjanov, N. 2014: SP0151Comorbidity in Rheumatic Diseases. Annals of the Rheumatic Diseases 73(Suppl 2): 40.4-41

Buttgereit, F. 2014: SP0152 Novel Glucocorticoids and Glucocorticoid Receptor Ligands: Teaching Old Drugs New Tricks. Annals of the Rheumatic Diseases 73(Suppl 2): 41-41

Bianchi, G. 2014: SP0153 Pathophysiology and Management of Glucorticoid Induced Osteoporosis. Annals of the Rheumatic Diseases 73(Suppl 2): 41-41

Pascual Gomez, E. 2014: SP0155Eular Gout Treatment. Annals of the Rheumatic Diseases 73(Suppl 2): 41.4-42

Mallen, C.D. 2014: SP0156Improving Access to Rheumatologist for Patients with Inflammatory Arthritis: What Role Should the GP Play?. Annals of the Rheumatic Diseases 73(Suppl 2): 42.1-42

Fautrel, B. 2014: SP0157Which Option is the Most Cost-Effective?. Annals of the Rheumatic Diseases 73(Suppl 2): 42.2-42

Raza, K. 2014: SP0158Why do Patients Delay in Seeking Help. Annals of the Rheumatic Diseases 73(Suppl 2): 42.3-42

Barczyk-Kahlert, K. 2014: SP0160Regulatory Functions of Macrophages. Annals of the Rheumatic Diseases 73(Suppl 2): 43.1-43

Darrah, E. 2014: SP0161Functional Consequences of Anti-Pad-Antibodies in RA. Annals of the Rheumatic Diseases 73(Suppl 2): 43.2-43

Van Der Woude, D. 2014: SP0162ACPA Fine Specificities: What do They Really Mean?. Annals of the Rheumatic Diseases 73(Suppl 2): 43.3-43

Kania, G. 2014: SP0164Inflammatory-Driven Myocardial Fibrosis the Role of Inflammatory Progenitors. Annals of the Rheumatic Diseases 73(Suppl 2): 43.5-44

Semb, A.G.P. 2014: SP0165How to Evaluate Cardiovascular Risk in Patients with Inflammatory Joint Disease A Review of the Evidence. Annals of the Rheumatic Diseases 73(Suppl 2): 44.1-44

Primdahl, J. 2014: SP0166How to Implement Systematic Cardio-Vascular Risk Assessment in Outpatients with Inflammatory Arthritis in Nursing Consultations in Accordance with the Eular Recommendations A Danish Example. Annals of the Rheumatic Diseases 73(Suppl 2): 44.2-44

Ikdahl, E. 2014: SP0167How to Secure Cardiovascular Risk Factor Recording in Patients with Inflammatory Joint Diseases in Rheumatology Outpatient Clinics A Norwegian Example. Annals of the Rheumatic Diseases 73(Suppl 2): 45.1-45

Diekhoff, T. 2014: SP0169Mri of Sacroiliitis - How to Increase Sensitivity. Annals of the Rheumatic Diseases 73(Suppl 2): 45.3-45

Herrick, A. 2014: SP0170Clinical Manifestations of Raynaud's Phenomenon during Different Ages. Annals of the Rheumatic Diseases 73(Suppl 2): 45.4-45

Smith, V. 2014: SP0171How to Differentiate Normal from Abnormal Capillaroscopic Patterns and Its Role in Distinguishing between Primary and Secondary Rp. Annals of the Rheumatic Diseases 73(Suppl 2): 45.5-46

Cutolo, M. 2014: SP0172The Predictive and Prognostic Power of the Capillaroscopic Analysis. Annals of the Rheumatic Diseases 73(Suppl 2): 46.1-46

Sulli, A. 2014: SP0173Manual and Semi Automatic Identification and Scoring of the Qualitative Capillaroscopic Patterns in Systemic Sclerosis. Annals of the Rheumatic Diseases 73(Suppl 2): 46.2-46

Sokka-Isler, T. 2014: SP0174Co- or Multimorbidities. Growing Older with an Rmd. Annals of the Rheumatic Diseases 73(Suppl 2): 47.1-47

Mau, W. 2014: SP0175Services Provided by Patient Associations for People with RMDS Who Are Growing Old in Europe. Annals of the Rheumatic Diseases 73(Suppl 2): 47.2-47

Ioulianos, C. 2014: SP0176Healthy Aging! Preventing Falls in People with RMDS. Annals of the Rheumatic Diseases 73(Suppl 2): 47.3-47

Dobrin, M. 2014: SP0177An RMD Senior Facing Life Working Challenges with Professionalism. Annals of the Rheumatic Diseases 73(Suppl 2): 47.4-47

Perez-Ruiz, F.P. 2014: SP0178Gout and Crystal-Induced Diseases: Year in Review 2013-2014. Annals of the Rheumatic Diseases 73(Suppl 2): 47.5-48

Vettori, S. 2014: SP0179Biological Changes in Early Systemic Sclerosis. Annals of the Rheumatic Diseases 73(Suppl 2): 48.1-48

Khanna, D. 2014: SP0180How do We Treat Early Ssc: Consequences for Clinical Practice. Annals of the Rheumatic Diseases 73(Suppl 2): 48.2-48

Schett, G. 2014: SP0181Bone Loss in RA- Why Both Cytokines and ACPA Matter. Annals of the Rheumatic Diseases 73(Suppl 2): 48.3-48

Haugeberg, G. 2014: SP0182Can We Prevent Bone Loss in Rheumatoid Arthritis by Modern Treatment with Biologics?. Annals of the Rheumatic Diseases 73(Suppl 2): 48.4-48

Bultink, I. E. 2014: SP0183 Multifactorial Pathogenesis of Osteoporosis in Sle. Annals of the Rheumatic Diseases 73(Suppl 2): 48-49

Hofer, M. 2014: SP0184How to Treat/Manage Juvenile Idiopathic Arthritis JIA and Other Paediatric Diseases. Annals of the Rheumatic Diseases 73(Suppl 2): 49.1-49

Marzo-Ortega, H. 2014: SP0185How to Treat Psoriatic Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 49.2-49

Tobias, A. 2014: SP0188Statistical Interaction, Friend or Foe?. Annals of the Rheumatic Diseases 73(Suppl 2): 49.5-50

Humrich, J.Y. 2014: SP0189Induction of Remission by Low-Dose IL-2-Therapy in One SLE Patient with Increased Disease Activity Refractory to Standard Therapies. Annals of the Rheumatic Diseases 73(Suppl 2): 50.1-50

Thomas, R. 2014: SP0191Live Attenuated Vaccines in Rheumatic Diseases. Annals of the Rheumatic Diseases 73(Suppl 2): 50.3-50

Straub, R.H. 2014: SP0192Energy Metabolism and Chronic Inflammatory Rheumatic Diseases. Annals of the Rheumatic Diseases 73(Suppl 2): 50.4-50

Chawla, A. 2014: SP0193Physiologic Functions of Innate Immunity in Metabolic Homeostasis. Annals of the Rheumatic Diseases 73(Suppl 2): 50.5-51

Thombs, B.D. 2014: SP0194Leveraging an Innovative TRIAL Design for A Rare Disease Context: the Cohort Multiple RCT (CMRCT) Design. Annals of the Rheumatic Diseases 73(Suppl 2): 51.1-51

Kwakkenbos, L. 2014: SP0195Measurement Considerations in Cross-National Studies: Translation and Assessment of Metric Equivalencies. Annals of the Rheumatic Diseases 73(Suppl 2): 51.2-51

Mouthon, L. 2014: SP0196Delivering an Online Disease-Specific Rehabilitation Intervention: Examples from the SPIN Hand Project. Annals of the Rheumatic Diseases 73(Suppl 2): 51.3-51

Voorneveld-Nieuwenhuis, J.H.E. 2014: SP0198Vaccination YES or No, When Having A Rheumatic Disease?. Annals of the Rheumatic Diseases 73(Suppl 2): 51.5-52

Kyriakides, L. 2014: SP0199Overcoming the outside and Inner Barriers A Personal Experience of Travelling with an Rmd. Annals of the Rheumatic Diseases 73(Suppl 2): 52.1-52

Burkhardt, H. 2014: SP0200What is New in Psoriatic Arthritis?. Annals of the Rheumatic Diseases 73(Suppl 2): 52.2-52

Compston, J. E. 2014: SP0201 Usefulness and Limitations of DXA for Diagnosing Osteoporosis. Annals of the Rheumatic Diseases 73(Suppl 2): 52-52

van den Bergh, J. 2014: SP0202 How to Measure Bone Quality in Daily Practice?. Annals of the Rheumatic Diseases 73(Suppl 2): 52-52

Roux, C. 2014: SP0203Vertebral Fracture Assessment. Annals of the Rheumatic Diseases 73(Suppl 2): 52.5-52

Stone, J.H. 2014: SP0205Igg4-Related Disease. Annals of the Rheumatic Diseases 73(Suppl 2): 53.2-53

Buchbinder, R. 2014: SP0206Generalising from Clinical Trials to Treatment Recommendations. Annals of the Rheumatic Diseases 73(Suppl 2): 53.3-53

Raychaudhuri, S. 2014: SP0207Translating Genetic Findings into Applications for Individual Patients. Annals of the Rheumatic Diseases 73(Suppl 2): 53.4-53

Peterfy, C. 2014: SP0208Mri Comes of AGE for Clinical Trials in Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 53.5-53

Østergaard, M. 2014: SP0209Technical Validity of MRI for Evaluating Joint Damage and Inflammation in Rheumatoid Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 53.6-54

Maksymowych, W.P. 2014: SP0210Advanced Imaging in Clinical Trials for Spondyloarthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 54.1-54

Gaber, T. 2014: SP0211Effects of Hypoxia on Immune Cells. Annals of the Rheumatic Diseases 73(Suppl 2): 54.2-54

Distler, O. 2014: SP0212Hypoxia, Fibroblasts and Systemic Sclerosis. Annals of the Rheumatic Diseases 73(Suppl 2): 54.3-54

Van Der Meer, J.W. 2014: SP0213Clinical and Pathogenetic Aspects of Autoinflammatory Syndromes. Annals of the Rheumatic Diseases 73(Suppl 2): 55.1-55

Niedermann, K. 2014: SP0214Differences across Europe in the Delivery of Patient Education What Should BE Done?. Annals of the Rheumatic Diseases 73(Suppl 2): 55.2-55

Voshaar, M.J.H. 2014: SP0215Patients' Perspective of Patient Education-What is in IT for Us?. Annals of the Rheumatic Diseases 73(Suppl 2): 55.3-55

Zangi, H.A. 2014: SP0216The Evidence for Patient Education in Inflammatory Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 55.4-56

Ndosi, M. 2014: SP0217Eular Points to Consider for Patient Education of People with Inflammatory Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 56.1-56

Betteridge, N.J. 2014: SP0218Making the CASE for Rheumatic Diseases (RMDS) at the EU Level. Annals of the Rheumatic Diseases 73(Suppl 2): 56.2-56

Caeyers, N.P. 2014: SP0219Patient Involvement in Research: Flemish Training of 18 Patient Research Partners. Annals of the Rheumatic Diseases 73(Suppl 2): 56.3-56

Rocha, A. Cristina, S.; Almeida, C. Marisa, R.; Basto, M. Clara, P.; Vasconcelos, M. Teresa, S.D. 2014: SPE sample pre-treatment using a mixed-mode sorbent of reverse-phase and ionic exchange for determination of ALMWOAs in waters. International Journal of Environmental and Analytical Chemistry 94(3): 233-246

Geurts, J.; Paul, J.; Barg, A.; Kretzschmar, M.; Pagenstert, G.; Hügle, T.; Valderrabano, V. 2014: SPECT/CT imaging of ankle osteoarthritis: enhanced osseous tracer uptake due to subchondral intramembranous bone formation. Osteoarthritis and Cartilage 22: S284-S285

Xu, X; Ouyang, J; Li, W; Liu, Q 2014: SPH simulations of 2D transient viscoelastic flows using Brownian configuration fields. Journal of Non-Newtonian Fluid Mechanics 208-209: 59-71

Vitulo, P.; Callari, A.; Martino, L.; Stanziola, A.; Oggionni, T.; Meloni, F.; Confalonieri, M.; Libertucci, D.; Rottoli, P.; Poscia, R.; Badagliacca, R.; Vizza, D.C. 2014: SPHERIC-1 (Sildenafil and Pulmonary HypERtension in COPD): Intention-to-Treat (ITT) Analysis of Safety and Efficacy Data. Journal of Heart and Lung Transplantation 33(4): S148-S149

Ghotbinejad, M; Khosropour, A R.; Mohammadpoor-Baltork, I; Moghadam, M; Tangestaninejad, S; Mirkhani, V 2014: SPIONs-bis(NHC)-palladium(II): A novel, powerful and efficient catalyst for Mizoroki Heck and Suzuki Miyaura CC coupling reactions. Journal of Molecular Catalysis A: Chemical 385: 78-84

Lasslop, G; Thonicke, K; Kloster, S 2014: SPITFIRE within the MPI Earth system model: Model development and evaluation. Journal of Advances in Modeling Earth Systems 6(3): 740-755

Garnett, J. P. 2014: SPLUNC1: link between acidity and dehydration of the airway surface liquid in CF. Thorax 69(11): 1004-1004

Adiani, V; Gupta, S; Padole, R; Variyar, P S.; Sharma, A 2014: SPME-GCMS integrated with chemometrics as a rapid non-destructive method for predicting microbial quality of minimally processed jackfruit (Artocarpus heterophyllus) bulbs. Postharvest Biology and Technology 98: 34-40

Raymaekers, D.; Garcia, A.; Di Bella, C.; Beget, M.E.; Llavallol, C.; Oricchio, P.; Straschnoy, J.; Weiss, M.; Baret, F. 2014: SPOT-VEGETATION GEOV1 biophysical parameters in semi-arid agro-ecosystems. International Journal of Remote Sensing 35(7): 2534-2547

Aitkenhead, M 2014: SPOT-VEGETATION 15 years of success: whats next?. International Journal of Remote Sensing 35(7): 2397-2401

Bao, N; Lechner, A; Fletcher, A; Erskine, P; Mulligan, D; Bai, Z 2014: SPOTing long-term changes in vegetation over short-term variability. International Journal of Mining Reclamation and Environment 28(1): 2-24

Mishra, S K.; Tripathi, S N.; Choudhary, V; Gupta, B D. 2014: SPR based fibre optic ammonia gas sensor utilizing nanocomposite film of PMMA/reduced graphene oxide prepared by in situ polymerization. Sensors and Actuators B, Chemical 199: 190-200

Garibo, D.; Campbell, K.; Casanova, A.; de la Iglesia, P.; Fernández-Tejedor, M.; Diogène, J.; Elliott, C.T.; Campàs, M. 2014: SPR immunosensor for the detection of okadaic acid in mussels using magnetic particles as antibody carriers. Sensors and Actuators B, Chemical 190: 822-828

Statkus, T; Martinkus, V 2014: SPRAUSTINI POLI, APKRAUT VERTIKALIosiomis GNIUDYMO APKROVomis, smlinio pagrindo NUOSDI TEORINIS IR EKSPERIMENTINIS TYRIMAS; Experimentaland theoretical research of deformation of vertically loaded displacement piles in sand s;. Mokslas - Lietuvos Ateitis 6(5): 493-498

Della Ventura, G.; Marcelli, A.; Bellatreccia, F. 2014: SR-FTIR Microscopy and FTIR Imaging in the Earth Sciences. Reviews in Mineralogy and Geochemistry 78(1): 447-479

Mai, P. M.; Thingbaijam, K. K. S. 2014: SRCMOD: An Online Database of Finite-Fault Rupture Models. Seismological Research Letters 85(6): 1348-1357

KIM, I-Joong; WHANG, K-Young; KWON, H-Yoon 2014: SRT-Rank: Ranking Keyword Query Results in Relational Databases Using the Strongly Related Tree. Ieice Transactions on Information and Systems E97.D(9): 2398-2414

Zhou, W; Lal, B K.; Li, Z; Kyriakides, T; Matsumura, J; Lederle, F A.; Freischlag, J 2014: SS1. Predictors and Outcomes of Endoleaks in the OVER trial. Journal of Vascular Surgery 59(6): 21s-22s

He, Y; Desart, K; Butler, K; Irwin, A; Nelson, P R.; Berceli, S A. 2014: SS11 Geometric Remodeling of Vein Bypass Grafts and the Impact on Graft Failure. Journal of Vascular Surgery 59(6): 27s-28s

Mehta, M; Kahn, M; Paty, P S.K.; Hnath, J; Kreienberg, P B.; Shan, M; Byrne, J; Feustel, P J. 2014: SS14 Endovascular Treatment of Common Femoral Artery Occlusive Disease in 167 Consecutive Patients: Midterm Analysis. Journal of Vascular Surgery 59(6): 28s-29s

Wang, G.; Guo, Q.; Chen, D.; Liu, Z.; Zheng, X.; Xu, A.; Yang, S.; Ding, G. 2018: Facile and Highly Effective Synthesis of Controllable Lattice Sulfur-Doped Graphene Quantum Dots via Hydrothermal Treatment of Durian. Acs Applied Materials and Interfaces 10(6): 5750-5759

Friedell, M; VanWay, C; Freyberg, R; Almenoff, P 2014: SS18 The Effect of Beta Blockade on Operative Mortality: Harmful or Helpful?. Journal of Vascular Surgery 59(6): 30s-31s

Hicks, C W.; Canner, J K.; Arhuidese, I; Qazi, U; Glebova, N O.; Freischlag, J A.; Malas, M B. 2014: SS20 Mortality Benefits of Different Hemodialysis Access Types Are Age-Dependent. Journal of Vascular Surgery 59(6): 31s-32s

Likes, K; Orlando, M S.; Mirza, S; Salditch, Q; Cohen, A; Lum, Y W.; Reifsnyder, T; Freischlag, J 2014: SS24 Lessons Learned in the Surgical Treatment of Neurogenic Thoracic Outlet Syndrome over 10 years. Journal of Vascular Surgery 59(6): 33s-34s

DeMartino, R R.; Eldrup-Jorgensen, J; Hoel, A W.; Beck, A W.; Hallett, J W.; Upchurch, G R.; Cronenwett, J L.; Goodney, P P. 2014: SS25 Participation in the Vascular Quality Initiative (VQI) Is Associated With Improved Perioperative Medication Use and Longer Patient Survival. Journal of Vascular Surgery 59(6): 34s-35s

Gillespie, D L.; Cherry, K J.; Evans, T; Corpus, R; Rasmussen, T 2014: SS26 Civilian/Military Collaboration in the Management of Military Vascular Trauma: A 10-year Report of the SVS Volunteer Program. Journal of Vascular Surgery 59(6): 35s-36s

Sobel, J D.; Vartanian, S M.; Gasper, W J.; Grenon, M; Rapp, J H.; Hiramoto, J S.; Chuter, T A.; Reilly, L M. 2014: SS3. Factors Associated With Spinal Cord Ischemia After Multibranched Endovascular Thoracoabdominal Aneurysm Repair. Journal of Vascular Surgery 59(6): 22s-23s

Carson, J S.; Xiong, W; Worth, J M.; Meisinger, T; Dale, M; Yu, F; Klassen, L W.; Duryee, M J.; Hunter, C D.; Anderson, D R.; Thiele, G M.; Baxter, T 2014: SS5. Antibodies Against Malondialdehyde-Acetaldehyde Adducts Can Identify Patients With Abdominal Aortic Aneurysm. Journal of Vascular Surgery 59(6): 23s-24s

Lawrence, P F.; Klausner, J Q.; Harlander-Locke, M P.; Coleman, D M.; Stanley, J C.; Oderich, G S.; Inui, T S.; Mell, M W.; Humphries, M; Bove, P G.; Abularrage, C J.; Feezor, R J.; Azarbal, A F.; Smeds, M R.; Ladowski, J S.; Hsiang, Y N.; Dominguez, J A.; Morasch, M D. 2014: SS7. The Contemporary Guidelines for Asymptomatic Renal Artery Aneurysms Are Too Aggressive: A North American Experience. Journal of Vascular Surgery 59(6): 24s-25s

Shukla, A J.; Eid, R; Fish, L; Avgerinos, E; Marone, L; Makaroun, M; Chaer, R 2014: SS8. Contemporary Outcomes of Intact (iVAA) and Ruptured (rVAA) Visceral Artery Aneurysm Repair. Journal of Vascular Surgery 59(6): 25s-26s

He, F.; Jiao, H.; Tian, Y.; Zhao, L.; Liao, X.; Fan, Z.; Liu, B. 2018: Facile and large-scale synthesis of curcumin/PVA hydrogel: effectively kill bacteria and accelerate cutaneous wound healing in the rat. Journal of Biomaterials Science. Polymer Edition 29(4): 325-343

Minasidis, G.; Hatzigeorgiou, G.D.; Beskos, D.E. 2014: SSI in steel frames subjected to near-fault earthquakes. Soil Dynamics and Earthquake Engineering 66: 56-68

Wilbanks, T J.; Ebi, K L. 2014: SSPs from an impact and adaptation perspective. Climatic Change 122(3): 473-479

Schubert, C. 2014: SSR 2014: Australian Research Reins in Assisted Reproduction. Biology of Reproduction 91(6): 130-130

Adeyemo, O; Omidiji, O 2014: SSR-based and carotenoid diversity assessment of tropical yellow endosperm maize inbred lines. Plant Genetic Resources 12(01): 67-73

Hester, D. 2014: ST depression. Canadian Medical Association Journal 186(8): 617-617

Altabbakh, H; AlKazimi, M A.; Murray, S; Grantham, K 2014: STAMP Holistic system safety approach or just another risk model?. Journal of Loss Prevention in the Process Industries 32: 109-119

Hovden, R; Wolf, S E.; Holtz, M E.; Muller, D A.; Estroff, L A. 2014: STEM Characterization of Nano-Crystallites in the Nacre Biomineralization of Mollusk Shells (Pinna nobilis). Microscopy and Microanalysis 20(S3): 1332-1333

White, E. R.; Kerelsky, A; Jasmin, G; Hubbard, W A.; Mecklenburg, M; Regan, B. C. 2014: STEM EBIC to Study 2D Materials. Microscopy and Microanalysis 20(S3): 172-173

Nellist, P D; Yang, H; Lozano, J G; Pennycook, T J; Hirsch, P B 2014: STEM Optical Sectioning for Imaging Screw Displacements in Dislocation Core Structures. Microscopy and Microanalysis 20(S3): 86-87

Wang, Q; Zhu, Y; Huang, J; Han, Y 2014: STEM Tomography and Surface Plasmon Imaging of a Au-Pd Bi-metallic Nanorod with Exotic Morphology. Microscopy and Microanalysis 20(S3): 622-623

Winters, J V. 2014: STEM graduates, human capital externalities, and wages in the U.S. Regional Science and Urban Economics 48: 190-198

Smith, T. L.; Bowers, M. L.; De Graef, M.; Mills, M.J. 2014: STEM-Based Characterization of Dislocations and Stacking Faults in Structural Materials. Microscopy and Microanalysis 20(S3): 1032-1033

Anjum, D H.; Li, L 2014: STEM-EDS Characterization of Platinum-Modified Nickel Nanoparticles. Microscopy and Microanalysis 20(S3): 478-479

Zhang, W; Davis, K O.; Schoenfeld, W V.; Looney, P; Wang, F 2014: STEM-EELS Studies of the Local Structure and Coordination of Al2O3/Si interfaces in Si Solar Cells. Microscopy and Microanalysis 20(S3): 396-397

Sina, M.; Pereira, N.; Amatucci, G. G.; Cosandey, F. 2014: STEM/EELS Analysis of Conversion Reactions in Cycled FeOF/C. Microscopy and Microanalysis 20(S3): 190-191

Zhu, Y; Wang, B; Liu, X; Wang, H; Wu, H; Licht, S 2014: STEP organic synthesis: an efficient solar, electrochemical process for the synthesis of benzoic acid. Green Chemistry 16(11): 4758-4766

Scott, A. 2014: STEPS to Safety Culture Excellence. Occupational Medicine 64(5): 395-395

Cappello, S; Mancini, G; Pistone, A; Azzaro, M; Bottino, F; Genovese, L; Iannazzo, D; Luciano, A; Mamo, A; Neri, G; Galvagno, S; Santisi, S; Visco, A; Yakimov, M M. 2014: STRANgE, integrated physicalbiologicalmechanical system for recovery in of the oil spill in Antarctic environment. Reviews in Environmental Science and Bio/Technology 13(4): 369-375

Geza, M; Lowe, K S.; McCray, J E. 2014: STUMODa Tool for Predicting Fate and Transport of Nitrogen in Soil Treatment Units. Environmental Modeling and Assessment 19(3): 243-256

med. Homberg, V. 2014: SUDEP unter Beobachtung im Monitoring verstehen wir den Tod?. Info Neurologie and Psychiatrie 16(2): 24-25

Kang, F; Cournède, P-Henry; Lecoeur, Jérémie; Letort, Véronique 2014: SUNLAB: A functionalstructural model for genotypic and phenotypic characterization of the sunflower crop. Ecological Modelling 290: 21-33

Ismail Ozkaya, S 2014: SUPERPOSEAn excel visual basic program for fracture modeling based on the stress superposition method. Computers and Geosciences 64: 41-51

Burguete, J.; Lacasta, A.; García-Navarro, P. 2014: SURCOS: A software tool to simulate irrigation and fertigation in isolated furrows and furrow networks. Computers and Electronics in Agriculture 103: 91-103

Golshan, F.; Mohammadi, K. 2014: SVD-based digital image watermarking using adaptive generated watermark. Imaging Science Journal 62(1): 3-10

Pasolli, E; Melgani, F; Tuia, D; Pacifici, F; Emery, W J. 2014: SVM Active Learning Approach for Image Classification Using Spatial Information. IEEE Transactions on Geoscience and Remote Sensing 52(4): 2217-2233

De Lisi, S.; Crosignani, A.; Roffi, L.; Rossi, S.; Boccaccio, V.; Zermiani, P.; Maisonneuve, P.; Bruno, S. 2014: SVR is associated with no risk reduction of HCC development in patients with HCV-related cirrhosis. A prospective, up-to 23 years, cohort follow-up study. Digestive and Liver Disease 46: E33-E34

Baydaroğlu, Özlem; Koçak, Kım 2014: SVR-based prediction of evaporation combined with chaotic approach. Journal of Hydrology 508: 356-363

Javed, K; Gouriveau, R; Zerhouni, N 2014: SW-ELM: A summation wavelet extreme learning machine algorithm with a priori parameter initialization. Neurocomputing 123: 299-307

Texier, I.; Dudnik, G.; Kristensen, J.N.; Laurenza, M.; Lymperopoulos, L.; Soudris, D.; Saxby, C.; Navarro, T.; Di Francesco, F.; Salvo, P.; Romanelli, M.; Benhamou, P.Y.; Muller, M. 2014: SWAN-iCare : prise en charge des plaies de pied diabtique par pression ngative et monitoring distance de la cicatrisation. Annales D'endocrinologie 75(5-6): 391-392

Ficklin, D L.; Barnhart, B L. 2014: SWAT hydrologic model parameter uncertainty and its implications for hydroclimatic projections in snowmelt-dependent watersheds. Journal of Hydrology 519: 2081-2090

Park, J-Yoon; Yu, Y-Seok; Hwang, S-Jin; Kim, C; Kim, S-Joon 2014: SWAT modeling of best management practices for Chungju dam watershed in South Korea under future climate change scenarios. Paddy and Water Environment 12(1 Suppl): 65-75

Gangsheng Wang, M E. Barber… 2014: SWAT modeling with uncertainty and cluster analyses of tillage impacts on hydrological processes. Stochastic Environmental Research and Risk Assessment 28(2): 225-238

Fu, C; James, A L.; Yao, H 2014: SWAT-CS: Revision and testing of SWAT for Canadian Shield catchments. Journal of Hydrology 511: 719-735

Memarian, H; Balasundram, S K.; Abbaspour, K C.; Talib, J B.; Boon Sung, C Teh; Sood, A Mohd 2014: SWAT-based hydrological modelling of tropical land-use scenarios. Hydrological Sciences Journal 59(10): 1808-1829

Tanaka, T. 2014: SY1-4: Dosing and monitoring GH treatment in Turner syndrome. Growth Hormone and Igf Research 24: S1-S2